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Abstract 
 
Under normal physiological conditions, insulin is released from the pancreas in 
response to an increase in blood-sugar concentration. The insulin signalling 
pathway culminates with the presentation of the glucose transporter GLUT4 on 
the plasma membrane of muscle and adipose tissue, leading to the uptake of 
glucose into these tissues and the subsequent lowering of blood-glucose 
concentration to basal levels. This system is faulty in patients with Type 2 diabetes. 
SNARE proteins have been identified as important regulators of membrane fusion 
in vivo. Formation of SNARE complexes has been shown to provide the energy 
required for two opposing membranes to fuse. The SNARE complex consisting of 
Syntaxin 4, SNAP-23 and VAMP 2 has been implicated in the fusion of GLUT4 
Storage Vesicles (GSVs) with the plasma membrane of adipocytes in response to 
insulin, and thus unravelling the interactions involved in complex formation will 
allow a greater understanding into the translocation of GLUT4 in response to 
insulin. 
In this thesis I developed an in vitro fusion assay, which confirmed that the SNARE 
complex consisting of Syntaxin 4, SNAP-23 and VAMP 2 is able to sustain fusion of 
two vesicle populations. This assay was utilised further to investigate the role of 
the SM protein Munc-18c on SNARE-mediated membrane fusion. Using this 
method, Munc-18c was shown to have both positive and negative regulatory roles, 
depending on experimental conditions. Site-directed mutagenesis of the SM 
protein was also used in an attempt to dissect the interactions involved in binding 
of the SM protein to the assembled SNARE complex. 
Finally, I developed a second in vitro fusion assay which utilised isolated plasma 
membrane fractions from 3T3-L1 adipocytes. This assay was used to investigate the 
effect of insulin on the plasma membrane proteins found in these cells. Analysis of 
the fractions showed that insulin increased the rate of SNARE-mediated membrane 
fusion; however the levels of the t-SNAREs were unaltered in response to insulin, 
indicating that the hormone functions to alter protein structure or function, but 
not amount.
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1 Introduction 
1.1 Membrane trafficking 
The plasma membrane of eukaryotic cells serves two important functions: to 
provide a physical barrier between a cell and its neighbouring environment, and to 
carefully regulate the transport of molecules to and from the extracellular 
environment in order to maintain homeostasis inside the cell. Membranes are also 
important inside the cell: each organelle within the cell (for example, the nucleus or 
the endoplasmic reticulum (ER)) is encompassed by a lipid membrane which, 
similar to the plasma membrane, carefully regulates transport into and out of each 
organelle. 
Early experiments into the transport of newly synthesised secretory proteins in 
pancreatic cells showed that before reaching the plasma membrane, the peptide 
chains were trafficked in vesicles through a series of organelle (Palade, 1975). This 
carefully controlled mechanism of vesicle trafficking highlights both the spatial and 
temporal regulation which is required to ensure that vesicle cargo reaches its 
intended destination. 
One system controlled in such a fashion is the translocation of the glucose 
transporter GLUT4 to the plasma membrane upon stimulation by insulin. After a 
meal, the increase in blood sugar causes the hormone insulin to be released from the 
pancreas. Insulin binds its receptor, triggering a signalling cascade which 
ultimately results in the translocation of GLUT4 Storage Vesicles (GSVs) from 
intracellular pools to the cell surface, where they dock and fuse with the plasma 
membrane (Cushman & Wardzala, 1980; Suzuki & Kono, 1980; Bryant et al, 2002). 
1.2 Membrane fusion 
Membranes are fluid structures, which contain lipids, proteins and carbohydrates. 
The ratio of components varies depending on the membrane, for example, retina 
rods contain roughly a 50:50 protein:lipid mix; however myelin is composed 
predominantly of lipid (Guidotti, 1972). Both lipids and proteins are important in 
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the trafficking of vesicles between cellular compartments, from signalling pathways 
to the budding of transport vesicles. 
Membrane fusion is neither spontaneous nor random. In close proximity, lipid 
bilayers experience strong electrostatic repulsion, which must be overcome before 
the two membranes can interact (Rand, 1981; Jahn et al, 2003). Furthermore, when 
the two bilayers do come together, water molecules around the hydrophilic head 
group of the lipid molecules create a repulsive force: the energy required to remove 
these water molecules from this favourable conformation is termed the hydration 
force (PH) and hinders spontaneous fusion between membranes (Rand, 1981). 
Removal of this water allows transition states to form, where the interface between 
the hydrophilic head groups and the hydrophobic tails is disrupted.  
Studies into membrane fusion by viral fusion proteins, such as haemagglutinin 
(HA), helped to define a fusion intermediate called hemifusion (Kemble et al, 1994). 
During hemifusion, the two proximal (outer) monolayers of the lipid bilayer 
interact, but the distal (inner) layers do not (Figure 1.1). Hemifusion is thought to 
help overcome the hydration force by bringing two opposing membranes together, 
allowing full lipid and content mixing to occur (Zimmerberg et al, 1993). Small 
molecules, such as Ca2+ and Mg2+, have been implicated in the dehydration of lipid 
head groups and aggregation of vesicles with high phosphatidylserine content 
through formation of trans complexes between lipids on opposing membranes 
(Portis et al, 1979). Membranes containing lipids with lower levels of hydration, 
such as phosphatidylethanolamine also promote interaction between bilayers 
(Zimmerberg et al, 1993). 
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Figure 1.1 The Mechanism of Hemifusion 
When two membranes come into close proximity (A and B), the proximal lipids from the two 
populations (shown in blue and red) mix – this is called hemifusion (C). After hemifusion, the 
two distal leaflets form a fusion stalk (D) which expands and allows the two membranes to 
merge (E).  
 
Unlike viral systems, where one protein (such as haemagglutinin found on the 
influenza virus (Kemble et al, 1994)) is able to sustain fusion, in intracellular 
membrane fusion, multiple proteins were found to regulate the system. One 
candidate family of proteins are the Soluble N-ethylmaleimide sensitive attachment 
protein receptors (SNAREs), which are thought to provide the energy required to 
overcome the energy barrier required for two opposing bilayers to fuse, as well as 
contributing to the specificity of membrane fusion. 
1.3 The SNARE hypothesis 
The SNARE hypothesis proposes that each trafficking event within cells is 
regulated by specific target (t-) and vesicle (v-) SNAREs. This hypothesis was 
based on the discovery of SNARE proteins, which were isolated from brain extract 
via their ability to bind NSF (N-ethylmaleimide sensitive factor) and its adapter 
protein α SNAP (soluble NSF attachment protein), two proteins known to play a 
role in synaptic vesicle fusion (Söllner et al, 1993; 1993b; see also Section 1.8.1). 
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Following this discovery, members of the SNARE superfamily were discovered out 
with brain tissue, leading to the hypothesis that almost all fusion events in 
intracellular trafficking pathways are mediated by SNARE protein (Chen & 
Scheller, 2001). 
Experiments utilising the neuronal SNARE proteins Syntaxin 1a, SNAP-25 and 
VAMP 2 in an in vitro fusion assay identified that four helical SNARE domains 
(three helixes donated by the t-SNAREs and one by the v-SNARE) interact to form 
a SNARE complex, the “minimal machinery” necessary for membrane fusion 
(Weber et al, 1998). This is discussed in more detail in Section 1.7. 
Initially, SNARE proteins were classified according to the membrane they reside in, 
either the target (t-SNAREs) or vesicle (v-SNARE). However, elucidation of the 3D 
structure of the neuronal SNARE complex showed that the central ionic layer of 
the helical bundle contained three glutamine (Q) residues and one arginine (R), 
leading to the reclassification of SNARE proteins as either R- or Q-SNAREs 
depending on which residue they contribute to this polar region (Fasshauer et al, 
1998). 
1.4 Syntaxins (Qa SNARE) 
Syntaxins are a family of Qa SNARE proteins which were first identified in neurons 
(Inoue et al, 1992) and characterised as -SNAP binding proteins (Bennett et al, 
1992).  Syntaxin 1 was the first to be identified as being involved in the docking of 
synaptic vesicles (Bennett et al, 1992), but since then more family members have 
been identified. Syntaxins are localised to different membrane compartments, and 
function at different stages of trafficking pathways. For example, Syntaxin 16 is a 
Golgi t-SNARE which is involved in the recycling of GLUT4 from the recycling 
endosome to the trans-Golgi network (Simonsen et al, 1994), whilst Syntaxin 4 is 
found on the plasma membrane and regulates the fusion of GLUT4 Storage Vesicles 
(GSVs) with the plasma membrane in response to insulin signalling (Tellam et al, 
1997). 
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With the exception of Syntaxin 11, all Syntaxin family members are transmembrane 
proteins, anchored at their C-terminus (Teng et al, 2001). The cytoplasmic domain 
of Syntaxin proteins contains a conserved coiled-coil SNARE domain, which is 
involved in the formation of SNARE complexes (Section 1.7) and, in some 
Syntaxins, a regulatory Habc domain at the N-terminus which consists of three 
anti-parallel helices (Fernandez et al, 1998). The Habc domain is able to regulate 
SNARE complex formation by the adoption of two distinct conformations, termed 
open and closed (Figure 1.2). In the open conformation the Habc is separated from 
the SNARE domain, allowing the Syntaxin to interact with its cognate partners 
and form a SNARE complex. However, in the closed conformation, the Habc 
domain folds back onto the SNARE domain, creating a physical barrier which 
prevents SNARE complex formation (Dulubova et al, 1999). 
 
Figure 1.2 (A) Schematic structure and (B) proposed conformations of Syntaxins 
Some Syntaxin proteins are able to form two distinct conformations: a closed conformation 
where the Habc domain autoinhibits binding to the SNARE domain, and second open 
conformation where the Habc domain is spatially removed from the SNARE domain, 
allowing SNARE complex formation. 
 
1.5 SNAP-25 proteins (Qb and Qc SNARE) 
Synaptosome-associated protein of 25 kiloDaltons (SNAP-25) was the first 
identified SNAP protein (Oyler et al, 1989), and was implicated in neurotransmitter 
release. In mammalian systems, three other SNAP proteins have been identified; 
SNAP-23 (Ravichandran et al, 1996), SNAP-29 (Steegmaier et al, 1998) and SNAP-47 
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(Holt et al, 2006). These SNAP-25 homologues are ubiquitously expressed, unlike 
SNAP-25 which is mainly found in neuronal tissue. 
SNAP-25 family members have a unique structure amongst SNARE proteins. They 
contain two Q-SNARE domains which are termed Qb and Qc. These two SNARE 
domains are separated by a flexible linker region which contains a cluster of 
cysteine residues. Rather than being inserted into the membrane via a 
transmembrane domain (as is the case for Syntaxins and Synaptobrevins), most 
family members associate with the membrane by post-translational palmitoylation 
of these cysteine residues (Hess et al, 1992). Both SNARE domains of SNAP-25 
family proteins are contributed to the SNARE complex, as deletion of one or both 
SNARE domains inhibits neurotransmitter release in neurons (Yang et al, 2000). 
1.6 Synaptobrevins (R SNARE) 
Vesicle-associated membrane proteins (VAMPs) are members of the Synaptobrevin 
family of R-SNAREs. VAMPs are the smallest members of the SNARE family, and 
consist of a C-terminal transmembrane domain followed by a SNARE domain and a 
non-conserved N-terminus. 
Multiple VAMP isoforms have been identified, each functioning at different fusion 
events in different membrane compartments. VAMP 2 has been located in the 
membranes of both synaptic vesicles (Südhof et al, 1995) and GLUT4 storage 
vesicles (Martin et al, 1996), indicating a more generic role in the mechanism of 
exocytosis. Other VAMP isoforms have a more specialised role, including VAMP 7 
which transports GLUT4 to the plasma membrane in response to osmotic shock, 
and VAMP 8 which is involved in retrograde transport of GLUT4 from the plasma 
membrane to the recycling endosome (Williams & Pessin, 2008). 
1.7 SNARE complex formation and membrane fusion 
In 1993, the publication of two studies laid the foundation for what later became 
known as the SNARE hypothesis. The first study identified that the proteins 
Syntaxin 1, SNAP-25 and VAMP 2 formed a complex with NSF and α SNAP, two 
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proteins known to play a role in membrane fusion (Glick & Rothman, 1987; Clary et 
al, 1990). As Syntaxin 1 is localised to the plasma membrane, and VAMP 2 to the 
synaptic vesicle membrane, it was postulated that this complex may contribute to 
the fusion of synaptic vesicles with the presynaptic membrane (Söllner et al, 1993). 
This was further developed in a second study, which purified a stable complex 
consisting of stoichiometric amounts of Synatxin 1, SNAP-25 and VAMP 2 from 
brain membrane extract. This complex was found to bind both α SNAP and a 
second protein called Synaptotagmin, believed to be a calcium sensor. By 
monitoring the association and dissociation of Synaptotagmin with the protein 
complex, a sequential series of events was postulated, including vesicle fusion, 
activation and docking (Söllner et al, 1993b). 
Membrane fusion is a multi-step process, starting with the disassembly of SNARE 
complexes formed in the previous round of fusion.  SNARE complexes are 
incredibly stable, and thus energy (in the form of ATP) is required to disrupt the 
complex. After SNARE complex assembly and membrane fusion, N-ethylmaleimide 
Sensitive Factor (NSF), an ATPase and Soluble NSF Attachment Protein (SNAP) 
bind to the cis-SNARE complex, releasing the SNAREs and allowing another round 
of fusion to occur (Söllner et al, 1993b). The free t-SNAREs are then able to recruit 
their cognate v-SNAREs causing the vesicle to dock on the plasma membrane. 
Upon docking of the vesicle, the t- and v-SNAREs interact to form the stable 
SNARE complex (Figure 1.3). Elucidation of the crystal structure of the neuronal 
SNARE complex (consisting of soluble fragments of Syntaxin 1, SNAP-25 and 
VAMP 2) showed that the SNARE domains of the proteins orientate parallel, with 
the N-termini at one end of the bundle, and the C-termini at the other (Sutton et al, 
1998). 
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Figure 1.3 The Neuronal SNARE Complex 
The 3D structure of a truncated (cytosolic SNARE domains only) neuronal SNARE complex, 
containing Syntaxin 1 (red), VAMP (blue) and the Qb and Qc domains of SNAP-25 (green 
and yellow respectively). PDB ID: 1N7S (Ernst & Brunger, 2003). 
 
Further to the main SNARE complex, the high resolution crystal structure 
highlighted some grooves on the outside of the SNARE complex which, similar to 
transcription factors with DNA, may indicate binding sites for effector proteins, 
such as α SNAP (Sutton et al, 1998). 
1.8 Regulation of SNARE-mediated membrane fusion 
Studies using recombinant SNAREs reconstituted into synthetic liposomes 
identified SNARE complexes as the “minimal machinery” required for bilayer 
fusion to occur, however the rate observed for these reactions was slower than that 
observed in vivo (hours in vitro compared to minutes physiologically), indicating that 
other factors are necessary to recreate the fast fusion event observed in cells 
(Weber et al, 1998).  
1.8.1 NSF and SNAP 
NSF was identified as a cytosolic protein which was able to restore vesicle 
transport to the Golgi apparatus in a cell-free system (Glick & Rothman, 1987). 
When active, NSF exists as a homo-hexamer with subunits of 76 kDa (Block et al, 
1988) with each subunit containing two ATP binding sites (Wilson et al, 1989). 
NSF was initially believed to activate membrane fusion (Malhotra et al, 1988) 
however subsequent study showed that its effect on membrane fusion was to 
disassemble SNARE complexes, priming them for another round of fusion (Söllner 
et al, 1993b; Hayashi et al, 1995). 
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Although implicated in the dissociation of SNARE complexes, NSF does not 
directly bind to the complex. Instead, it functions through an adapter protein 
called Soluble NSF Attachment Protein; SNAP (Weidman et al, 1989; Clary et al, 
1990). Upon cis-SNARE complex formation and membrane fusion, three SNAP 
molecules bind to the surface of the SNARE complex (Rossi et al, 1997; Wimmer et al, 
2001). The N-terminus of NSF subsequently binds to the SNAP/cis-SNARE 
complex (Hohl et al, 1998), where ATP-hydrolysis dissociates the SNARE bundle, 
allowing subsequent rounds of fusion to occur (Söllner et al, 1993b). 
1.8.2 Sec1/Munc-18 (SM) proteins 
Sec1/Munc-18 (SM) proteins were initially identified through genetic screening 
uncoordinated mutants of the nematode Caenorhabditis elegans (Brenner, 1974). One 
of the genes identified encoded the protein unc-18, which was discovered to play a 
role in the transport of acetylcholine in motor neurons (Gengyo-Ando et al, 1993). 
Orthologues of unc-18 were subsequently identified in Saccharomyces cerevisiae 
(Novick & Schekman, 1979), Drosophila melanogaster (Salzberg et al, 1993) and 
mammalian systems (Hata et al, 1993). 
SM proteins are 60-70 kDa proteins, found both in the cytosol and associated with 
membranes via their interaction with membrane-bound proteins. Studies in 
neuronal tissue identified Syntaxins as major binding partners of SM proteins 
(Pevsner et al, 1994), however defining their role as either positive or negative 
regulators has been controversial. Initial studies into the functional interactions 
between the neuronal t-SNARE Syntaxin 1 and its cognate SM partner Munc-18a 
indicated that the SM protein functioned as a negative regulator, by preventing the 
SNARE protein from forming SNARE complexes (Dulubova et al, 1999). This was 
supported by in vivo studies in 3T3-L1 adipocytes which showed that 
overexpression of the SM protein Munc-18c inhibited insulin-stimulated GLUT4 
translocation (Thurmond et al, 1998). However, subsequent studies showed that 
Munc-18a is essential for neurotransmitter release in vivo (Verhage et al, 2000). 
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In order to explain these apparently contradictory functions of SM proteins, it was 
hypothesised that different SM proteins may bind to their SNARE proteins in 
different ways. To date, three potential binding modes being identified: a binary 
interaction between the closed Syntaxin and Munc-18 (Mode 1, Section 1.8.2.1); an 
interaction between the Syntaxin N-terminal peptide and Munc-18c via a 
hydrophobic pocket on the SM protein (Mode 2, Section 1.8.2.2); and an interaction 
between the SNARE complex and the SM protein (Mode 3, Section 1.8.2.3).  
1.8.2.1 Mode 1 
Elucidation of the crystal structure of Syntaxin 1 bound to Munc-18a (nSec1) led to 
the identification of the first binding mode between SM proteins and Syntaxins 
(Misura et al, 2000). This structure identified Munc-18a as an arch-shaped molecule 
with three domains, which contains a 15 Å central cavity. In Mode 1 binding, this 
cavity “clamps” over the closed Syntaxin molecule, holding it in a non-functional 
conformation, preventing the SNARE domain from binding to its cognate partners 
(Figure 1.4). 
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Figure 1.4 Mode 1 binding between Munc-18a and Syntaxin 1 
(A) The 3D structure of the SM protein Munc-18a and the cytosolic domain of Syntaxin 1 
(PDB ID: 3C98) and (B) a schematic showing how the SM protein “clamps” over the closed 
Syntaxin, holding it in an inactive conformation. Munc-18a is shown in purple; the SNARE 
domain of Syntaxin 1 in red and the Habc domain in pink. Figure (A) was created using 
RasMol software. 
This interaction is strong, as a mutant of Syntaxin 1 which is unable to form the 
“closed” conformation displays reduced binding to Munc-18a (Dulubova et al, 1999). 
Not all Syntaxin/SM protein pairs exhibit Mode 1 binding, as some Syntaxins are 
unable to form this closed conformation. 
 
1.8.2.2 Mode 2 
Determination of the structure of the yeast SM protein Sly1p in complex with the 
N-terminal peptide of the Golgi Syntaxin Sed5p showed a second mode of binding 
which did not utilise the central cavity of the SM protein (Bracher et al, 2002). 
Instead, this second binding mode, Mode 2, involved binding of the N-terminal 
peptide of Sed5p to a small hydrophobic pocket on domain 1 of Sly1p (Figure 1.5). 
This binding mode has also been observed between the mammalian t-SNARE 
Syntaxin 4 and Munc-18c (Hu et al, 2007). 
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Figure 1.5 Mode 2 binding between Sly1p and Sed5p 
(A) The 3D structure of the SM protein Sly1p bound to the N-terminal peptide of Sed5p, a 
yeast t-SNARE (PDB ID: 1MQS) and (B) a schematic showing the full-length Syntaxin in its 
“open” conformation, allowing the SM protein to bind to the N-terminus of the protein via its 
hydrophobic pocket (displayed in green). Residues found in this pocket are conserved between 
some SM proteins, but not all, suggesting that this binding mode is semi-conserved. Figure (A) 
was created using RasMol software. 
 
Like Mode 1 binding, Mode 2 binding is not observed between all cognate 
SNARE/SM pairs. Sequence comparisons have shown that if an SM protein 
contains a hydrophobic pocket, its cognate SNARE partner will most likely have an 
N-terminal domain (Hu et al, 2007). 
Investigations into the functional role of Mode 2 binding showed that by abolishing 
this binding mode, the function of Sly1p is not affected (Peng et al, 2004). This is 
also true for a second yeast SM protein, Vps55p (Carpp et al¸2006). This has 
implied that this second binding mode is perhaps facilitative, rather than essential 
(Burgoyne and Morgan, 2007). However, in Caenorhabditis elegans a mutant of the 
protein UNC-18 which disrupts Mode 2 binding (F113R) is unable to rescue 
neurotransmitter release in unc-18 knockout worms, indicating that in this 
organism Mode 2 binding is essential for correction neuronal function. The varying 
results obtained from disruption of Mode 2 binding indicate that the physiological 
relevance of this binding mode is complex (Munson and Bryant, 2009). 
 
Kimberley Boney, 2013  Chapter 1, 26 
 
1.8.2.3 Mode 3 
Experiments using the yeast t-SNARE Ssop and its cognate SM protein Sec1p 
showed that the SM protein displayed weak binding to monomeric Ssop; instead it 
bound to the t-SNARE complex (containing Ssop and Sec9p) and the assembled 
SNARE complex (Carr et al, 1999; Scott et al, 2004). Subsequently, it was discovered 
that although this t-SNARE could adopt an inhibitory “closed” conformation, it 
was unable to bind the SM protein in this form. This led to the classification of a 
third binding mode between SNAREs and SM proteins, termed Mode 3. In this 
mode, the SM protein binds to the ternary SNARE complex, possibly with 
stimulatory effects (Scott et al, 2004). This binding mechanism is the least studied 
of the three; however it has been discovered that the mammalian SM protein  
Munc-18c is able to bind its cognate SNARE complex in this manner (Latham et al, 
2006). Studies using the neuronal SM protein Munc-18a have given contradictory 
results, with some showing that Munc-18a is able to bind to the ternary SNARE 
complex (Zilly et al, 2006), however others have shown that it is unable to do so 
(Yang et al, 2000). 
1.8.2.4 Other SM-SNARE binding modes 
As well as binding monomeric t-SNAREs, some SM proteins have been found to 
interact with v-SNAREs. The yeast SM protein Vps45p, which functions at the 
TGN/early endosome, has been shown to bind to the v-SNARE Snc2p in a way that 
can be out-competed with the t-SNARE Tlg2p (Carpp et al, 2006). Similarly,  
Munc-18c can bind to the v-SNARE VAMP 2 (Brandie et al, 2008). 
1.9 In vitro liposome fusion assay 
The discovery that SNAREs are able to form stable, exothermic complexes led to 
the hypothesis that the formation of such complexes would be sufficient to 
overcome the repulsive forces which prevent fusion. To test this hypothesis, a 
FRET-based liposome fusion assay was utilised (Struck et al, 1981). Full-length t- 
and v-SNAREs were purified, and reconstituted into two populations of liposomes. 
t-SNARE complexes were reconstituted into non-fluorescent “acceptor” liposomes, 
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whilst the v-SNARE was reconstituted into a second, fluorescent “donor” 
population. This fluorescent population took advantage of the overlap in the 
excitation/emission spectra of two fluorophores; (N-(7-nitro-2,1,3-benzoxadiazol-
4-yl)-1,2-dipalmitoylphosphatidylethanolamine (NBD-DPPE) and (N-(lissamine 
rhodamine B sulphonyl))-1,2-dipalmitoylphosphatidylethanolamine (Rhodamine-
DPPE). These flurophores are attached to the lipid head groups of the donor 
population, and when excited by light, the energy emitted by the NBD is absorbed 
by the Rhodamine. If fusion occurs between the two vesicle populations through 
formation of a functional SNARE complex, then the two flurophores should be 
diluted in the larger merged lipid membrane, thus preventing FRET from occurring. 
This allows a direct correlation between rate of fusion and NDB fluorescence 
(Weber et al, 1998; Figure 1.6). 
 
Figure 1.6 Liposome Fusion Assay 
The fusion assay utilises two populations of vesicles, one of which contains the flurophores 
NBD (shown in yellow) and Rhodamine (pink). Before fusion occurs, the flurophores are in 
close proximity, causing the energy emitted by the NBD to be absorbed by the Rhodamine 
when excited at 485 nm. After fusion occurs, the flurophores become diluted in the larger 
population of non-labelled lipids, causing them to separate and the energy emitted by the 
NBD can be measured at 520 nm. 
 
This technique was used to show that the t-SNAREs Syntaxin 1 and SNAP-25 and 
the v-SNARE VAMP 2 were the “minimal machinery” required for membrane 
fusion to occur (Weber et al, 1998). The assay can also be developed further to 
identify the effects of different factors on SNARE complex formation. For example, 
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addition of Munc-18a to the in vitro fusion assay stimulated the rate of SNARE-
mediated fusion (Shen et al, 2007), with later experiments identifying that the SM 
protein may function by recruiting VAMP 2 to the t-SNAREs as well as positioning 
the N-terminal domain of Syntaxin 1 in a position which allows SNARE complex 
formation to occur (Rodkey et al, 2008). The function of other chaperones has also 
been tested in this manner, for example, Ca2+-dependent activator protein for 
secretion (CAPS) was shown to bind to Syntaxin 1 and stimulate SNARE complex 
formation in the presence of Ca2+ and synaptotagmin (James et al, 2009). It is also 
possible to alter the lipid composition of the liposomes to better match that found 
physiologically (Mima et al, 2008), making it possible to manipulate the assay to 
allow for the study of various biological factors which may affect SNARE protein 
function.  
1.10 Glucose transport 
Glucose is a monosaccharide which is used as the primary energy source in 
mammalian cells. As glucose is highly hydrophilic, it is unable to pass through the 
plasma membrane by simple diffusion; instead a family of specialised glucose 
transporters (GLUTs) are required to provide cells with this preferred energy 
source (Bell et al, 1990). There are 13 members of the GLUT protein family (Joost et 
al, 2001), which vary in their affinities for glucose and tissue localisation. GLUT4 is 
the insulin-regulated glucose transporter and is primarily found in muscle and 
adipose tissue (James et al, 1988). 
1.11 GLUT4 translocation in response to insulin 
1.11.1 Intracellular localisation of  GLUT4 
Studies in rat adipocytes showed that stimulation with insulin caused a 
translocation of the glucose transporters within these cells to the plasma 
membrane (Cushman & Wardzala, 1980; Suzuki & Kono, 1980). cDNA sequence 
comparison and reaction with a monoclonal antibody identified the transporter as 
GLUT4 and the primary glucose transporter in muscle and adipose tissue (James et 
al, 1988). 
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GLUT4 is found in multiple organelles due to its trafficking between different 
cellular compartments (Bryant et al, 2002). Studies into the co-localisation of 
GLUT4 with the transferrin receptor (TfR, a marker for the recycling endosome) 
showed that under basal conditions, around 40 % of cellular GLUT4 is found 
cycling between endosomes and the plasma membrane in the constitutive recycling 
pathway (Livingstone et al, 1996). This leads to the presence of a small amount of 
GLUT4 on the cell surface, allowing basal glucose uptake under resting conditions. 
However, chemical destruction of endosomes in adipocytes does not affect insulin-
stimulated glucose transport, indicating that this recycling pathway is not 
responsible for insulin-responsive GLUT4 translocation (Martin et al, 1998). 
The remaining GLUT4 is found in a second pathway, trafficking between the 
endosomes and the trans-Golgi network (TGN), where it co-localises with the       t-
SNAREs Syntaxin 6 and 16 but not with the transferrin receptor (Shewan et al, 
2003). Upon insulin stimulation, this second pool is mobilised to the plasma 
membrane, increasing the quantity of GLUT4 on the plasma membrane around    
10-fold. This allows for increased glucose uptake from the bloodstream, lowering 
blood-glucose to basal levels. Termination of insulin signalling causes the GLUT4 
to again be sequestered away from the plasma membrane, and the levels of glucose 
uptake to return to basal.  
1.11.2 The effect of  insulin on GLUT4 trafficking 
Unlike GLUT proteins found in other tissues which are constitutively found on the 
cell surface, GLUT4 sub-cellular distribution in fat and muscle cells is highly 
regulated; large increases in GLUT4 are observed at the cell surface within minutes 
of stimulation (Bryant et al, 2002). The mechanism by which GLUT4 reaches the 
plasma membrane is complex, and two theories have been proposed to explain how 
insulin signalling causes the mobilisation of the transporter: these are termed 
dynamic exchange and static retention. 
The dynamic exchange model proposes that GLUT4 is constantly being cycled 
between the plasma membrane and intracellular compartments. Upon insulin 
stimulation, the rate of GLUT4 exocytosis to the cell surface is increased, and the 
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rate of endocytosis simultaneously decreased, leading to an increase in GLUT4 on 
the plasma membrane (Karylowski et al, 2004). 
The second model, static retention, proposes that GLUT4 is instead retained in 
distinct GLUT4 Storage Vesicle (GSVs) which are responsive to insulin. Thus, 
upon insulin stimulation, these GSVs are mobilised to the plasma membrane where 
they dock and fuse, increasing the amount of GLUT4 on the cell surface, and thus 
glucose transport into the cell with no effect on the kinetics of the recycling 
pathway (Govers et al, 2004; Coster et al, 2004).  
Although the mechanism by which GLUT4 is excluded from the plasma membrane 
is still unknown, TIRF (Total Internal Reflection) microscopy has been used to 
track the movement of fluorescently labelled GLUT4 in cells and pinpoint the 
location of insulin action.  Initial studies showed that GLUT4 moves along a 
cytoskeletal network adjacent to the plasma membrane. Upon insulin signalling 
this trafficking slows and the vesicles become tightly tethered to the plasma 
membrane, suggesting that insulin acts by regulating the tethering of GSVs to the 
cell membrane (Lizunov et al, 2005). These experiments were developed upon by 
further time-lapse TIRF microscopy, which identified distinct steps in GLUT4 
translocation to the plasma membrane in response to insulin: namely docking, 
priming and finally fusion of the GSVs with the membrane. These experiments also 
identified that the PKB substrate AS160 is responsible for GSV docking whereas 
insulin functions to prepare the GSVs for fusion post-docking (Bai et al, 2007). 
1.11.3 GLUT4 Storage Vesicles (GSVs) 
The discovery that ablation of recycling endosomes did not affect insulin-
stimulated GLUT4 translocation in 3T3-L1 adipocytes led to the hypothesis that a 
population of cellular GLUT4 was removed from the endosomal system, in a TfR-
negative compartment (Martin et al, 1998; Livingstone et al, 1996). Early electron 
microscopy studies indicated that the majority of GLUT4 in basal fat and muscle 
was located in a tubulo-vesicular system in the cytoplasm of the cells (Slot et al, 
1991), and that disruption of this cytokeletal system prevented long-range 
movement of GLUT4 (Fletcher et al, 2000). A novel EM technique, which used 
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intact adipocytes to obtain a 3D structure of organelle, built upon this data and 
indicated that in rat adipocytes, the majority of GLUT4 was located in vesicles 
which were distinct from early and late endosomes and the TGN (Ramm et al, 
2000). Similar observations were made in skeletal muscle, where two pools of 
GLUT4 exist: one co-localising with the endosomal marker TfR, and one which 
does not (Aledo et al, 1997). However, insulin stimulation was found to decrease the 
amount of GLUT4 in all intracellular locations, which indicates that the entire 
GLUT4 population contributes to insulin-stimulated GLUT4 translocation 
(Malide et al, 2000), which matches closer to mathematical models which propose 
that GLUT4 translocation is not a simple two-pool model (Holman et al, 1994). 
Further characterisation of the intracellular pool of GSVs indicated that this 
population may also contain functionally distinct vesicle pools: one containing the 
protein cellugyrin, and one which does not (Kupriyanova & Kandror, 2000). 
Cellugyrin is an isoform of Synaptogyrin, a neuronal phosphoprotein which is 
found in synaptic vesicles and may play a role in synapse plasticity (Baumert et al, 
1990; Janz et al, 1998; 1999). Synaptogyrin I is a potent inhibitor of exocytosis in 
transfected PC12 cells, suggesting that it functions as an inhibitor of regulated 
exocytosis (Sugita et al, 1999). Similarly, cellugyrin was found in a sub-population 
of GSVs which do not translocate to the plasma membrane upon insulin 
stimulation (Kupriyanova et al, 2002). This suggests that cellugyrin may also play a 
role in the regulation of insulin-stimulated GLUT4 translocation. 
The formation of insulin-responsive GSVs has also been linked to ubiquitination of 
GLUT4. Mutation of the seven cytosolic lysine residues on GLUT4 (7K-R) leads to 
a ubiquitin-resistant protein which is not correctly sorted into the GSV-rich 
fraction of 3T3-L1 adipocytes (Lamb et al, 2010). It is estimated that only 0.1 % of 
the total GLUT4 in these cells is ubiquitiated at any one time, indicating that this 
post-translational modification is transient, and that a deubiquitination event is 
required to prevent the trafficking of these GSVs from the trans-Golgi network to 
the lysosome for degredation (Lamb et al, 2010). 
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1.12 GLUT4-specific SNARE and SM proteins 
1.12.1 Syntaxin 4 
Syntaxin 4 was first identified as an isoform of the neuronal protein Syntaxin 1, and 
was found to have a much more ubiquitous distribution within cells, compared to 
the neuronal (Bennett et al, 1993) and, to a lesser extent, renal (Li et al, 2003) 
expression of Syntaxin 1. Syntaxin 4 was found on the plasma membrane of 3T3-L1 
adipocytes, and addition of a Syntaxin 4-specific antibody prevented insulin-
stimulated GLUT4 translocation, implicating this protein as the Syntaxin isoform 
involved in the docking and fusion of GSVs with the plasma membrane (Rea et al, 
1998, Volchuk et al, 1996). The importance of Syntaxin 4 was further emphasised by 
the generation of Syntaxin 4 knockout mice (Yang et al, 2001). Homozygotic 
knockout (Syn4-/-) resulted in embryonic lethality, whilst heterozygotic mice 
(Syn4-/+) were viable. However, these mice exhibited a 50 % reduction in glucose 
uptake, which was linked to a decrease in insulin-stimulated glucose uptake in 
their skeletal muscle (Yang et al, 2001). 
Sub-cellular fractionation showed that in red and white skeletal muscle, Syntaxin 4 
was located in plasma membrane-enriched fractions (Sumitani et al, 1995). In     
3T3-L1 adipocytes, around two-thirds of the cellular Syntaxin 4 was located at the 
plasma membrane, further suggesting that this protein plays a role in regulated 
exocytosis (Volchuk et al, 1996). 
1.12.2 SNAP-23 
In the SNARE hypothesis, it is proposed that two of the SNARE domains are 
donated by a SNAP-25 homologue (Söllner et al, 1993b). SNAP-25 is predominantly 
expressed in neuronal tissue (Ravichandran et al, 1996) and is not detectable in 3T3-
L1 adipocytes (Chen et al, 1997), suggesting a role for another family member in GSV 
translocation. Yeast-two-hybrid assays were used to identify this isoform, and a    
23 kDa protein with 59 % sequence similarity to SNAP-25 was located 
(Ravichandran et al, 1996). This protein, SNAP-23, was found ubiquitously 
expressed and bound tightly to Syntaxin 4 and the cognate v-SNARE VAMP 2, 
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identifying is as an important regulator of fusion in mammalian cells (Ravichandran 
et al, 1996). 
SNAP-23 was linked to insulin-stimulated GSV exocytosis by the addition of a 
peptide chain comprising the C-terminal 24 residues. Addition of this peptide 
inhibited around 40 % of GSV translocation to the cell surface in response to 
insulin, without affecting GLUT1 translocation. The same result is observed when 
the cells are treated with an anti-SNAP-23 antibody (Rea et al, 1998). 
Redistribution of SNAP-23 within skeletal muscle cells has also been linked to 
insulin resistance (Boström et al, 2007; 2010). In the skeletal muscle of patients with 
Type 2 diabetes, SNAP-23 was found in microsomal/cytosolic cell fractions 
compared to the plasma membrane in control patients (Boström et al, 2010). 
In human neutrophils, a second isoform of SNAP-23 was discovered, named   
SNAP-23B (Mollinedo et al, 1997). This isoform differed from full-length SNAP-23 
by the deletion of 153 base pairs, causing omission of residues 90-142. This missing 
domain of SNAP-23B contains a recognition site for post-translational fatty acid 
acylation, indicating that this smaller isoform may have limited association with 
the plasma membrane of the cells (Mollinedo et al, 1997). 
1.12.3 VAMP 2 
VAMP 2 was initially located in synaptic vesicle membranes (Bauert et al, 1989), 
and was found to be part of the 20S particle postulated to be involved in synaptic 
vesicle fusion (Söller et al, 1993). VAMP 2 was the first SNARE protein implicated 
in the translocation of GLUT4 to the plasma membrane: GLUT4 and VAMP 2 were 
found to co-localise in transport vesicles in rat adipocytes (Cain et al, 1992), and 
translocated to the plasma membrane with the transporter upon insulin 
stimulation (Cain et al, 1992; Martin et al, 1996; 1998). Furthermore, introduction of 
VAMP 2 peptides into 3T3-L1 adipocytes (Millar et al, 1999), or cleavage of the v-
SNARE with botulinum toxin D resulted in a reduction in GLUT4 translocation 
upon insulin stimulation (Cheatham et al, 1996).  
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A second VAMP isoform, cellubrevin (VAMP 3), was also found to co-localise with 
GLUT4, but there is debate as to whether this v-SNARE is involved in GLUT4 
translocation in response to insulin. Addition of VAMP 3 peptides into 3T3-L1 
adipocytes did not affect the rate of insulin-stimulated GLUT4 translocation 
(Millar et al, 1999) and did not translocate to the plasma membrane with GLUT4 
upon stimulation (Volchuk et al¸ 1995; Martin et al, 1996) nor appear to regulate 
GSV fusion at the plasma membrane (Randhawa et al, 2000). However, mouse 
embryonic fibroblasts (MEFs) isolated from VAMP 2 knockout mice showed no 
decrease in the rate of insulin-stimulated GLUT4 translocation, with GLUT4 
translocation only being completely abolished with the disruption of VAMP 3 and 
VAMP 8 (Zhao et al, 2009). It has been postulated that these two pools of GSVs, 
one containing VAMP 2 and the other VAMP 3, are derived from two different 
compartments: one from an exocytotic compartment and one derived from the 
endosome (Martin et al, 1996). The results from these studies suggest some 
redundancy in the requirement for a specific v-SNARE in the insulin-stimulated 
translocation of GLUT4. 
1.12.4 Munc-18c 
Screening of a 3T3-L1 adipocyte cDNA library with a oligonucleotides 
corresponding to the 5’ and 3’ termini of rat brain Munc-18 identified the presence 
of three Munc-18 isoforms: Munc-18a, -18b and -18c (Tellam et al, 1995). Early 
experiments into the function of the SM proteins identified Munc-18c as having 
potential involvement in GSV translocation and fusion as it is able to bind to 
Syntaxin 4, which is found in 3T3-L1 adipocytes (Tellam et al, 1997). Binding 
between Syntaxin 4 and Munc-18c was further characterised and it was shown that 
the SM protein is able to bind to both the closed conformation of Syntaxin 4, and 
also a constitutively open (L173A/E174A) mutant (D’Andrea-Merrins et al, 2007). 
The binding between the open mutant and SM protein is mediated by the N-
terminal domain of Syntaxin 4, and also appears to be stabilised by an interaction 
between the SNARE domain of Syntaxin 4 and Munc-18c (Hu et al, 2007). It has 
also been demonstrated that Munc-18c is able to bind to the assembled Syntaxin 
4/SNAP-23/VAMP 2 SNARE complex (Brandie et al, 2008). 
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Although it has been shown that Munc-18c and Syntaxin 4 are able to interact, 
assigning functional significance to this interaction has been difficult. Initial 
experiments identified that binding of Munc-18c to Syntaxin 4 prevents the 
Syntaxin from binding to its cognate v-SNARE VAMP 2, suggesting that the SM 
protein may negatively regulate SNARE complex formation (Tellam et al, 1997). 
However, like most SM proteins, the role of Munc-18c in GLUT4 translocation is 
somewhat controversial. In vitro characterisation of Munc-18c aimed to assign the 
SM protein a function in fat and muscle cells: overexpression of Munc-18c in 3T3-L1 
adipocytes resulted in a decrease in insulin-stimulated GLUT4 translocation, 
confirming a negative role for the SM protein (Tamori et al, 1998). However, further 
testing revealed that overexpression of Munc-18c in 3T3-L1 adipocytes resulted in 
the SM protein co-localising with Syntaxin 4 under basal conditions, however the 
complex between the two proteins dissociated upon insulin stimulation 
(Thurmond et al, 1998). This suggests that Munc-18c functions as a negative 
regulator of fusion under basal insulin conditions, preventing Syntaxin 4 and 
VAMP 2 from forming fusogenic complexes in the absence of insulin. 
As understanding of SM/Syntaxin binding developed, the function of Munc-18c 
during insulin-stimulated GLUT4 translocation became less clear, and data began 
to suggest that Munc-18c may act as a positive regulator of GSV translocation and 
fusion. Homozygous knockout mice (Munc-18c -/-) were embryonic lethal, however 
heterozygous mice (Munc-18c -/+) were viable and displayed decreased insulin 
sensitivity and a large decrease in insulin-stimulated GLUT4 translocation 
compared to wild-type mice (Oh et al, 2005). Further to this, heterozygous Munc-
18c knockout was found to also inhibit glucose-stimulated insulin secretion in 
mouse islet cells (Oh & Thurmond, 2009). Disruption of the interaction between 
endogenous Munc-18c and Syntaxin 4 was also found to cause a decrease in the 
fusion of GSVs with the plasma membrane (Thurmond et al, 2000). 
The complexity of the interactions between Munc-18c and its cognate SNARE 
proteins have been subject to various studies which have tried to link the multiple 
binding modes observed between the proteins to the different functions observed 
within cells. Single-cell analysis using Fluorescence Correlation Spectroscopy 
Kimberley Boney, 2013  Chapter 1, 36 
 
(FCS) showed that Munc-18c is able to bind to Syntaxin 4 in cells under basal and 
insulin-stimulated conditions; however insulin-signalling caused repositioning of 
the SM protein on the Syntaxin, allowing the recruitment of other proteins 
involved in vesicle fusion (Smithers et al, 2008). This repositioning hypothesis is 
further supported by the observation that Mode 2 binding (between the SM 
protein and the N-terminal peptide of the Syntaxin) is the least specific binding 
mode, and confers minimal binding between the two proteins (Dulubova et al, 
2003); and also the 3D structure of the Syntaxin 4/ Munc-18c complex which 
shows that stabilisation of Mode 2 binding (between the SM protein and the        
N-terminus of the Syntaxin) requires an interaction with the SNARE domain of the 
Syntaxin protein (Hu et al, 2007).  
Munc-18c is also regulated at a post-translational level. Using a full-length     
Munc-18c probe, a cDNA screen was performed using human brain tissue; this 
identified the Protein Kinase C isoform zeta (PKCζ) as a binding partner of Munc-
18c, with the interaction between the proteins becoming three times stronger upon 
insulin stimulation (Hodgkinson et al, 2005). Developing on this, more 
phosphosites were discovered on Munc-18c, including Tyrosine 219 and Tyrosine 
521 (Oh & Thurmond, 2006; Umahara et al, 2008). More recently, the insulin 
receptor has been linked as a direct kinase of Munc-18c residue Tyr521 in an 
insulin-dependent manner, which also disrupts Munc-18c/Syntaxin 4 complexes 
(Jewell et al, 2011). 
1.12.5 Link with Type II diabetes 
Diabetes mellitus is a metabolic condition which is characterised as an inability of 
the body to clear high blood glucose after a meal. The condition was linked to a 
specific area of the pancreas, termed the Islets of Langerhans, and more specifically 
the beta cells in this region. The condition is sub-divided into two types 
(Himsworth, 1936); Type 1 diabetes is an autoimmune condition where the beta 
cells of the pancreas are destroyed, resulting in insulin deficiency; whilst Type 2 
diabetes is characterised as insulin resistance, rather than underproduction, as the 
Kimberley Boney, 2013  Chapter 1, 37 
 
body is still able to produce insulin but cells, in particular within fat, muscle and 
liver tissue, are unable to respond to this signal. 
Around 346 million people worldwide have diabetes, with 90 % of these having 
Type 2 (WHO estimate, 2011). In recent years, Type 2 diabetes has been 
increasingly linked to sedentary lifestyle, in particular a rise in the prevalence of 
obesity. However, the link between obesity and the development of Type 2 diabetes 
is complex, with more than one factor appearing important in the development of 
the disease. It has been proposed that an intake of fatty acids in the diet can affect 
the fatty acid composition of the cell membrane, and thus could potentially affect 
the function of the cell membrane and its components, including binding of insulin 
to its receptor, translocation of glucose transporters and second messenger 
signalling (Storlien et al, 1996; Vessby, 2000). 
The link between Type 2 diabetes, obesity and perturbed function of SNARE and 
SM proteins has not been fully characterised, however data is emerging identifying 
possible links between disease phenotype and SNARE/SM protein function. When 
fed a normal diet, heterozygous knockout (KO) mice were able to clear glucose 
from the bloodstream at a similar rate to wild-type mice; however when switched 
to a high fat diet the heterozygous KO mice showed low insulin sensitivity 
compared to wild-type mice on an identical high-fat diet, suggesting that a 
decrease in Munc-18c protein levels may lead to an increased susceptibility of 
developing Type 2 diabetes when a high fat diet is consumed (Oh et al, 2005). 
Furthermore, knockdown of the SNAREs involved in GLUT4 fusion with the 
plasma membrane indicate that Syntaxin 4 and SNAP-23 are indispensable for the 
tethering of GSVs to the plasma membrane in response to insulin (Kawaguchi et al, 
2010). 
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1.13 Aims of this thesis 
The aim of this project was to characterise the interactions between the SM protein 
Munc-18c and its cognate SNARE proteins, the v-SNARE VAMP 2 and the              
t-SNAREs Syntaxin 4 and SNAP-23. 
The first stage of this investigation was to reconstitute the SNAREs into liposomes, 
and to test the fusogenic ability of these proteins using an in vitro liposome fusion 
assay (Section 1.9 and Chapter 3).  
The second stage of this project involved assessing the fusion between the t- and   
v-SNARE vesicles in the presence of wild-type and mutant Munc-18c. Point 
mutations were made in Munc-18c with the aim of disrupting Mode 3 binding. The 
function of these mutants was assessed using both the liposome fusion assay and in 
vitro pull down assays using individual SNAREs and assembled SNARE complex. 
This aimed to narrow down the residues in the SM protein which are important in 
this (proposed) positive binding mode (Chapter 4). 
The final aim of this project was to establish a liposome fusion assay using proteins 
isolated from the plasma membranes of 3T3-L1 adipocytes, rather than recombinant 
proteins. This technique has been performed using SNAREs purified from primary 
rat adipocytes; however the aim was to establish this assay using a cell line so that 
any changes in the fusogenic abilities of SNARE proteins based on the knockdown 
of other proteins (which is easier to accomplish using cell lines than knocking out 
the gene in an animal) could be assessed (Chapter 5).  
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2 Materials and Methods 
2.1 Materials 
2.1.1 General reagents 
Avanti Polar Lipids, Alabaster, USA 
1,2-dioleoyl phosphatidyl serine (DOPS) 
(N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-1,2-dipalmitoylphosphatidylethanolamine 
(NBD) 
1-palmitoyl-2-oleoyl phosphatidyl choline (POPC) 
(N-(lissamine rhodamine B sulphonyl))-1,2-dipalmitoylphosphatidylethanolamine 
(Rhodamine) 
 
Applied Biosystems, Warrington, UK 
Nuclease-free Water 
 
BioRad Laboratories Ltd., Hemel Hempstead, Hampshire, UK 
BioBeads 
EcoPac Disposable Chromatography Columns 
Quick Start Bradford 1x Dye Reagent 
Broad Range Protein Markers 
 
Fischer Scientific UK Ltd., Loughborough, Leicestershire, UK 
2-[4-(2-hydroxyethyl)-1-piperazine] ethanesuphonic acid (HEPES) 
Chloroform 
Ethanol 
Ethidium Bromide 
Glycine 
Tris(hydroxymethyl)aminoethane Base (Tris Base) 
 
Formedium Ltd., Hunstanton, Norfolk, UK 
Bacterial Agar 
Tryptone 
Yeast Extract Powder 
 
GE Healthcare BioSciences, Chalfont, Buckinghamshire, UK 
Glutathione-S-Sepharose 4B 
 
Invitrogen Ltd., Paisley, UK 
One Shot Chemically Competent BL21 (DE3) E. coli 
One Shot Chemically Competent TOP10 E. coli 
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Kodak, Hemel Hempstead, Hertfordshire, UK 
X-ray film 
 
Melford Laboratories Ltd., Chelsworth, Ipswich, UK 
Dithiothreitol (DTT) 
Isopropyl--D-thiogalactopyranoside (IPTG) 
 
New England Bioscience (UK) Ltd., Hitchin, Hertfordshire, UK 
1 kb DNA Ladder 
100 bp DNA Ladder 
6x DNA Loading Buffer 
10x T4 DNA Ligase Buffer 
T4 DNA Ligase 
 
Premier Foods, Long Sutton, Spalding, Linconshire, UK 
Marvel Dried Milk Powder 
 
Promega, Southampton, UK 
100 mM dNTPs (dATP, dTTP, dGTP, dCTG) 
Alkaline Phosphatase (Shrimp) 
DpnI 
NcoI 
NdeI 
NheI 
Taq buffer 
Taq DNA Polymerase 
Wizard® Plus SV Minipreps DNA Purification System 
XhoI 
 
Qiagen Ltd., Crawley, West Sussex, UK 
Ni-NTA Agarose 
QIAfilter™ Plasmid Maxi Kit 
QIAquick Gel Extraction Kit 
 
Roche Diagnostic Ltd., Burgess Hill, UK 
Agarose MP 
Complete™ Protease Inhibitor Cocktail Tablets 
Complete™ EDTA-free Protease Inhibitor Cocktail Tablets 
 
Severn Biotech Ltd., Kidderminster, Worcestershire, UK 
30 % Acrylamide [Acrylamide: Bis-acrylamide ratio 37.5:1] 
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Sigma-Aldrich Ltd., Gillingham, Dorset, UK 
 ((5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N’-bis(2,3-
dihyrdoxypropyl)isophthalamide)) (Histodenz) 
Ammonium Persulphate 
Ampicillin 
-mercaptoethanol 
Bovine Serum Albumin (BSA) 
Brilliant BlueR 
Bromophenol Blue 
Dimethyl Suphoxide (DMSO) 
Ethylenediaminetetracetic Acid (EDTA) 
Ficoll 
Gelatin from Cold Water Fish Skin 
Glycerol 
Imidazole 
Isopropanol 
Kanamycin 
Methanol 
N,N,N’,N’-Tetramethylethylenediamine (TEMED) 
n-octyl--D-glucopyranoside (OG) 
Phenylmethylsulphonyl fluoride (PMSF) 
Polyoxyethylene Sorbitan Monolaurate (Tween20) 
Ponceau Stain 
Potassium Hydroxide (KOH) 
Reduced Glutathione 
Sodium Dodecyl Sulphate (SDS) 
Thrombin (Bovine) 
Triton-X100 
 
Spectrum Europe BV., Breda, The Netherlands 
Float-a-lyzer, 5 ml 5 kDa MWCO 
Float-a-lyzer, 5 ml 10 kDa MWCO 
Float-a-lyzer, 5 ml 50 kDa MWCO 
 
VWR International Ltd., Lutterworth, Leicestershire, UK 
Formaldehyde 
Glacial Acetic Acid 
Disodium hydrogen orthophosphate (Na2HPO4) 
Potassium Acetate 
Potassium Chloride (KCl) 
Potassium dihydrogen orthophosphate (KH2PO4) 
Silver Nitrate (AgNO3) 
Sodium Carbonate (Na2CO3) 
Sodium Thiosulphate (Na2S2O3) 
Sodium Chloride (NaCl) 
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2.1.2 General cell culture reagents 
Dulbecco’s Modified Eagle Medium (DMEM), Newborn Calf Serum (NCS) and 
Foetal Bovine Serum (FBS) were purchased from Invitrogen Ltd, Paisley. Porcine 
insulin, 3-isobutylmethylxanthine (IBMX) and Dexamethasone were purchased 
from Sigma-Aldrich Ltd. 
 
2.1.3 Escherichia coli strains 
All bacterial strains used are modfications of E. coli 
 
TOP10 F
- 
mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacΧ74 
recA1 araD139 Δ(ara-leu) 7697 galU galK rpsL (Str
R
) 
endA1 nupG λ-  
BL21 (DE3) F- ompT hsdSB (rB-mB-) gal dcm rne131(DE3) 
  
 
2.1.4 Primary antibodies 
Rabbit polyclonal Syntaxin 4 antiserum was purchased from Synaptic Systems 
(#110042) 
Rabbit polyclonal SNAP-23 antibody was purchased from Synaptic Systems 
(#111203) 
Rabbit polyclonal VAMP 2 antibody was purchased from Abcam (#ab18014) 
Rabbit polyclonal GLUT4 antibody was purchased from Synaptic Systems 
(#235003) 
Mouse monoclonal Munc-18c antibody was purchased from Abcam (#ab117632) 
2.1.5 Secondary antibodies 
Anti-rabbit and anti-mouse secondary antibodies were purchased from GE 
Healthcare (Buckinghamshire, UK) and used at a dilution of 1:2000.  
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2.1.6 General solutions 
Breaking Buffer 50 mM HEPES-KOH (pH 7.4), 400 mM 
KCl, 10 % (w/v) Glycerol, 4 % (v/v) 
Triton-X100, 2 mM -mercaptoethanol 
DNA Loading Buffer 40 % Ficol (w/v), 0.25 % Bromophenol 
Blue 
Coomassie Brilliant Blue Solution 0.25 g Coomassie Brilliant BlueR in H2O: 
Methanol: Glacial Acetic Acid (4.5:4.5:1 
v/v/v) 
Destain Solution 5 % (v/v) Methanol, 10 % (v/v) Glacial 
Acetic Acid 
ECL Solution A 100 mM Tris-HCl (pH 8.5), 2.25 mM 
Luminol, 0.4 mM p-Coumaric Acid, 1.4 % 
(v/v) DMSO 
ECL Solution B 100 mM Tris-HCl (pH 8.5), 0.018 % (v/v) 
H2O2 
Exchange/Reconstitution Buffer 25 mM HEPES-KOH (pH 7.4), 100 mM 
KCl, 10 % (w/v) Glycerol, 1 % (w/v)           
n-octyl--D-glucopyranoside, 2 mM          
-mercaptoethanol 
GST Elution Buffer 50 mM Tris (pH 8.8), 200 mM NaCl,         
25 mM Reduced Glutathione 
HES Buffer 20 mM HEPES-KOH (pH 7.4), 225 mM 
Sucrose, 1 mM EDTA, EDTA-free 
Complete™ Protease Inhibitor Tablets 
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High Sucrose HES Buffer 20 mM HEPES-KOH (pH 7.4), 1.12 M 
Sucrose, 1 mM EDTA, EDTA-free 
Complete™ Protease Inhibitor Tablets 
Phosphate Buffered Saline (PBS) 136 mM NaCl, 10 mM Na2HPO4, 2.5 mM 
KCl, 1.8 mM KH2PO4 pH 7.4 
PBS-T  PBS, 0.1 % (v/v) Tween-20 
SDS PAGE Electrode Buffer 25 mM Tris base, 190 mM Glycine,            
0.1 % (w/v) SDS 
SDS PAGE Loading Buffer 9.3 mM Tris-HCl (pH 6.8), 1 mM Sodium 
EDTA, 10 % (w/v) Glycerol, 2 % (w/v) 
SDS, 0.002 % (w/v) Bromophenol Blue,    
20 mM DTT 
SOC Media 2 % (w/v) Typtone, 0.5 % (w/v) Yeast 
Extract, 20 mM Glucose, 20 mM MgSO4, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2 
Superbroth 3.2 % (w/v) Tryptone, 2 % (w/v) Yeast 
Extract, 5 % NaCl 
TAE 40 mM Tris-acetate, 1 mM EDTA (pH 7.8) 
Terrific Broth 1.2 % (w/v) Tryptone, 2.4 % (w/v) Yeast 
extract, 0.4 % (v/v) Glycerol, 2.3 % (w/v) 
KH2PO4, 12.5 % (w/v) K2HPO4 
Thrombin Cleavage Buffer 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 
2.5 mM CaCl2 
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Transfer Buffer 192 mM Glycine, 25 mM Tris Base, 20 % 
(v/v) Methanol 
Wash Buffer 25 mM HEPES-KOH (pH 7.4), 400 mM 
KCl, 10 % (w/v) Glycerol, 1 % Triton-X100, 
2 mM -mercaptoethanol 
2 YT Medium 1.6 % (w/v) Tryptone, 1 % (w/v) Yeast 
Extract, 0.5 % (w/v) NaCl 
2 YT Agar 1.6 % (w/v) Tryptone, 1 % (w/v) Yeast 
Extract, 0.5 % (w/v) NaCl, 2 % (w/v) Agar 
2.2 Methods 
For all buffer compositions, please refer to Section 2.1.6. 
2.2.1 General Molecular Biology 
2.2.1.1 DNA amplification by Polymerase Chain Reaction (PCR) 
Appropriate forward and reverse oligonucleotide primers were designed to amplify 
the DNA sequence of interest and also containing the appropriate restriction sites. 
Primers were synthesised by York Bioscience Ltd, and routinely diluted to 50 pM 
with sterile water and stored at -20 °C. PCR reactions were set up on ice in thin 
walled PCR tubes using existing plasmid or genomic DNA as a template. The 
following general protocol was followed: 
Template DNA (~1 g/l) 1 l 
Forward Primer (5 pM) 1.5 l 
Reverse Primer 1.5 l 
10x DNA Polymerase buffer (containing 20 mM MgSO4) 5 l 
dNTP Mix (10mM each dATP, dTTP, dGTP, dCTP) 1 l 
Pfu Polymerase 1 l 
Nuclease Free Water 39 l 
  
PCR reactions were carried out in a thermocycler using the following standard 
conditions: 
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95 °C (initial denaturing)  2 min   
94 °C (denature)  1 min   
55 °C (primer annealing)  1 min 25-35 cycles 
72 °C (elongation)  2 min/kb  
72 °C (final elongation)  10 min   
4 °C (chill)  HOLD   
The melting temperature of the primers had to be taken into account when 
selecting the annealing temperature: the optimal annealing temperature is generally 
5 °C lower than the lowest melting temperature of the primers. After the PCR was 
finished a sample of the reaction was run on an agarose gel to check if the correct 
size product was formed. 
2.2.1.2 Site Directed Mutagenesis 
The desired mutations were incorporated into the forward and reverse primers, and 
a standard PCR was carried out with a few alterations: the elongation step was 
reduced to 68 °C for 1 min/kb and only 18 cycles were performed. After the reaction 
was complete 1 l of DpnI was added to the SDM mixture and incubated at 37 °C 
for 1 h to digest any methylated parental DNA. 10 l of the reaction mix was then 
transformed into TOP10 E. coli cells. Successful mutants were selected on antibiotic 
agar plates, and the DNA isolated from single colonies by small-scale DNA 
preparations (Section 2.2.1.6) and the mutant confirmed by DNA sequencing. 
2.2.1.3 DNA agarose Gel Electrophoresis 
Agarose powder (0.8 % w/v) was dissolved in TAE buffer by boiling in a microwave 
oven. Once the powder was totally dissolved the solution was allowed to cool to 
~50 °C before 10 µl Ethidium Bromide (1 % w/v) was added from a dropper bottle. 
This was mixed and then poured into a gel casting cassette containing the 
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appropriate loading comb, where it was left to polymerise. Once set, the gel was 
transferred to a horizontal gel tank containing TAE buffer. DNA samples were 
prepared in 6x DNA Loading Buffer (40 % (w/v) Ficoll, 0.25 % (w/v) Bromophenol 
Blue) were loaded into the wells alongside 0.5 µg of 1 kb DNA ladder (New England 
Biolabs). Electrophoresis was carried out at 100 volts and the gel visualised and 
recorded using a BioRad Molecular Imager ChemiDoc XRS+ System. 
2.2.1.4 Gel extraction/purification 
DNA samples were separated by agarose gel electrophoresis and products of the 
correct size were identified under UV light. Bands of interest were excised using a 
clean scalpel blade and placed in sterile eppendorf tubes. The DNA was then 
purified using the QIAGEN Gel Extraction Kit following the manufacturer’s 
instructions. Typically, 600 l of solubilisation buffer QC was added to each gel 
slice and the samples heated at 50 °C for 10 mins or until the gel slice had 
completely dissolved. Then, 200 l isopropanol was added and the solution 
transferred to a QIASpin Column. The column was spun at 14000g for 1 min and the 
flow through discarded. 750 l wash buffer PE was added and the column spun for 
a further minute and the flow through discarded. To remove any residual ethanol 
the column was spun for another minute before being transferred to a sterile 
eppendorf tube. 30 l nuclease free water was added to the centre of the column 
and incubated at room temperature for 1 min to maximise the amount of DNA 
eluted. The column was spun for 1 min at 14000g to collect the eluted DNA, which 
was typically stored at -20 °C. 
2.2.1.5 Transformation of E. coli cells 
Chemically competent cells were defrosted on ice for 15 mins. DNA was added (1-10 
µl) and the cells incubated on ice for a further 15 mins. The cells were then heat 
shocked for 1 min at 42 °C before recovering on ice for a further minute. 250 µl SOC 
media was added and the tubes incubated at 37 °C for at least 1 h with shaking. 
After incubation, the mixture was plated onto agar plates containing the 
appropriate antibiotic. The plates were inverted and incubated overnight at 37 °C. 
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2.2.1.6 Small-scale DNA preparations from E. coli (Miniprep) 
A single colony from a fresh bacterial transformation was used to inoculate 5 ml      
2 YT media containing the appropriate antibiotic, and the culture grown overnight 
with shaking at 37 °C. DNA purification was carried out using Promega Wizard® 
Plus SV Miniprep Kit. Cells were collected by centrifugation at 3000g for 5 mins in 
a refrigerated bench top centrifuge. The pellet was then resuspended in 250 l cell 
resuspension buffer and transferred to a sterile eppendorf tube. 250 l cell lysis 
buffer was added and the tubes mixed by inversion 4 times. Then, 10 l alkaline 
protease solution was added and the tubes again mixed by inversion. The mixture 
was incubated at room temperature for 5 mins. After this incubation, 350 l 
neutralisation solution was added and the sample mixed by inversion before being 
spun for 10 mins at 14000g in a microfuge. The cleared lysate was transferred to a 
Wizard® Plus spin column and centrifuged for 1 min at 14000g. The flow through 
was discarded and the column washed with firstly 750 l column wash solution 
(containing ethanol), then 250 l column wash solution, with the flow though 
being discarded after each spin. The columns were then spun for an additional 2 
mins to remove any residual column wash solution. The columns were then placed 
in sterile eppendorf tubes and 50 l nuclease free water was added to the centre of 
the column. These were then spun for 1 min to elute the DNA from the column. 
DNA concentration was determined using a spectrophotometer set at 260 nm and 
the DNA was generally stored at -20 °C. 
2.2.1.7 TOPO®-TA cloning  
High fidelity proof-reading PCR was used to amplify DNA, which was 
subsequently gel purified. Taq polymerase possesses terminal transferase activity 
which allows it to generate adenosine overhangs to the PCR product, allowing it to 
be cloned into linearised pCR®2.1-TOPO® vector (Invitrogen), which contains 
overhanging deoxythymidine residues. Reactions were set up as outlined: 
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Gel purified DNA 10 l 
10x Mg-free buffer 1 l 
MgCl2  0.6 l 
Taq polymerase 0.4 l 
dNTPs 0.4 l 
 
The reactions were incubated at 72 °C for 20 mins. 2 l of the mixture was cloned 
into the pCR2.1®-TOPO® vector using the pCRII-TOPO® kit (Invitrogen). The 
ligation mixture was then transformed into TOP10 cells and successful 
transformation selected for on 2 YT agar plates containing the appropriate 
antibiotic and X-Gal at a concentration of 0.04 g/ml. The DNA from white 
colonies was isolated by mini DNA preparation and sequenced to ensure the 
correct sequence was cloned. 
2.2.1.8 Sequencing 
Sequencing of DNA samples was carried out by the University of Dundee 
Sequencing Service and was generally performed after the generation of new DNA 
(PCR, SDM). 
2.2.1.9 Restriction endonuclease digestion 
A pair of enzymes was usually chosen to cut plasmid DNA or PCR product. 
Enzymes were chosen based on the restriction sites of interest and reactions were 
carried out in an appropriate buffer which retained 75-100 % of enzyme activity. 
Reactions were set up in eppendorf tubes, for example: 
DNA (~0.5-1 g/l) 5 l 
10x buffer 1 l 
Restriction Enzyme #1 1 l (20 units) 
Restriction Enzyme #2 1 l (20 units) 
Sterile water 2 l 
 
Samples were mixed and spun briefly before incubation at 37 °C for 3-4 h. After the 
digestion was complete, the product was analysed using agarose gel 
electrophoresis. 
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2.2.1.10  Ligation reactions 
The target vector and vector containing the desired insert were restriction digested 
using the same restriction enzymes as outlined in Section 2.2.1.9.  The required 
fragments (insert and linearised target vector) were isolated by gel extraction 
(Section 2.2.1.4). The linearised vector was treated with Shrimp Alkaline 
Phosphatase (Promega) for 30 mins at 37 °C to remove any phosphate groups from 
the 5’ end of the plasmid. The alkaline phosphatase was the inactivated by 
incubation at 65°C for a further 30 mins. Ligation reactions were carried out in 
thin-walled PCR tubes and set up on ice: 
Linearised Vector DNA (0.5 g/l) 2 l 
Insert DNA (0.5 g/l) 6 l 
10x T4 DNA Ligase Buffer 1 l 
T4 DNA Ligase (NEB) 1 l 
 
Vector only, insert only, and DNA-free controls were also set up. The reactions 
were incubated at 16 °C overnight. The reaction mixture was the transformed into 
TOP10 cells and plated on the appropriate antibiotic. 
2.2.2 General biochemical methods 
2.2.2.1 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS PAGE was used to resolve proteins on the basis of size, using Tris-HCl gels.   
30 % acrylamide was used to form a 5 % stacking layer in stacking buffer (25 mM 
Tris-HCl (pH 6.8), 0.2 % (w/v) SDS) and a resolving layer (75 mM Tris-HCl (pH 
8.8), 0.2 % (w/v) SDS), which ranged in acrylamide content from 8-15 %, depending 
on the protein being studied. Gels were polymerised by addition of Ammonium 
Persulphate and N,N,N’,N’-Tetramethylethylenediamine (TEMED). Protein 
samples were prepared in an equal volume of SDS-PAGE Loading Buffer and 
incubated for 5 mins at 95°C. Gels were run in BioRad Mini PROTEAN-III 
apparatus. The samples were loaded into the lanes of the gel alongside 5 l of 
BioRad Broad Range Protein Marker. Gels were run at 80 volts until the samples 
had cleared the separating gel, at which point the voltage was increased to 150 volts 
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and the gels run until the markers had separated adequately and the dye-front had 
cleared the bottom of the gels. 
2.2.2.2 Western blotting 
Following SDS PAGE, proteins were transferred to nitrocellulose membrane. Gels 
were separated from their glass plates, and the stacking gel removed, before being 
submerged in transfer buffer for 2 mins, along with Whatman 3 mm Filter Paper, 
nitrocellulose membrane (45 m pore size) and two sponge pads. The system was 
set up as follows (cathode to anode): sponge pad, Whatman filter paper, 
nitrocellulose membrane, gel containing electrophoresed samples (Section 2.2.2.1), 
Whatman filter paper, and sponge pad. The assembly was encased in a cassette and 
inserted into a BioRad Mini Tras-Blot cell filled with Transfer Buffer. The proteins 
were transferred onto the membrane at room temperature for 2 h at 200 mA or 
overnight at 40 mA. 
2.2.2.3 Immundetection of proteins 
Following western blotting, proteins transferred to nitrocellulose were visualised 
by Enhanced Chemiluminescence (ECL). After transfer, membranes were removed 
from the cassette and washed briefly in PBS-T. Non-specific binding of the 
antibody was minimised by blocking membranes in PBS-T containing 5 % dried 
milk powder for 30 mins. Membranes were briefly washed again, and primary 
antibody (diluted to an appropriate concentration in 1 % PBS-T/dried milk) was 
added before incubation for 1 h at room temperature, or at 4°C overnight with 
rolling. Unbound antibody was removed by washing membranes three times in 
PBS-T over the course of 30 mins. Secondary IgG Horseradish Peroxidase 
conjugated antibodies (IgG-HRP) were diluted to an appropriate concentration in 
5 % PBS-T/dried milk and incubated with membranes for 1 h at room temperature. 
Membranes were then washed a further three times in PBS-T . Labelled proteins 
were visualised using the ECL system. ECL solutions A (100 mM Tris-HCl (pH 
8.5), 2.25 mM Luminol, 0.4 mM p-Coumaric Acid, 1.4 % (v/v) DMSO) and B (100 
mM Tris-HCl (pH 8.5), 0.018 % (v/v) H2O2) were mixed in a 1:1 ratio and incubated 
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with membranes for 1 min. The membrane was then exposed to X-Ray film in a 
lightproof cassette and processed in a Kodak X-Omat processor. 
2.2.2.4 Coomassie staining 
To detect proteins on an SDS PAGE gel, Coomassie Blue Stain solution was used. 
After removal from the glass plates, the gel was immersed in Coomassie stain for at 
least 1 h with gently agitation. After this, the stain was poured off, and the gel 
washed in distilled water. To remove the excess stain from the gel and allow 
visualisation of the proteins, the gel was submerged in Destain Solution, typically 
overnight. 
2.2.2.5 Silver staining 
Silver staining was used to detect low levels (0.5-5 ng) of protein on an SDS PAGE 
gel. The gel was first submerged in fixer solution (40 % ethanol, 10 % acetic acid,  
50 % H2O) for 1 h with gentle agitation. The gel was then washed 6x 10 mins to 
remove excess acetic acid. Then, the gel was sensitised using 0.02 % sodium 
thiosulphate for one minute, before being incubated for 20 mins in ice cold silver 
nitrate solution (0.1 % silver nitrate, 0.02 % formaldehyde added just before use). 
After staining, the gel was washed three times in water before being transferred to 
a second staining tray. The gel was developed using 3 % sodium carbonate (0.05 % 
formaldehyde added just before use). Staining was terminated by washing once in 
water, followed by incubation with 5 % acetic acid for 5 mins. The gel was then 
photographed and stored at 4 °C in 1 % acetic acid in case further analysis was 
required. 
2.2.3 General protein methods 
2.2.3.1 Expression of recombinant proteins 
A single colony from a fresh transformation was used to inoculate 400 ml of 2 YT 
containing the appropriate antibiotic. The culture was incubated overnight at 37 °C 
with shaking. The next morning, the cells were collected by centrifugation at 1000g 
for 15 mins and typically resuspended in 6 L of Terrific Broth and incubated at 37 °C 
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with shaking until an OD600 of 0.8 was reached. Expression was induced by 
addition of 1 mM sopropyl--D-thiogalactopyranoside (IPTG) at 37 °C for 4 h. Cells 
were collected by centrifugation at 3000g for 15 mins. Cell pellets were typically 
resuspended in 120 ml of cold PBS containing two Complete™ protease inhibitor 
tablets. This was homogenised using a blender, and the cells lysed by one pass 
through a Microfluidics M-110P cell disruptor at 10 kpsi. The lysate was clarified by 
centrifugation at 15000g at 4°C for 15 mins in a Beckman JA-25.5 rotor. The clarified 
lysate was then incubated with the appropriate beads, which had been washed in 
Breaking Buffer, and incubated overnight at 4 °C on a roller. 
2.2.3.2 Purification of His-tagged proteins 
E. coli cells producing His-tagged recombinant protein were resuspended in PBS 
containing EDTA-free Complete™ protease inhibitor tablets and clarified lysate 
was obtained as described in Section 2.2.3.1. The lysate was incubated overnight 
with Ni-NTA agarose beads which had been washed in PBS containing 25 mM 
Imidazole. The beads were harvested the next day by collection in an EcoPac 
disposable chromatography column. The beads were washed ten times with 10 ml 
of PBS containing 25 mM Imidazole. The protein was then eluted from the beads on 
a linear gradient from 50 mM-500 mM Imidazole. 1 ml elutions were typically 
collected and a sample from each eluate was run on an SDS PAGE gel (Section 
2.2.2.1). The most abundant protein fractions were pooled, and dialysed against 4 L 
PBS overnight at 4 °C to remove any Imidazole. The sample was then split into 
aliquotes, snap-frozen in liquid nitrogen and stored at -80 °C.  
2.2.3.3 Purification of GST-tagged proteins 
E. coli cells producing GST-tagged proteins were resuspended in PBS containing 
Complete™ protease inhibitor tablets and clarified lysate was obtained as outlined 
in Section 2.2.3.1. The lysate was incubated overnight with Glutathione Sepharose 
4B beads which had been washed with PBS. The next day the beads were harvested 
by collection in an EcoPac disposable chromatography column. The beads were 
washed ten times with 10 ml of PBS. The protein was either eluted from the beads 
by incubation with reduced Glutathione or the affinity tag removed by Thrombin 
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cleavage. For elution by reduced Glutathione the beads were incubated in a 
suitable volume of GST Elution Buffer for 15 mins at room temperature. The elution 
was separated from the beads and the supernantent retained. The elution step was 
usually repeated 3 times to maximise the amount of protein eluted. Samples from 
each elution were run on an SDS PAGE gel (Section 2.2.2.1) before being split into 
aliquots and stored at -80°C. If Thrombin cleavage was required the beads were 
incubated in a suitable volume of Thrombin cleavage buffer containing 100 units of 
Thrombin and incubated at room temperature for 4 h. After this time, the 
Thrombin was inactivated by the addition of 0.2 mM PMSF. The eluted protein 
was the separated from the beads by centrifugation at 14000g at 4 °C for 3 mins in a 
benchtop microfuge. The supernatant was retained, and the sample dialysed 
against 4 L PBS overnight at 4 °C to remove the Reduced Glutathione. The sample 
was split into aliquots, snap-frozen and stored at -80°C. 
2.2.3.4 Analysis of protein concentration 
The concentration of proteins in recombinant and whole-cell lysates samples was 
assessed by Bradford analysis. Bovine Serum Albumin (BSA) was used to prepare 
standards ranging from 0-6 µg/ ml. The amount of sample assayed varied, however 
usually a 1:300 dilution of protein was prepared in water. 150 µl of standard and 
sample was analysed in triplicate in a 96-well plate. 150 µl of Bradford reagent was 
added to each well and the plate incubated at 37 °C for 1 h. After incubation, the 
samples were analysed in a FLUOstar Optima Plate reader set to 595 nm. Protein 
concentrations were calculated using a standard curve derived from the BSA 
standards. 
2.2.4 Mammalian cell culture 
2.2.4.1 Culture of 3T3-L1 murine fibroblasts and adipocytes 
3T3-L1 fibroblasts were cultured in Dulbecco’s modified Eagle Medium (DMEM) 
supplemented with 10 % (v/v) Newborn Calf Serum (NCS) and 1 % (v/v) penicillin 
and streptomycin. Fibroblasts were maintained at sub-confluency in a 10 % CO2 
incubator at 37 °C. Fibroblasts were differentiated into adipocytes 3 days post-
confluency by addition of DMEM containing 10 % (v/v) Foetal Bovine Serum (FBS), 
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1 % (v/v) penicillin and streptomycin, 1.25 µM dexamethasone, 0.5 mM 3-isobutyl-
1-methylxanthine (IBMX) and 1 µg/ µl insulin. After 3 days, the differentiation 
media was replaced with DMEM containing 10 % FBS, 1 % penicillin and 
streptomycin and 1 µg/µl insulin. Differentiated adipocytes were fed with DMEM 
containing 10 % FBS and 1 % penicillin and streptomycin every three days and 
harvested for experimentation 8-12 days post-differentiation. 
2.2.4.2 Sub-cellular fractionation of 3T3-L1 adipocytes 
Ten 10 cm2 plates of confluent adipocytes were washed three times in chilled HES 
buffer containing EDTA-free protease inhibitor tablets (HES + PI). The cells were 
then scraped in 1 ml chilled HES + PI on ice and homogenised by ten passes through 
a 25G needle and two passes through a 26G needle. All centrifugation steps were 
carried out at 4 ⁰C. Cell debris was pelleted by centrifugation at 500g in a chilled 
bench microfuge. The supernatant was retained and spun at 6000g in a TLA 110 
rotor for 10 mins. At this stage, the supernatant and pellet were retained for 
separate fractionation steps. 
2.2.4.2.1 Isolation of Cytosol, High-Density Microsome (HDM) and Low-
density microsome (LDM) fractions 
The retained supernatant (Section 2.2.4.2) was spun at 9400g for 17 mins in a TLA 
110 rotor. The pellet, which contained the high-density microsome (HDM) was 
resuspended in 100µl HES + PI. The supernatant was centrifuged at 104300g for 75 
mins in a TLS 55 rotor. The supernatant, containing the cytosol, was removed and 
retained; whist the pellet contained the low-density microsome (LDM) fraction 
and was resuspended in 100 µl HES + PI. All fractions were snap-frozen and stored 
at -20 °C until use. 
2.2.4.2.2 Isolation of Plasma Membrane (PM) and Nuclear/Mitochondrial 
(N/M) fractions 
The pellet retained after centrifugation at 6000g (Section 2.2.4.2) was resuspended 
in 4 ml HES + PI and centrifuged again at 6000g for 12 mins in a TLA 110 rotor. The 
supernatant was discarded and the pellet resuspended in 1 ml HES + PI and layered 
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over 1 ml high sucrose HES containing protease inhibitors. This gradient was 
centrifuged at 42000g for 1 h in a TLS 55 rotor. The pellet obtained contained the 
nuclear/mitochondrial fraction and was resuspended in 100 µl HES + PI. The 
plasma membrane (PM) fraction was collected from the layer above the high 
sucrose HES + PI and mixed with 3 volumes of HES + PI. This was centrifuged at 
9400g for 15 mins in a TLA 110 rotor and the pellet, containing the PM fraction, 
resuspended in 100 µl HES + PI containing 0.8 % (w/v) n-octyl--D-
glucopyranoside to solubilise the membrane proteins. Samples were snap-frozen 
and stored at -20 °C until use. 
2.2.5 Liposome Fusion Assay 
2.2.5.1 Purification of recombinant SNARE proteins 
Full-length SNARE proteins were purified separately: Syntaxin 4 and SNAP-23 
were co-expressed from the vector pETDuet-1, and VAMP 2 from pQE30. 
Overnight cultures of each construct were set up in 2 YT containing the 
appropriate antibiotic. This overnight culture was then used to inoculate 8 L of 
Superbroth containing antibiotic. Proteins were expressed and harvested 
essentially as described in Section 2.2.3.1, however the cell pellet was resuspended 
in 160 ml Breaking Buffer containing 3 Complete™ Protease Inhibitor tablets. Cells 
were lysed by one pass through a Microfluidics M-110P cell disruptor at 10 kpsi. 
Lysates were clarified as described previously and incubated overnight with 4 ml of 
the appropriate affinity beads. The next day, the beads were isolated by collection 
in an EcoPac disposable chromatography column and washed 5 times in Wash 
Buffer. For His-tagged proteins, this wash included 25 mM Imidazole. The Triton-
X100 was exchanged for n-octyl--D-glucopyranoside by washing 5 times in 
Exchange/Reconstitution Buffer containing 0.8 % (w/v) n-octyl--D-
glucopyranoside. His-tagged proteins were eluted from the beads on a linear 
gradient of Imidazole in Exchange/Reconstitution Buffer containing 0.8 % (w/v)   
n-octyl--D-glucopyranoside. GST-tagged proteins were cleaved from their affinity 
tag by incubation with 125 units of Thrombin in 4 ml Exchange/Reconstitution 
buffer for 4 h at room temperature. The thrombin was inactivated by incubation 
with 0.2 mM PMSF and the elution isolated from the beads and analysed by SDS-
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PAGE and/or western blotting. The protein sample was then concentrated (if 
necessary) and snap-frozen and stored at -80 °C. 
2.2.5.2 Preparation of lipid stocks 
A 15 mM lipid stock of acceptor liposomes was made up containing 85 mol % 
POPC and 15 mol % DOPS in Chloroform. For donor liposomes, a 3 mM and 15 mM 
stock was made up containing 82 mol % POPC, 15 mol % DOPS, 1.5 mol % NBD-
DPPE and 1.5 mol % Rhodamine-DPPE in Chloroform. Lipid stocks were stored 
under nitrogen at -80 °C. 
2.2.5.3 Formation of proteoliposomes 
100 µl of unlabelled acceptor liposomes, for t-SNAREs, and 500 µl of donor 
liposomes were added to 12x75 mm glass tubes and dried under nitrogen for            
15 mins. The samples were further dried in a vacuum desiccator for 30 mins to 
remove any traces of chloroform. 500 µl of purified t- or v-SNARE protein (Section 
2.2.5.1) containing 0.8 % n-octyl--D-glucopyranoside was added to the 
appropriate tube and the lipid film resuspended with the protein by vortexing for   
5 mins. After resuspension, 1 ml of Exchange/Reconstitution Buffer containing   1 
mM DTT was added drop-wise to each tube while vortexing in order to dilute the 
detergent below its critical micellar concentration (CMC). The samples were 
transferred to 3 ml Float-a-lyzer tubes and dialysed overnight in 4 L of 
Exchange/Reconstitution buffer containing 4 g BioBeads to absorb any detergent. 
Samples were collected the following day and stored on ice before proteoliposome 
recovery by gradient centrifugation. 
2.2.5.4 Proteoliposome recovery by gradient centrifugation 
Proteoliposomes were isolated by floatation of a three step ((5-[N-(2,3-
dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N’-bis(2,3-
dihyrdoxypropyl)isophthalamide)) (Histodenz) gradient. Each 1.5 ml dialysate 
was added to 1.5 ml 80 % Histodenz containing 1 mM DTT and mixed 
extensively. This was carefully overlaid with 1.5 ml 30 % Histodenz containing     
1 mM DTT. Finally, 250 µl of glycerol free Exchange/Reconstitution buffer was 
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layered on top. Gradients were centrifuged for 4 h at ~375 000g. 400 µl of 
proteoliposomes were recovered from the top of each gradient and transferred into 
screw-cap eppendorf tubes. The protein content of the liposomes was assessed by 
SDS-PAGE analysis and the samples stored at -80 °C. 
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3 Development of an in vitro liposome fusion assay to 
study SNARE protein function 
3.1 Introduction 
In 1981, Struck and colleague developed an assay which utilised lipid-conjugated 
fluorophores to measure the rate of fusion between two vesicle populations. This 
assay is dependent on the Fluorescence Resonance Energy Transfer (FRET) that 
occurs between the fluorophores NDB ((N-(7-nitro-2,1,3-benzoxadiazol-4-yl)) and 
Rhodamine ((N-(lissamine rhodamine B sulphonyl)).  
FRET is the transfer of energy from a donor fluorophore (in this case, NBD) to an 
acceptor (rhodamine): when excited, the donor fluorophore emits a photon which, 
when in close proximity is absorbed by the second (acceptor) fluorophore. The 
transfer of energy in this way is dependent on the distance between fluorophores 
and the overlap between the emission spectrum of the donor and excitation 
spectrum of the acceptor fluorophore (Förster, 1948; Stryer, 1978). When utilised in 
the in vitro fusion assay, two populations of vesicles are used. Acceptor vesicles are 
produced using non-fluorescent lipids, whilst donor vesicles are produced using 
lipid-conjugated fluorophores. Before fusion occurs, the flurophores present in the 
donor vesicles are in close proximity to one another, allowing FRET to occur 
between the NBD and rhodamine. Upon fusion, the fluorophores are spatially 
separated as they are diluted within the larger (non-fluorescent) lipid volume. This 
prevents the rhodamine from absorbing the photons emitted from the excited NBD, 
allowing levels of fusion to be measured as an increase in NBD fluorescence (Struck 
et al, 1981; Figure 3.1). 
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Figure 3.1 The mechanism of FRET in the in vitro fusion assay 
In order for FRET to occur between NBD and rhodamine, the fluorophores must be within   
4-7 nm of one another (Wolf et al, 1992). Upon fusion between the two liposome populations 
in the in vitro fusion assay, FRET is unable to occur between the fluorophores as they are 
diluted in the larger (unlabelled) membrane of the donor vesicle. This allows the levels of 
fusion between the two vesicle populations to be measured as an increase in NDB 
fluorescence. 
 
This in vitro fusion assay was further developed by Weber and colleagues in 1998, 
whereby they reconstituted full-length neuronal t-SNAREs (Syntaxin 1 and   
SNAP-25) into unlabelled vesicles and full-length VAMP 2 into fluorescence 
vesicles, allowing them to measure the rate at which the SNARE complex fused the 
two populations of liposomes (Weber et al, 1998). 
Once established, the in vitro fusion assay can be used to study the interactions 
between SNARE proteins and their effectors, for example signalling molecules or 
SM proteins, in order to determine the function of any interactions between the 
proteins. For example, the yeast SM protein Sec1p was added to a liposome fusion 
assay where it was found predominantly to interact with the t-SNAREs Sso1p and 
Sec9c and the ternary SNARE complex where it stimulated fusion between the two 
vesicle populations (Scott et al, 2003). 
The v-SNARE VAMP 2 is known to form functional SNARE complexes with the t-
SNAREs Syntaxin 4 and SNAP-23, and formation of this ternary complex is 
responsible for the fusion of GSVs with the plasma membrane in adipose and 
muscle cells in response to insulin (Rea et al, 1998). Although this SNARE complex 
forms the basis of GSV fusion, many other factors are involved, including the 
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signalling molecules PKB and PI-3-K (Holman et al, 1997; Jiang et al, 2003), and the 
SM protein Munc-18c (Tellam et al, 1997).  
 
3.2 Aims of this chapter 
The aim of this chapter was to purify and reconstitute the full-length SNARE 
proteins Syntaxin 4, SNAP-23 and VAMP 2 into proteoliposomes in order to 
establish an in vitro fusion assay as a method to study the regulation of membrane 
fusion by this SNARE complex. This assay would then be further used to assess the 
effect of regulatory SM proteins on SNARE complex formation. 
This assay was previously established in our lab by Dr Fiona Brandie (Brandie et al, 
2008), however problems with reconstitution and SNARE complex formation 
necessitated that the assay be re-established and re-optimised. We were able to 
optimise the assay in order to produce adequate levels of fusion, similar to those 
found in literature (Brandie et al, 2008; Ji et al, 2010). 
3.3 Results 
3.3.1 Purification of  full-length and cytosolic VAMP 2 
Full-length VAMP 2 was expressed as an N-terminally His6-tagged protein from 
the vector pQE30 (QIAGEN) in BL21 (DE3) E. coli cells. Ni-NTA agarose 
chromatography was used to purify the protein, which was eluted from the beads 
using a linear Imidazole gradient from 50-500 mM. A sample from each fraction 
was analysed by SDS PAGE analysis and Coomassie staining. A typical purification 
is shown in Figure 3.2. 
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Figure 3.2 Purification of full-length VAMP 2 
Full-length VAMP 2 was expressed from the vector pQE30 in BL21 (DE3) E. coli cells. The 
protein was purified using an N-terminal His6 tag as described as in Section 2.2.5.1, using 3 ml 
Ni-NTA agarose. 6 L of bacteria were grown to an OD600 of ~0.8 before induction with 1 mM 
IPTG for four hours. After elution using a linear Imidazole gradient, 5 µl of each fraction was 
analysed for protein content on an 18 % SDS PAGE gel and the largest yielding fractions were 
combined and concentrated, usually to a volume of 1 ml. Molecular weight markers are 
indicated. 
 
By combining the highest yielding elutions of VAMP 2 (lanes 4-7) were able to 
obtain a sufficient concentration of protein to continue with reconstitution into 
proteoliposomes for the in vitro fusion assay. 
Cytosolic VAMP 2 was required as a control for the in vitro fusion assay: this 
protein contains the SNARE domain of the v-SNARE but not the transmembrane 
domain. By adding the protein to a mixture of t- and v-SNARE proteoliposomes, 
the cytosolic VAMP 2 is able to bind to the binary t-SNARE complex, preventing 
the v-SNARE in the donor vesicles from binding and forming a fusogenic SNARE 
complex. This allows us to ensure that fusion observed is the result of SNARE 
complex formation, and not simply spontaneous fusion of the vesicles. Cytosolic 
VAMP 2 was also expressed as an N-terminally His6-tagged protein from pQE30 
(QIAGEN) and was purified in an similar manner to the full-length v-SNARE, 
except Triton X-100 and n-octyl--D-glucopyranoside were omitted from the 
buffers. Data from a typical purification is shown in Figure 3.3. 
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Figure 3.3 Purification of cytosolic VAMP 2 
The cytosolic domain of VAMP 2 was expressed from the vector pQE30, and purified as 
outlined in Section 2.2.5.1. 5 µl of each elution was analysed on an 18 % SDS PAGE gel and 
Coomassie stained to visualise the protein. The highest yielding fractions were pooled and 
concentrated to 1 ml before being split into aliquots and stored at -80 C. Molecular weight 
markers are indicated, and this figure represents a typical purification. 
 
As shown in Figure 3.3, although high levels of cytosolic VAMP 2 were produced, a 
second band can be seen on the gel with a similar elution profile as the v-SNARE. 
Interestingly, a band of similar molecular weight (~25 kDa) was observed in 
cytosolic v-SNARE preparations by previous students in our lab who studied both 
the mammalian (Dr V. Aran-Ponte) and yeast (Dr C. MacDonald) fusion systems, 
however the presence of this band did not appear to effect cytosolic v-SNARE 
functioning as a control for the in vitro fusion assay (Brandie et al, 2008). Again, 
combining the highest yielding elutions (lanes 4-7) allowed us to obtain sufficient 
cytosolic VAMP 2 protein to use as a control in our experiments. 
3.3.2 Initial purification of  the t-SNARE Syntaxin 4/SNAP-23 complex 
Early fusion assay studies into neuronal SNARE complex function used 
reconstituted t-SNARE complexes that were purified from co-transformed 
bacteria: that is, both t-SNAREs (Syntaxin 1 and SNAP-25) were expressed from 
two different plasmids which were co-transformed into the same BL21 (DE3) E. coli 
and selected using dual antibiotic resistance (Weber et al, 1998). t-SNARE 
complexes could then be purified via the GST-tag on SNAP-25 and both t-SNAREs 
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reconstituted as a complex. Indeed, initial studies into the insulin-responsive 
SNAREs in our lab used this same technique (Brandie et al, 2008).  
Full-length Syntaxin 4 was expressed as an untagged protein from the vector 
pQE30 (QIAGEN). Full-length SNAP-23 was expressed as a Thrombin-cleavable 
GST-tagged protein from the vector pET41A (Novagen). Both plasmids were        
co-transformed into BL21 (DE3) E. coli cells and successful transformations selected 
for on dual antibiotic (Ampicillin and Kanamycin) agar plates.  
t-SNARE complexes were purified utilising the C-terminal GST tag present on 
SNAP-23. After incubation overnight with Glutathione Sepharose 4B beads (GE 
Healthcare) the sample was washed and cleaved from the beads using 100 units of 
Thrombin (Sigma-Aldrich). Aliquots of the wash steps and elution were analysed 
by SDS PAGE and Coomassie staining, as shown in Figure 3.4. 
 
Figure 3.4 Purification of t-SNARE complexes 
Syntaxin 4/SNAP-23 t-SNARE complexes were purified in BL21 (DE3) E. coli which had 
been co-transformed with both pQE30 and pET41A plasmids. Usually 8 L of bacteria was 
grown to OD600 of 0.8 before 4 hour induction with 1 mM IPTG. Molecular weight markers 
are indicated, and data is representative of a standard purification. 
 
As Figure 3.4 shows, there appears to be an excess of Syntaxin 4 protein compared 
to SNAP-23. Ideally these proteins should form a binary t-SNARE complex with 1:1 
stoichiometry. As the complex is purified using the C-terminal GST tag present on 
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the SNAP-23, it is assumed that 1:1 t-SNARE complexes would be isolated, since 
the Syntaxin 4 is purified via the interaction between the SNARE domains of the 
two t-SNAREs. Since both proteins are expressed from different plasmids, it is 
plausible that one protein is being over-expressed relative to the other, which 
would explain why more Syntaxin 4 is present. This theory appears plausible as 
Syntaxin 4 is expressed from the vector pQE30, which is under the control of the 
T5 promoter, whilst SNAP-23 is expressed from the vector pET41A, under the 
control of the T7 promoter. Study of QIAGEN literature indicates that for best 
expression of the protein, the plasmid should be transformed into E. coli cells 
expressing the repressor plasmid pREP4: the T5 promoter is known to exhibit high 
levels of basal expression, and this plasmid is designed to regulate and repress this. 
Therefore, it is perhaps unsurprising that high levels of Syntaxin 4 are obtained. 
However, as the complex is purified as a whole, the excess Syntaxin 4 suggests that 
more of this t-SNARE is binding to the SNAP-23 than the 1:1 ratio we would expect 
to see in vivo. This correlates with data published by Ji et al (2010), who noted that 
the neuronal t-SNAREs Syntaxin 1a and SNAP-25 are able to form 2:1 complexes, 
where the second Syntaxin molecule functions in place of VAMP 2, which in turn 
lowers the rate of fusion observed. It is, therefore, possible that similar complexes 
are forming between Syntaxin 4 and SNAP-23, accounting for the greater amount 
of Syntaxin purified. 
We decided to continue and reconstitute these complexes into vesicles in order to 
test whether the ratio of Syntaxin 4 to SNAP-23 is altered by the reconstitution 
procedure. 
3.3.3 Preparation of  lipid stocks 
Lipid stocks were obtained from Avanti Polar Lipids (Alabaster, AL, USA) and 
prepared in chloroform. Two populations of liposomes were required for this study: 
and unlabelled acceptor mix and a second fluorescently labelled donor mix. 
Acceptor liposomes were made by mixing 85 mol % 1-palmitoyl-2-oleoyl 
phosphatidylcholine (POPC) and 15 mol % 1,2-dioleoyl phosphatidylserine (DOPS) 
to a final lipid concentration of 15 mM. Fluorescent donor liposomes were made by 
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decreasing the amount of POPC to 82 mol % and adding the lipid-conjugated 
fluorophores NBD-DPPE and Rhodamine-DPPE at 1.5 mol % each to a final lipid 
concentration of 15 mM. Historically, t-SNARE complexes are reconstituted into 
acceptor liposomes, and v-SNAREs into donor, however fusion also occurs if 
proteins are reconstituted into the “opposite” liposomes (Scott et al, 2003). Lipid 
stocks were generally made to a volume of 3 ml and stored under nitrogen at -80 °C 
until use. 
3.3.4 Reconstitution of  SNAREs into liposomes 
SNARE proteins/complexes were reconstituted into liposomes as specified in 
Section 2.2.5.3. Briefly, dried acceptor or donor lipid films were resuspended in 
500 µl t-SNARE complex or VAMP 2 protein containing 0.8 % n-octyl--D-
glucopyranoside respectively. 1 ml Exchange/Reconstitution buffer was added 
drop-wise while vortexing the samples in order to dilute the detergent below its 
CMC and form proteoliposomes. The samples were dialysed overnight in 4 L 
Exchange/Reconstitution buffer containing 4 g Biobeads (BioRad) to absorb any 
detergent. 
Reconstitution efficiency was assessed by running samples of protein before 
reconstitution alongside a sample of the proteoliposomes recovered after gradient 
centrifugation (Section 2.2.5.4). Figure 3.5 shows data from a standard 
reconstitution. 
 
Kimberley Boney, 2013  Chapter 3, 67 
 
 
Figure 3.5 Reconstitution of full-length SNARE proteins 
500 µl of (A) t-SNARE or (B) v-SNARE protein was reconstituted into proteoliposomes as 
described. Proteoliposomes were purified using a 3-step Histodenz gradient. The 1.5 ml 
dialysate was mixed with 1.5 ml  80 % Histodenz in Exchange/Reconstitution buffer, before 
being overlayed with 1 ml of 30 % Histodenz in Exchange/Reconstitution buffer. Finally, 
250 µl of Buffer (without glycerol) was overlayed. The gradients were spun for 4 hours at 
~375000 g in a Beckman SW60 rotor. 400 µl proteoliposomes were harvested from the top of 
the gradient (the interface between the 0 % and 30 % layers). A sample of each proteoliposome 
population was analysed by SDS PAGE along with a sample of protein retained before 
reconstitution. 
 
As shown in Figure 3.5A, the Syntaxin 4 protein appears to reconstitute into the 
liposomes, whilst the levels of reconstituted SNAP-23 protein are low (lane 2). It is 
perhaps unsurprising that the Syntaxin reconstitutes more efficiently than     
SNAP-23 as it contains a transmembrane domain which can be inserted into the 
lipid bilayer of the vesicles, whilst SNAP-23 is palmitoylated in vivo and is 
reconstituted into the vesicles by its interaction with Syntaxin 4 (much in the same 
way Syntaxin 4 is purified in complex with SNAP-23). 
To ensure that SNAP-23 was being reconstituted, the samples were subjected to 
Western Blot analysis, as shown in Figure 3.6. 
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Figure 3.6 Western blot analysis of acceptor liposomes 
A 5 µl sample of protein retained before reconstitution was analysed alongside 5 µl of two 
proteoliposome populations to check for levels of t-SNARE reconstitution. After transfer, the 
nitrocellulose membrane was cut into strips, and blotted for t-SNARE proteins using the 
antibodies specified. 
 
Analysis of the proteoliposomes by western blotting confirms that there is     
SNAP-23 protein in the vesicles; however the levels appear much lower than 
Syntaxin 4, although this could be attributed to a lower affinity of the antibody for 
SNAP-23. We decided to continue with the assay, as there was t-SNARE protein 
present in the vesicles and, even at these somewhat low levels, this may be enough 
to stimulate fusion between the vesicle populations. 
3.3.5 Initial fusion assays 
The reconstituted acceptor and donor proteoliposomes were used in an in vitro 
fusion assay. A control reaction was set up in addition to the fusion assay to ensure 
that any observed fusion was due to the formation of SNARE complexes and not 
spontaneous fusion of the vesicles. For the control reaction, 45 µl of acceptor         
(t-SNARE) liposome was mixed with 5 µl of VAMP 2 cytosolic domain and 
incubated for 15 minutes on ice in one well of a white-bottomed 96-well plate. After 
this incubation, 5 µl of donor (v-SNARE) liposome was added. 45 µl of acceptor 
liposomes was added to a second well of the 96-well plate, and to this 5 µl of 
Exchange/Reconstitution buffer was added along with 5 µl of donor liposome. The 
plate was covered and incubated overnight at 4 °C to induce pre-docking of the 
SNARE complexes. 
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The next day, the plate was warmed in to 37 °C in a FLUOstar Optima 
spectrophotometer for 15 minutes in order to bring the plate to reaction 
temperature. Fluorescence was measured every two minutes for 2 hours, at which 
point 10 µl of 2.5 % (w/v) n-dodecylmaltoside was added in order to lyse the 
vesicles and allow for measurement of the maximum NBD fluorescence of the donor 
liposomes. Fluorescence was measured for a further 40 minutes, after which the 
data was collated. Data was normalised (for this and future experiments) by 
assigning the lowest fluorescence reading to 0 % and maximal readings after 
detergent addition as 100 %, with data plotted as a percentage of this maximum 
fluorescence, as shown in Figure 3.7. 
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Figure 3.7 Initial Fusion Assays 
45 µl of t-SNARE liposome was mixed in the presence (black circles) or absence (red squares) 
of 5 µl of the cytosolic SNARE domain of VAMP 2 – this functions as a control by binding to 
the t-SNARE proteins in the acceptor liposomes preventing fusion with the VAMP 2 present 
in the donor liposomes. Fusion was measured over a two hour period, and maximum NBD 
fluorescence obtained by lysis of the donor vesicles with detergent. Figures (A) and (B) show 
normalised data obtained from two separate protein purifications and reconstitutions, and are 
representative of data obtained from these experiments. 
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As Figure 3.7 shows, we were able to obtain moderate (~3 %) fusion between the 
two vesicle populations, although this level was lower than data previously 
produced in our lab (Brandie et al, 2008). Given that there are low levels of      
SNAP-23 being purified and reconstituted (as shown in Figure 3.4 and Figure 3.5), 
there are a few possible reasons that little fusion is occurring. Firstly, as suggested 
previously in Section 3.3.2, it is possible that the increased amounts of Syntaxin 4 
protein relative to SNAP-23 is causing non-functional SNARE complex formation. 
It is also possible that the low levels of SNAP-23 in the vesicles is limiting the 
amount of binary t-SNARE complexes that can fuse with the v-SNARE donor 
vesicles, leading to low levels of fusion. 
Furthermore, there was little difference between the control reaction (containing 
cytosolic VAMP 2) and the fusion reactions, suggesting that the cytosolic VAMP 2 
was not functioning as an adequate control reaction for this experiment. Cytosolic 
VAMP 2 was added in excess to the control reaction, and should have been 
sufficient to inhibit fusion as it has done in previous experiments (Weber et al, 1998; 
Brandie et al, 2008; Ji et al, 2010).  
We decided at this point to investigate other methods of t-SNARE protein 
purification and reconstitution in order to increase the amount of binary complex 
in our liposomes and, in theory, increase the levels of fusion. 
3.3.6 Formation of  t-SNARE binary complexes for reconstitution 
In an attempt to solve the issue of low fusion, t-SNARE binary complexes were 
formed in solution by mixing protein from separate t-SNARE purifications. By 
mixing the t-SNAREs in a 1:1 molar ratio, it was hoped that this would help prevent 
the formation of non-functional t-SNARE complexes which we hypothesised may 
responsible for the low levels of fusion obtained in previous assays (shown in 
Figure 3.7). 
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Figure 3.8 Mixing t-SNARE proteins before reconstitution 
His-tagged Syntaxin 4 was expressed from the vector pQE30, and GST-tagged SNAP-23 was 
purified from pET41A. After elution from Ni-NTA and Glutathione Sepharose 4B 
respectively, the proteins were mixed overnight at 4 °C in a molar ratio of 1:1. The next day, 
proteoliposomes were formed by resuspension of the lipid film in the protein mixture and, 
after overnight dialysis; proteoliposomes were recovered by gradient centrifugation (Sections 
2.2.5.3 and 3.3.4). 
 
Although both t-SNAREs were present in the pre-reconstitution protein mix, only 
Syntaxin 4 appeared to be reconstituted into the liposomes (Figure 3.8lanes 2   and 
3). This suggests that the binary t-SNARE complex was not forming, preventing 
SNAP-23 from being reconstituted along with the Syntaxin 4. As these proteins 
were expressed from the same plasmids as the co-expression experiments (Section 
3.3.2), this suggests that the reason we are not obtaining much SNAP-23 
reconstitution is because the binary t-SNARE complex is not forming between the 
proteins. At this stage, we decided to investigate new methods for purifying 
recombinant t-SNARE complexes. 
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3.3.7 pETDuet-1 purification and reconstitution of  t-SNARE complexes 
As previously discussed in Section 3.3.5, there was no difference in the rate of fusion 
obtained between the control and fusion reactions, and the overall rate of fusion is 
moderate (~3 %).  Previously published data show that it is possible to obtain a rate 
of 10-20 % fusion (Ji et al, 2010). These higher rates allow for a better analysis of the 
effects of proteins, for example SM proteins, on the rate of fusion as there is a 
greater difference between the rate of fusion, and the rate of the control (~0-1 %).  
In order to address the issue of binary t-SNARE complex formation, we located a 
construct containing Syntaxin 4 and SNAP-23 which had been generated in our lab 
by Dr Fiona Brandie. This utilised the two multiple cloning sites in the vector 
pETDuet-1 (Novagen) – both cloning sites are under the control of the T7lac 
promoter, meaning that both genes expressed in the vector are transcribed and 
translated at a similar rate. This construct contained an N-terminally His-tagged 
Syntaxin 4 in multiple cloning site 1 (MCS1) and a C-terminally GST-tagged 
SNAP-23 in the second multiple cloning site (MCS2). Protein was purified in an 
identical manner to the co-expressed t-SNARE complexes; however Kanamycin 
was omitted from the growth media as this vector only confers Ampicillin 
resistance. The complexes were thrombin-cleaved from Glutathione Sepharose 4B 
beads and an aliquot from the wash steps and elution analysed by SDS-PAGE and 
Coomassie staining. 
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Figure 3.9 Purification of t-SNARE complex from pETDuet-1 
pETDuet-1 was used to express full-length t-SNAREs in complex via a C-terminal GST-tag on 
SNAP-23. Protein was purified as described in Section 2.2.5.1 using 4 ml of Glutathione 
Sepharose 4B beads. Usually 8 L of bacterial culture was grown to an OD600 of ~0.8 before 
induction of protein expression for 4 hours with 1 mM IPTG. After thrombin cleavage of the 
complexes, a 5 µl aliquot of the elution was analysed alongside the wash/detergent exchange 
fractions on a 15 % SDS-PAGE gel. The cleaved protein was generally concentrated to a 
volume of 500 µl and snap-frozen in liquid nitrogen. 
 
As shown in Figure 3.9, using pETDuet-1 to express the t-SNARE proteins resulted 
in a more equal expression of the t-SNARE proteins compared to co-expressing 
separate plasmids. Once purified, these t-SNARE complexes were reconstituted 
into acceptor liposomes as outlined in Sections 2.2.5.3 and 2.2.5.4. 
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Figure 3.10 Reconstitution of t-SNARE proteins 
500 µl purified t-SNARE complex was used to resuspend 100 µl 15 mM acceptor lipid mix 
before overnight dialysis to remove detergent. Proteoliposomes were recovered by floatation 
on a Histodenz density gradient. Two liposome populations are shown, both reconstituted 
from the shown protein sample. 
 
As Figure 3.10 shows, the t-SNARE proteins expressed from pETDuet-1 
reconstitute evenly, suggesting that binary t-SNARE complexes are forming. It is 
important to note the two contaminant bands in the protein preparation that are 
reconstituted into the liposomes alongside the full-length SNARE proteins. These 
are postulated to be degradation products of the SNARE proteins: in particular 
with the Syntaxin 4 degradation product, it is postulated to be N-terminal 
degradation as the C-terminal transmembrane domain is required for successful 
reconstitution. As it is theorised that the N-terminal peptide of Syntaxin is 
required for SNARE complex regulation (Hu et al, 2007; Section 1.8.2.2) it is 
possible that these proteins may inhibit SNARE complex formation. 
The fusogenic properties of these liposomes could then be assessed using the in vitro 
fusion assay. 
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3.3.8 Fusion assays 
Acceptor t-SNARE liposomes prepared from the plasmid pETDuet-1 were used in a 
fusion assay with donor v-SNARE vesicles. The experimental setup was similar to 
that described previously (Section 3.3.5), however the donor vesicles were 
produced using 100 µl of a 3 mM lipid mix rather than 500 µl (covered in detail in 
Section 3.3.9) and fluorescence readings were measured every two minutes for 2 
hours before addition of detergent to lyse the vesicles in order to obtain maximum 
NBD fluorescence readings. As before, data was normalised and plotted as a 
percentage of the maximum observed NBD fluorescence. 
  
Figure 3.11 pETDuet-1 Fusion Data 
45 µl t-SNARE liposome was mixed with 5 µl v-SNARE donor liposome in the presence 
(black circles) or absence (red squares) of 5 µl of the cytosolic SNARE domain of VAMP 2. 
Fusion was measured over a two hour period, and maximum NBD fluorescence obtained by 
lysis of the donor vesicles with detergent. This figure shows representative data from three 
independent experiments. 
 
As Figure 3.11 shows, we are now able to show fusion between our t- and v-SNARE 
vesicles, indicating that the complexes formed using the vector pETDuet-1 are 
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stable and functional, and that fusion between the two vesicle populations is 
SNARE dependent. All future in vitro fusion assay experiments were performed 
using t-SNARE proteins expressed from this vector. 
3.3.9  Functional significance of  lipid content of  donor vesicles 
While researching possible solutions to overcome the low levels of fusion being 
observed in the assay (Section 3.3.5), it was discovered that it is possible to 
reconstitute v-SNAREs into liposomes containing only 20 % of the usual donor 
lipid level, whilst still maintaining fusion (Vicogne & Pessin, 2008). 
Studies into the structure and function of the v-SNARE VAMP 1 indicated that the 
protein was sensitive to protein-lipid interactions, especially in the transmembrane 
domain of the protein (Yassine et al, 2010). To test whether the lipid content of the 
vesicles affects the function of VAMP 2, v-SNARE protein was reconstituted into 
vesicles using either 100 µl or 500 µl fluorescent donor lipid stock, and their ability 
to fuse with t-SNARE liposomes was assessed using the in vitro fusion assay. 
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Figure 3.12 Test of v-SNARE protein reconstitution and function 
 (A) 500 µl v-SNARE protein was reconstituted into liposomes using either 100 µl or 500 µl 
fluorescent lipid mix. Levels of protein reconstitution were tested by running 5 µl protein input 
alongside 5 µl of each liposome population on an SDS PAGE gel and Coomassie staining.   
(B) 45 µl t-SNARE liposome were mixed with 5 µl v-SNARE donor liposome in the presence 
(black triangles/circles) or absence (red triangles/circles) of cytosolic VAMP 2. Fusion was 
measured over a two hour period, and maximum NBD fluorescence obtained by lysis of the 
donor vesicles with detergent. This figure shows representative data from three independent 
experiments. 
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Although the vesicles with a lower lipid:protein ratio contain slightly lower levels 
of VAMP 2 protein, as shown in Figure 3.12A, they are able to sustain higher levels 
of SNARE-mediated membrane fusion, leading to around a 4-fold increase in the 
final fluorescence percentage (Figure 3.12B). This appears to support the previous 
observations regarding VAMP 1 (Yassine et al, 2010), and extends the model to 
VAMP 2, although further studies would be required to determine how the lipids 
are affecting VAMP 2 function and/or structure. 
3.3.10 Characterisation of  proteoliposome size 
Critics of the in vitro fusion assay argue that the reconstitution method used to 
incorporate the SNARE proteins into the vesicles results in small (<20 nm) 
liposomes, which have a tendency to spontaneously fuse due to high membrane 
curvature (Chen et al, 2006). To ensure that our vesicles were within the generally 
accepted diameter range of 20-100 nm, Transmission Electron Microscopy was 
used to estimate the size of the t- and v-SNARE vesicles. Samples of 
proteoliposome were diluted 1/10 in reconstitution buffer and imaged at 16000x 
magnification.  
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Figure 3.13 Transmission EM of (A) t- and (B) v-SNARE proteoliposomes 
Diluted samples of SNARE proteoliposomes were applied to a glow-discharged copper grid 
before 1 % methylamine vanadate was applied as a negative stain. Samples were imaged at  
120 kV. SIS iTEM imaging software (Olympus) was used to directly measure the liposome 
diameter from multiple grids before calculating the percentage of total population for each 
diameter range. 
 
As Figure 3.13 shows, both the t- and v-SNARE vesicles fall within the 20-100 nm 
diameter range, indicating that high membrane curvature is not a factor in our 
assay, and that the levels of fusion we observed are due to SNARE complex 
formation, as fusion between the vesicles is blocked by the addition of the cytosolic 
domain of VAMP 2 (Figure 3.11 and Figure 3.12B). 
3.4 Conclusions 
Whilst the in vitro fusion assay is a useful tool for studying the fusogenic properties 
of SNARE proteins, establishing this assay to study the SNAREs involved in the 
fusion of GSVs with the plasma membrane has been difficult. Using a standard co-
expression method (with each t-SNARE in a separate vector, but transformed into 
Kimberley Boney, 2013  Chapter 3, 81 
 
the same E. coli cells) we observed the formation of non-functional SNARE 
complexes, possibly due to the different levels of translation of the t-SNAREs, as 
Syntaxin 4 appeared to be produced in vast excess to SNAP-23 (Figure 3.4To 
overcome this, both t-SNAREs were expressed from one vector which contains two 
multiple cloning sites (pETDuet-1, Novagen). Using this vector, we were able to 
produce t-SNARE complexes with similar levels of each t-SNARE, thus preventing 
(or reducing) non-functional complex formation (Figure 3.9 
These protein complexes were then reconstituted into acceptor liposomes in order 
to test their ability to fuse with VAMP 2-containing donor vesicles. Experiments 
using the initial t-SNARE complexes resulted in moderate levels of fusion (Section 
3.3.5). Experiments using the complexes purified from pETDuet-1 showed higher 
levels of fusion compared to the control experiment (Figure 3.11), indicating that 
protein expression from pETDuet-1 resulted in formation of functional binary         
t-SNAREs which were able to from SNARE complexes with VAMP 2.  
Once the in vitro fusion assay was established, we were able to use it to test the 
importance of the protein/lipid ratio in the donor v-SNARE vesicles. Altering the 
amount of lipid used to reconstitute the vesicles showed that higher levels of fusion 
are obtained with lower lipid concentrations in the donor vesicles, despite slightly 
less protein being reconstituted in comparison to the vesicles with a higher 
lipid:protein ratio (Figure 3.12).  Based on these findings, we chose to continue the 
experiments using donor liposomes reconstituted using 100 µl of lipid stock. 
Finally, we tested the physical properties of the liposomes by measuring their 
diameter using transmission electron microscopy. It is argued that vesicles smaller 
than 20 nm have a tendency to spontaneously fuse (Chen et al, 2006), however 
analysis of our vesicles showed that the majority of both donor and acceptor 
vesicles have a diameter greater than 20 nm, indicating that membrane curvature 
should not be a contributing factor to fusion in our assay. 
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4 The effect of Munc-18c on SNARE-mediated 
membrane fusion 
4.1 Introduction 
The rate of fusion observed in in vitro experiments, such as the liposome fusion 
assay, are many times slower than those observed in vivo, indicating an additional 
level of regulation than SNARE proteins alone. One such family of proteins 
identified as regulators of SNARE-mediated fusion are the Sec1/Munc-18 (SM) 
family of proteins, with Munc-18c being implicated in the regulation of GLUT4 
exocytosis (Tellam et al, 1995, 1997). 
The exact function of SM proteins is highly debated, as many of these proteins 
exhibit different functions depending on the experimental conditions. There are, 
however, three widely-accepted modes of binding observed between SM proteins 
and their cognate SNARE partners, outlined in Figure 4.1. 
 
Figure 4.1 Binding modes between SNARE and Sec1/Munc-18 proteins 
Three binding modes have been shown to exist between SM proteins and their SNARE 
partners. (A) Binding between the “closed” conformation of Syntaxin (red) and the SM 
protein (purple) is termed Mode 1. (B) Binding between the N-terminus of the Syntaxin and a 
pocket on the outside of the SM protein is Mode 2. (C) Binding between the assembled 
SNARE complex (SNAP-23 green, VAMP 2 blue) and the SM protein is Mode 3. Not all 
SM/SNARE partners exhibit all modes of binding. 
 
Mode 3 binding between SM and SNARE proteins has been characterised in yeast, 
where the SM protein Sec1p was shown to co-precipitate with its cognate 
SNAREs, and is localised to areas in the plasma membrane where SNARE 
complexes are believed to assemble and function (Carr et al, 1999). However, 
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studies in mammalian systems have been less conclusive and conflicting data exists 
as to whether mammalian SM proteins are able to bind their cognate SNARE 
complexes in this manner. Initial studies identified that the neuronal SM protein 
Munc-18a was only able to bind its cognate Syntaxin, and that this binding 
(presumed to be Mode 1 binding) prevented the Syntaxin forming a SNARE 
complex with SNAP-25 and VAMP 2 (Yang et al, 2000). In contrast, subsequent 
studies showed that in PC12 cells, Munc-18a-bound Syntaxin is able to form 
SNARE complexes with its cognate SNARE partners, and that Munc-18a is 
involved in SNARE complex formation (Zilly et al, 2006). 
It has previously been shown in our lab that Munc-18c is able to bind to both the   
v-SNARE VAMP 2 and the t-SNARE Syntaxin 4 (Brandie et al, 2008; Aran et al, 
2009). Mutants of Syntaxin 4 were generated that were unable to exhibit the 
“closed” conformation (L173A/E174A); were missing the N-terminal peptide 
(ΔN36) or both (ΔN36/LE) in order to test the interactions between Syntaxin 4 
and Munc-18c. Using pull-down assays and Surface Plasmon Resonance (SPR) 
experiments, the interactions between wild-type/mutant Syntaxin 4 and Munc-18c 
were further characterised, and it was shown that Syntaxin 4 and Munc-18c 
exhibit both Mode 1 and Mode 2 binding (Aran et al, 2009). Low-resolution 
structural studies have also indicated that the N-terminal peptide of Syntaxin 4 is 
critical in binding to Munc-18c, regardless of binding mode (Christie et al, 2012). 
Furthermore, it has been shown that Munc-18c is also able to bind to the SNARE 
complex consisting of Syntaxin 4, SNAP-23 and VAMP 2 (Latham et al, 2006); 
however this interaction has not yet been investigated on a molecular level. 
In order to characterise Mode 3 binding between SM proteins and SNARE 
complexes, point mutations have been made to the SM proteins at key residues 
which are believed to have involvement in the interactions involved in these 
complexes. The residues are labelled according to the position of the amino acid in 
the protein studied – the homologous position in Munc-18c (based on sequence 
alignment) is given in parenthesis. 
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Analysis of the structure of the Munc-18a/SNARE complex produced by Nuclear 
Magnetic Resonance (NMR) imaging shows that formation of the complex 
requires the Syntaxin N-terminal peptide, the Habc domain and the SNARE bundle 
(Dulubova et al, 2007; Deák et al, 2009). Based on this structure, mutations were 
made in the sequence of Munc-18a that targeted residues that interact with these 
domains, and are conserved between homologous SM proteins. Glutamic Acid 59 
(E63) makes contact with the Habc domain of the Syntaxin, whilst Glutamic Acid 
66 (E70) contacts both the Habc and N-terminal domains of the Syntaxin. These 
residues were mutated to Alanine and Lysine respectively, and both were found to 
retain tight binding to Syntaxin 1a in the “closed” conformation (Mode 1) but 
binding between the SM protein and the SNARE complex (Mode 3) was decreased 
leading to a decrease in vesicle priming, but not to vesicle fusion (Deák et al, 2009). 
Studies using the nematode worm Caenorhabditis elegans identified a residue in the 
SM protein unc-18 which also impairs binding of the SM protein to its cognate 
SNARE complex. Using pull-down assays, it was observed that a mutation of 
Aspartic Acid 214 (D222) to Asparagine caused a decreased in binding to the 
SNARE proteins involved in complex formation with no effect on binding to 
Syntaxin in either its “open” or “closed” conformations (Graham et al, 2009). 
4.2 Aims of this chapter 
This chapter aimed to generate recombinant wild-type and mutant Munc-18c 
(E63K, E70A and D222N) and to test the function of these proteins through pull-
down assays and the in vitro fusion assay. 
4.3 Results 
4.3.1 Purification of  N- and C-terminally tagged Munc-18c 
With several binding modes between Syntaxin and SM proteins being identified, 
and each of these binding modes utilising a different domain of the SM protein, it is 
plausible that N- and C-terminally located purification tags on the SM protein may 
interfere with or alter binding between the proteins. Therefore, it was important to 
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firstly determine whether the location of the polyhistidine affinity tags affected the 
ability of Munc-18c to bind to SNAREs and the SNARE complex. Indeed, earlier 
work in our lab has established that the location of GST purification tags on 
Syntaxin 4 can affect its binding to Munc-18c (Aran et al, 2009); however reciprocal 
experiments on the SM protein have not been performed as yet. 
Previous experiments in our laboratory utilised full length murine Munc-18c cloned 
into the QIAGEN vector pQE30 to generate an N-terminally polyhistidine tagged 
protein. This construct was then transformed into bacterial cells containing a 
plasmid expressing the chaperone protein GroEL, which was thought to aid 
protein folding and stability. Although the addition of GroEL may aid in the overall 
purification of the SM protein, it is very difficult to remove from the final protein 
solution, even after extensive washes with Mg-ATP (Hu et al, 2003, Aran et al, 
unpublished).  
In order to eliminate (or reduce) the need for GroEL, full-length Munc-18c was 
cloned into a new vector, pET28B (Novagen). This vector is able to create both N- 
and C-terminally His6-tagged proteins, depending on the restriction sites used. 
Two full-length murine Munc-18c constructs were generated by PCR; N-terminally 
tagged Munc-18c (NHis M18c) was cloned between the NheI and XhoI sites and  
C-terminally tagged Munc-18c (CHis M18c) was cloned between the NcoI and 
XhoI sites (all oligonucleotide sequences used in this study are presented in the 
Appendix). 
After successful cloning was confirmed by sequencing, full-length SM proteins 
were purified as outlined in Section 2.2.3.2, without co-expressed GroEL. Briefly, 
~200 ml clarified E. coli lysate was incubated overnight at 4⁰C with 3 ml Ni-NTA 
agarose washed in PBS. The next morning, the lysate was applied to an EcoPac 
disposable chromatography column and washed 10 times with 10 ml PBS 
containing 25 mM Imidazole. Protein was eluted from the column using a linear 
gradient of Imidazole, and each fraction analysed by SDS PAGE and Coomassie 
staining. Peak fractions were combined and dialysed overnight to remove any traces 
of Imidazole. 
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Figure 4.2  Purification of (A) N- and (B) C-terminally tagged Munc-18c 
Full-length N- and C-terminally tagged Munc-18c was produced in BL21 (DE3) E. coli cells. 
Purification utilised the polyhistidine tags on the termini of the proteins using 3ml Ni-NTA 
agarose (QIAGEN). Typically 6 L of bacteria were grown to an OD600 of ~0.8 before 
overnight induction with 1 mM IPTG at 22 C. After purification using a linear Imidazole 
gradient a 5 l sample of each fraction was run on an 10 % SDS PAGE gel, and the highest 
yielding fractions combined, and dialysed against either PST + 10 % glycerol, or 
Exchange/Reconstitution buffer before concentration to ~1 ml. 
 
Unlike our previous pQE30 construct, co-expressed GroEL was not required to 
express the protein, and sufficient levels of Munc-18c could be produced from the 
pET28B vector in BL21 (DE3) E. coli. Both pQE30 and pET28b are derived from the 
vector pBR222 (Bolivar et al, 1977), however pET28b is controlled by the T7 
promoter and is a medium-copy number plasmid, whilst pQE30 is a low-copy 
number plasmid (The Qiaexpressionist, QIAGEN). Both proteins also appeared to be 
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purified to similar levels, suggesting that the tag location does not affect binding to 
Ni-NTA agarose. 
4.3.2 The effect of  purification tags on wild-type Munc-18c function 
In order to test for any functional consequences of His6-tag location on the SM 
protein, we performed GST pull-down assays using the two wild-type Munc-18c 
proteins and Syntaxin 4, as this is the best characterised of our SNARE/SM protein 
binding pairs. Further to this, we added both wild-type SM proteins into our in 
vitro fusion assay to assess whether and differences occur in their ability to regulate 
SNARE-mediated membrane fusion. 
4.3.2.1 GST pull-down assays to assess binding between wild-type 
Munc-18c and Syntaxin 4 
In order to assess binding between the wild-type SM proteins and Syntaxin 4, a 1:1 
molar ratio of recombinant Syntaxin 4 and Munc-18c was incubated overnight at    
4 °C in a final volume of 500 µl PBS with rotation. The next day, 20 µl Glutathione 
Sepharose 4B beads (50 % slurry in PBS) was added to each tube and incubated at 
room temperature for 1 hour with rotation. The beads were harvested by 
centrifugation at 14000xg for 2 minutes and washed 5 times with 1 ml PBS + 10 % 
glycerol. After the final wash all supernatant was carefully removed and 20 µl 
2xLSB added. The samples were boiled at 95 °C for 5 minutes and the beads 
collected by centrifugation at 14000xg for 5 minutes. A sample of supernatant was 
run on a 15 % SDS PAGE gel, along with an input sample for each experiment, and 
proteins visualised using Coomassie staining. 
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Figure 4.3  Syntaxin 4/GST Pull-down of (A) N- and (B) C-terminally tagged Munc-18c 
40 µg full-length (A) N- and (B) C-terminally His6-tagged Munc-18c was incubated with 20 µg 
cytosolic Syntaxin 4 or GST overnight at 4 °C. After incubation the next morning with 20 µl 
Glutathione Sepharose 4B for 1 hour at room temperature, the beads were washed and boiled 
with 2x LSB. 15 µl of input sample was run alongside 10 µl pull-down supernatant. 
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As Figure 4.3 shows, both Munc-18c constructs bind to the C-terminally tagged 
cytosolic Syntaxin 4 after overnight incubation, with limited binding to the beads 
and GST controls. This suggests that the location of the purification tag has no 
effect on the ability of the SM proteins interactions with Syntaxin 4. In order to 
test any functional differences between the proteins, both constructs were analysed 
using the in vitro fusion assay. 
4.3.2.2 The effect of Munc-18c on the liposome fusion assays 
As our in vitro liposome fusion assay was now functional, as outlined in Chapter 3, 
we were able to use it to investigate the effect of Munc-18c on SNARE-mediated 
membrane fusion. 
During this time, experiments were underway for Chapter 5, where I was 
attempting to establish a fusion assay utilising proteins isolated from the plasma 
membrane of 3T3-L1 adipocytes. During the optimisation for this assay, we 
discovered that the cytosolic domain of VAMP 2 was an ineffective control (see 
Chapter 5 for further details). We chose at this stage to use a different control, 
using protein-free donor vesicles. As these vesicles do not contain any v-SNARE, 
they should not fuse with the t-SNARE containing acceptor vesicles, indicating 
that fusion between the vesicle populations is SNARE-dependent. This control was 
tested in the initial SNARE-mediated in vitro fusion assay, where the protein-free 
vesicle control was shown to exhibit similarly low levels of fusion to adding 
cytosolic VAMP 2 (Weber et al, 1998). 
To test whether the N- and C-terminally located purification tags conferred 
different functional effects, both proteins were added to the fusion assay. t- and     
v-SNARE-containing liposomes were incubated overnight in the presence 
(triangles) or absence (squares) of wild-type Munc-18c. After heating to 37 °C, 
fluorescence readings were obtained every two minutes for two hours before 
addition of n-dodecylmaltoside in order to lyse the donor vesicles and obtain a 
maximum NBD fluorescence level. Data was normalised (as outlined in Chapter 3) 
and expressed as a percentage of maximum NBD fluorescence. 
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Figure 4.4 The effect of wild-type Munc-18c on SNARE-mediated liposome fusion 
45 µl t-SNARE liposomes was incubated overnight in the presence of VAMP 2-containing (red 
squares) or empty (black circles) donor vesicles. N-terminal (purple triangles) or C-terminal 
(green triangles) wild-type Munc-18c was added to two of the fusion wells in a 1:1 molar ratio 
with the t-SNAREs, with Exchange/Reconstitution buffer added to the control and fusion 
reactions to account for volume. Fusion was measured over a two hour and maximum NBD 
fluorescence obtained by lysis of the donor vesicles with detergent. This figure shows 
representative data from three independent protein purifications and reconstitutions. 
 
As shown in Figure 4.4, both wild-type Munc-18c constructs cause a decrease in 
the rate of SNARE-mediated liposome fusion in our in vitro fusion assay. This 
supports previous data produced in our lab which indicated that N-terminally 
tagged Munc-18c acts as an inhibitor of SNARE-mediated fusion (Brandie et al, 
2008), and indicates that the C-terminally tagged Munc-18c also functions as a 
negative regulator of SNARE-mediated membrane fusion. 
4.3.3 Munc-18c Site-Directed Mutagenesis 
As previously described, three residues (E63, E70 and D222) were selected for 
mutation in Munc-18c based on studies into Mode 3 binding in homologous 
systems. The mutants were generated using site-directed mutagenesis (SDM) as 
outlined in Section 2.2.1.2, using the N-terminally tagged wild-type Munc-18c as a 
template. We chose to perform the mutagenesis in this context as the information 
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for the pET28B plasmid claimed that the N-terminal His6 tag was Thrombin 
cleavable. Unfortunately, we subsequently discovered that, despite multiple 
optimisation attempts, we were unable to remove the polyhistidine tag by 
Thrombin cleavage. However as we observed no functional difference between the 
N- and C-terminally tagged wild-type proteins (Figure 4.4), we hypothesised that 
the location of the purification tag would not affect the proteins’ function. 
Mutagenesis was performed using the Platinum® Pfx DNA polymerase kit 
(Invitrogen). Due to the large size of Munc-18c (1.8 kbp) and the large size of the 
pET28B vector (5.4 kbp), the mutants were generated in the vector pCR®2.1-
TOPO®, as this vector is significantly smaller than pET28B. Successful clones were 
identified by sequencing, excised from the carrier vector and sub-cloned into 
pET28B. 
Full-length proteins were purified as described for the wild-type SM protein 
(Sections 2.2.3.2 and 4.3.1), and eluted from Ni-NTA agarose using a linear 
imidazole gradient before analysis by SDS PAGE and Coomassie staining (Figure 
4.5). 
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Figure 4.5 Purification of Munc-18c point mutants  
Full-length (A) E63K (B) E70A and (C) D222N Munc-18c was produced in BL21 (DE3)       
E. coli cells. Purification utilised N-terminal polyhistidine tags on the proteins using Ni-NTA 
agarose. After elution from the beads using a linear Imidazole gradient a 5 l sample of each 
fraction was run on an 10 % SDS PAGE gel, and the most pure, highest yielding fractions 
combined and dialysed against either PST + 10 % glycerol, or Exchange/Reconstitution 
buffer. This figure is representative of typical purifications. Molecular weight markers are 
indicated. 
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Like the wild-type SM protein, the mutant Munc-18c proteins were expressed 
without the chaperone GroEL. The mutant proteins were also expressed and 
purified to similar levels as the wild-type protein, although the D222N protein 
appears to elute from the Ni-NTA column at a lower concentration of Imidazole 
than the other constructs.  
4.3.4 Effect of  Munc-18c point mutants on protein function 
We chose two experimental systems to test the effect of the selected point 
mutations on the function of Munc-18c. Firstly, we tested the ability of the wild-
type and mutant SM proteins to bind to their cognate SNAREs to assess whether 
the mutant proteins have a different affinity to the SNAREs compared to wild-type 
Munc-18c. Secondly, we assessed the ability of the mutant proteins to regulate 
SNARE-mediated membrane fusion in our newly established in vitro fusion assay. 
4.3.4.1 Test of Munc-18c antibody specificity 
Previous work in our lab showed that an α Syntaxin 4 antibody bound with 10-fold 
greater affinity to wild-type Syntaxin 4 than to the “open” L173A/E174A mutant (Dr 
Fiona Brandie, unpublished data), highlighting the importance of analysing ability 
of antibodies to bind both wild-type and mutant proteins. As it was possible that 
the mutations made to our SM protein may cause small structural changes, we 
tested three commercially available α Munc-18c antibodies for their ability to 
detect wild-type and mutant SM proteins with equal affinities. A known amount of 
wild-type and mutant Munc-18c was run on an SDS PAGE gel. The samples were 
then analysed by Coomassie staining and western blotting to test antibody 
affinities, as shown in Figure 4.6. 
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Figure 4.6 Test of Munc-18c antibody specificity 
1 µg wild-type and mutant Munc-18c were run on 10 % SDS PAGE gels. One set of samples 
was stained with Coomassie, to ensure equal loading of the proteins. The other samples were 
transferred to nitrocellulose and subjected to western blotting using different Munc-18c 
antibodies. Molecular weight markers are shown. 
 
Of all the antibodies tested, the α-human Munc-18c (Abcam) antibody appears to 
bind to the wild-type and mutant SM proteins with similar affinities, and thus was 
used in our further studies. 
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4.3.4.2 GST pull-down assays 
In order to test the function of the mutant Munc-18c proteins, their ability to bind 
to SNARE proteins was assessed. As these mutations are postulated to inhibit 
Mode 3 binding (i.e. to the assembled SNARE complex), we first attempted to form 
recombinant SNARE complexes, and to assess the mutant proteins’ ability to bind 
to them. 
The SNARE hypothesis postulates that for every membrane fusion event, there is a 
specific pairing of SNARE proteins which form a functional SNARE complex, 
providing specificity to the membrane fusion event (Söllner et at, 1993). Functional 
SNARE complexes can be identified by their resistance to denaturing by SDS 
(Hayashi et al, 1994); a characteristic that has been observed in complexes 
consisting of Syntaxin 4, SNAP-23 and VAMP 2 (Kawanishi et al, 2000). To form 
recombinant SNARE complexes, bacterial lysates were produced expressing 
Syntaxin 4/SNAP-23 binary complexes, cytosolic VAMP 2 or GST. Lysate 
containing cytosolic VAMP 2 was incubated overnight at 4 °C with GST lysate (as 
a control) or t-SNARE complex lysates. The next day, Glutathione Sepharose 4B 
was added to each mixture, and further incubated overnight at 4 °C. The beads 
were isolated and washed 5 times with 1 ml Exchange/Reconstitution buffer 
containing 1 % Triton X-100. After washing, a sample of the beads was analysed by 
SDS PAGE and western blotting: in order to identify successfully formed SNARE 
complexes, samples were analysed for the presence of two of the SNARE proteins 
(SNAP-23 and VAMP 2), as shown in Figure 4.7A. 
Once complexes had been assembled, they were used in pull-down assays. GST 
alone (control) or SNARE complex beads were incubated overnight at 4 °C with 
bacterial lysate expressing wild-type Munc-18c. The next day, beads were washed 
5 times with 1 ml Exchange/Reconstitution buffer containing 1 % Triton-X100, and 
binding of Munc-18c was analysed by SDS PAGE and western blotting. 
.  
Kimberley Boney, 2013  Chapter 4, 96 
 
 
Figure 4.7 Binding of wild-type Munc-18c to assembled SNARE complexes 
(A) Bacterial lysates containing GST and VAMP 2 (control reaction) or Syntaxin 4, SNAP-23 
and VAMP 2 were mixed overnight at 4 °C in order to assemble recombinant SNARE 
complexes. Assembled complexes were isolated on Glutathione Sepharose beads and, after 
washing, were analysed for the presence of SNARE proteins in the assembled complex. (B) 
Wild-type Munc-18c was incubated overnight with GST (control) or SNARE complex bound 
to Glutathione Sepharose 4B. After washing, binding of the SM protein was analysed by 
western blotting with the specified antibodies. 
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Our attempts to optimise this pull-down assay using assembled SNARE complexes 
proved unsuccessful, as we encountered high levels of binding between the        
wild-type SM protein to the GST-only control, as shown in the top panel of Figure 
4.7B. As it appeared difficult to assess binding of the SM protein to the assembled 
SNARE complexes, we chose to assess whether binding to the individual SNARE 
proteins was compromised. Using our previous method for pull-down assays 
(described in Section 4.3.2.1), we witnessed high levels of mutant Munc-18c/GST 
interaction in our negative control. In order to minimise this binding, we altered 
the assay and used E. coli lysates expressing recombinant SNARE proteins and 
Munc-18c, hypothesising that the proteins present in the bacterial lysates may act 
as a block, minimising non-specific binding to the GST control. 
1 mg GST-SNARE or GST alone E. coli lysates were incubated overnight with 1 mg 
wild-type or mutant Munc-18c lysate, in a total volume of 1 ml Exchange/ 
Reconstitution buffer containing 1 % Triton-X100. The next day, 40 µl Glutathione 
Sepharose 4B (as a 50 % slurry in PBS) was added to each tube and incubated at 
room temperature for 1.5 hours. The beads were then harvested by centrifugation at 
14000xg for 90 seconds and washed 5 times with 1 ml PBS + 10 % glycerol. After the 
final wash all supernatant was carefully removed and 20 µl 2xLSB added. The 
samples were boiled at 95 °C for 5 minutes and the beads collected by 
centrifugation at 14000xg for 5 minutes. A sample of supernatant was run on an 
SDS PAGE gel along with an input sample for each experiment. 
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Figure 4.8 Binding of Munc-18c mutants to SNARE proteins 
E. coli lysates expressing SNARE and SM proteins were incubated together overnight at 4 °C. 
The next morning and input sample of the protein mixture was retained and protein 
complexes were isolated using Glutathione Sepharose 4B. After washing, a sample of the 
beads was analysed by SDS PAGE and western blotting using the specified antibodies – A-D 
represent a sample from the same Munc-18c lysate preparation incubated with the individual 
SNARE lysates. Protein inputs are shown as “Input” samples; isolated complexes are shown 
as “Beads” samples. ImageJ software (NIH) was used to quantitatively analyse the amount of 
Munc-18c bound to each SNARE protein, expressed as a percentage of the wild-type binding. 
Error bars represent the standard deviation of the mean binding values, where n=2. 
 
As Figure 4.8A shows, the wild-type, E63K and E70A Munc-18c proteins bind to 
the GST control to varying degrees, with the E63K mutant showing the strongest 
binding. In contrast, the D222N mutant does not bind the GST control, however it 
does exhibit binding to all three SNARE proteins (Figure 4.8B, C and D). D222N 
Munc-18c binds Syntaxin 4 with similar affinity to the wild-type SM protein; 
however it exhibits higher levels of binding to both SNAP-23 and VAMP 2, as 
quantified in Figure 4.8E. These results partially confirm those observed in studies 
utilising Munc-18a, where D216N Munc-18a exhibited similar levels of binding to 
Syntaxin 1a, however reduced binding to SNAP-25 and VAMP 2 (Graham et al, 
2009). It is perhaps unsurprising that we observed these results, as these proteins 
are hypothesised to interfere with binding to the assembled SNARE complex, 
rather than individual SNAREs. This is not to say that the mutations only affect 
Mode 3 binding, and therefore what we observe may be a secondary effect of the 
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mutations. Ideally, we would hope to investigate the binding of the mutant SM 
proteins to the assembled SNARE complex, and with continued optimisation of 
our complex binding assay, it may be possible to assess the effect of SM protein 
binding to the assembled SNARE complex in this manner. 
4.3.4.3 Effect of mutant Munc-18c on SNARE-mediated membrane 
fusion 
Although our pull-down assays failed to highlight any functional significance of the 
Mode 3 mutations on the interactions between SNAREs and the SM protein (with 
the exception of the D222N mutant), we conducted further analysis into their 
function by adding the proteins to the in vitro fusion assay. As the point mutants we 
were investigating are hypothesised to interfere with binding to the assembled 
SNARE complex (Mode 3) we designed an alternative assay, in which the t- and    
v-SNARE liposomes are pre-incubated overnight in order to induce pre-docking of 
SNARE complexes before addition of the SM protein the next morning (unlike 
previous experiments, where all components of the assay were incubated together 
overnight, outlined in Section 4.3.2.2). As before, t-SNARE protein concentration 
was quantified by amido black protein assay, and Munc-18c was added in a 1:1 
molar ratio. 
After addition of SM protein, the plate was warmed to 37 °C for 15 minutes to bring 
it to reaction temperature. Fluorescence was measured every two minutes for 2 
hours, before addition of 10 µl n-dodecylmaltoside detergent in order to lyse the 
vesicles and obtain a maximum NBD fluorescence reading. Data was normalised 
and plotted as a percentage of the maximum NBD fluorescence. 
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Figure 4.9 The effect of mutant Munc-18c on the in vitro fusion assay 
(A) 2 µg of wild-type, E64K, E70A and D222N Munc-18c was analysed by SDS PAGE and 
Coomassie staining to ensure equal loading. 45 µl t-SNARE liposome and 5 µl v-SNARE (red 
squares) or empty donor (black circles) liposomes were incubated overnight at 4 °C in order to 
pre-dock SNARE complexes. The next morning, either wild-type or (B) E63K (C) E70A or 
(D) D222N mutant Munc-18c protein was added to the liposomes in a 1:1 molar ratio with the 
binary t-SNARE complex. After warming to reaction temperature, fluorescence readings were 
measured for 2 hours. Figure shows representative data from these experiments. 
 
The fusion data from these experiments shows that when added to pre-docked 
SNARE complexes, wild-type Munc-18c decreases the rate of fusion between 
SNARE-containing vesicles, as shown in Figure 4.9. The three point mutations we 
investigated appear to further inhibit the rate of fusion compared to wild-type, 
with the D222N mutation showing the most pronounced effect (Figure 4.9D), 
indicating that these mutations in the SM protein confer a dominant negative 
effect. This is perhaps surprising as experiments using the E63K and E70A 
mutations in the neuronal SM protein Munc-18a showed that these mutations 
caused no change in the rate of vesicle fusion compared to wild-type (Déak et al, 
2009).  
Furthermore, studies using Munc-18c knockout mice suggested that the SM 
protein has a positive regulatory role in SNARE-complex formation and/or vesicle 
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fusion as these heterozygous knockout mice (Munc-18c -/+) display reduced insulin 
sensitivity and decreased insulin-stimulated GLUT4 translocation to the plasma 
membrane (Oh et al, 2005). Previous experiments in our lab indicated that      
Munc-18c was able to interact with Syntaxin 4 via Mode 1 and Mode 2 binding, 
with Mode 1 conferring a negative regulatory role (Brandie et al, 2008). Experiments 
performed in this study confirmed this observation (Section 4.3.2.2), and we 
hypothesised that Mode 3 interactions between Munc-18c and the SNARE 
complex may confer the positive regulatory role indicated by previous knockout 
mice studies (Oh et al, 2005). 
In order to further dissect our results, we decided to reassess the ability of the           
C-terminally tagged wild-type Munc-18c in our “Mode 3 in vitro fusion assay”, 
where the SM protein is added to the liposomes after they have been incubated 
together overnight at 4°C to induce pre-docking of the SNARE complexes. As 
before, t- and v-SNARE containing liposomes were incubated overnight at 4°C, 
before addition of N- or C-terminally tagged wild-type Munc-18c in a 1:1 molar ratio 
(relative to the binary t-SNARE complex). Fusion was measured every two minutes 
for 2 hours and plotted as a percentage of the maximum NBD fluorescence obtained 
after vesicle lysis. 
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Figure 4.10 Effect of His-tag location on wild-type SM protein Mode 3 fusion 
45 µl t-SNARE vesicles was incubated with 5 µl v-SNARE containing (red squares) or protein-
free (black circles) donor vesicles overnight at 4 °C. The next morning, N- (purple triangles) or 
C- (green triangle) terminally tagged Munc-18c was added and fluorescence measured for two 
hours. Vesicles were lysed with 10 µl n-dodecylmaltoside and fluorescence measured for 40 
minutes. Data was plotted as a percentage of maximum NBD fluorescence. Figure shows 
representative data for these experiments. 
 
Unlike our previous experiment where N- and C-terminally tagged Munc-18c was 
incubated with the t- and v-SNARE overnight, when C-terminally tagged       
Munc-18c was added to assembled SNARE complexes, the rate of fusion increases 
(Figure 4.10, green triangles). Although we were unable to measure the exact 
change in fusion rate (as the absolute levels of fluorescence vary for each 
reconstitution), we have qualitatively observed this increase in at least three 
experiments, and the trend is maintained. This supports the expected results 
(discussed above), but raises concern with regards to the location of purification 
tags on recombinant SM proteins, as studies into SM protein function have used 
tags on both termini (N-terminal: Brandie et al, 2008; Scott et al, 2004; C-terminal: 
Rodkey et al, 2008). 
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4.4 Conclusions 
After establishing the in vitro fusion assay (discussed in Chapter 3), we were able to 
use it to study the effects of the SM protein Munc-18c on the rate of SNARE-
mediated membrane fusion. Previous experiments in our lab have indicated that 
this SM protein is a negative-regulator of SNARE mediated fusion (Brandie et al, 
2008), however the existence of a positive regulatory role in fusion has been 
suggested by knockout studies using mice (Oh et al, 2005). 
Our initial experiments using N- and C-terminally His6-tagged Munc-18c indicated 
that the purification tag did not affect the interaction between Syntaxin 4 and the 
SM protein (Figure 4.3); and both constructs equally inhibited the rate of Syntaxin 
4/ SNAP-23/VAMP 2-mediated fusion of the two liposome populations to a similar 
extent (Figure 4.4). 
We generated three point mutants of Munc-18c based on similar studies in 
homologous fusion systems. The effect of these point mutants was analysed by 
pull-down assay and addition to the in vitro fusion assay. Initial experiments using 
recombinant assembled SNARE complexes displayed high levels of non-specific 
binding between the SM protein and the complex (Figure 4.7), so we investigated 
binding between the individual SNAREs and wild-type/mutant Munc-18c.  
In order to prevent non-specific binding between the SNARE and SM proteins, we 
used bacterial lysates clarified from E. coli expressing the SM and SNARE proteins 
of interest: the bacterial proteins present in the lysates were intended to act as a 
blocking agent, binding to GST and the Glutathione Sepharose 4B beads 
preventing the SM proteins from binding non-specifically. Utilising this method, 
we were able to observe binding between the SM proteins and individual SNAREs, 
but no overall pattern was observed, and the SM proteins bound to the SNARE 
proteins with differing affinities (Figure 4.8).  
Although these initial binding studies did not indicate any functional differences 
between the wild-type and mutant Munc-18c with regards to binding individual 
SNARE proteins, we further analysed the mutant SM proteins by addition into the 
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in vitro fusion assay (Section 4.3.4.3). In order to assess the effect of the proteins on 
Mode 3 binding (to the assembled SNARE complex), we altered our protocol, 
adding the SM protein after overnight pre-incubation of the t- and v-SNARE 
liposomes in order to induce complex formation. In this instance, the mutant 
proteins decreased the rate of SNARE-mediated membrane fusion compared to the 
wild-type Munc-18c (Figure 4.9). This was a surprising observation, as studies in 
homologous systems indicated that the E63 and E70 mutations did not affect the 
rate of vesicle fusion in the neuronal system (Déak et al, 2009). The D222N mutant 
showed the greatest levels of inhibition, which suggests that this residue is 
important in the interactions between the SM protein and SNARE complex. 
In order to understand our findings, we added the C-terminally tagged Munc-18c 
into the in vitro fusion assay using our modified “Mode 3” protocol, and observed 
that this protein was able to increase the rate of SNARE-mediated membrane 
fusion (Figure 4.10). This calls into question previous studies performed not only 
on Munc-18c but on other SM proteins which have been purified using an              
N-terminal polyhistidine tag. Although the N-terminally tagged construct causes a 
decrease in SNARE-mediated membrane fusion regardless of when it is added to 
the assay, the location of the C-terminal tag appears to have a different functional 
effect. It could be that the location of the N-terminal tag prevents access to a 
binding pocket, or possibly masks an important residue for interactions between 
the SM/SNARE proteins. Further structural and binding studies, including NMR 
and Surface Plasmon Resonance could be of interest to investigate why the location 
of the polyhistidine tag causes such a drastic effect. 
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5 The effect of insulin on the plasma membrane of 
3T3-L1 adipocytes 
5.1 Introduction 
The presentation of GLUT4 on the plasma membrane of muscle and adipose tissue 
is the end result of a complex signalling pathway which begins with insulin 
binding to its receptor in response to an increased blood glucose concentration, and 
culminates with the transport of GLUT4 from an intracellular store to the cell 
surface (Cushman et al, 1980; Suzuki and Kono, 1980). It has been difficult to locate 
the exact site of insulin action on this trafficking pathway, or to resolve each of the 
steps leading up to GLUT4 storage vesicle (GSV) fusion with the plasma 
membrane, in particular the final fusion event itself (Bai et al, 2007).  
In adipocytes, insulin was found to restrict the movement of GSVs located on a 
microtubule network close to the plasma membrane (Lizunov et al, 2005). Indeed, 
early studies implicated insulin in the recruitment of the exocyst – a tethering 
complex which may be involved in targeting  GLUT4 to the cell surface (Inoue et al, 
2003) and tethering of the GSVs in response to insulin (Inoue et al, 2006). In an 
attempt to resolve the steps of this regulated exocytosis event, high-resolution total 
internal reflection (TIRF) microscopy has been used to visualise fusion events 
within 100 nm of the plasma membrane. Using this live-cell imaging technique, it 
was observed that the docking of GSVs at the cell membrane was not regulated by 
insulin, but that a post-docking “priming” step appeared to be the insulin-regulated 
step at the plasma membrane (Bai et al, 2007). This high-resolution data helped 
further confirm the earlier observation that fusion of GSVs with the plasma 
membrane is not constitutive, rather it is stimulated eight-fold by insulin, leading 
to the plasma membrane of rat adipocytes being described as the location of the 
“key regulated step in stimulation of fusion” (Koumanov et al, 2005). 
TIRF microscopy studies have further resolved the function of insulin at the plasma 
membrane. Using fluorescently-tagged GLUT4, it was observed that under basal 
conditions, GLUT4 appears to cluster at distinct sites in the plasma membrane. 
These sites were also observed to recruit clathrin (a coat protein involved in the 
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formation of endocytotic vesicles), and thus are likely sites of GLUT4 
internalisation. It is believed that this clustering is dependent on insulin, and 
mediates GLUT4 delivery to and removal from the plasma membrane (Stenkula et 
al, 2010). This study also observed that upon insulin stimulation, two linked events 
occur at the plasma membrane: in addition to the expected increase in GSV 
exocytosis there is an increase in the dispersal of GLUT4 within in the plasma 
membrane. Furthermore, three minutes post-insulin the rate of GSV fusion with 
the plasma membrane returns to around basal levels, indicating the increased 
dispersal of the glucose transporter is responsible for the increased glucose 
transport observed 15 minutes after the initial insulin signal (Stenkula et al, 2010). 
With the identification of the plasma membrane as the major site of insulin action, 
in particular a post-docking event, it is now important to pinpoint the proteins 
present at the plasma membrane which may be targets of insulin, and to study their 
effect on the rate of GSV fusion with the plasma membrane. 
5.2 Aims of this chapter 
The aim of this chapter was to purify basal and insulin-stimulated plasma 
membrane fractions from 3T3-L1 adipocytes and to reconstitute the proteins found 
in these fractions into liposomes, similar to the in vitro fusion assay. Once 
reconstituted, the liposomes were silver stained and western blotted to identify 
SNAREs and SNARE-binding proteins, and run in a modified fusion assay to test 
their fusogenic capabilities, and to assess the site of insulin action at the plasma 
membrane. 
5.3 Results 
5.3.1 Purification of  Plasma Membrane fractions from 3T3-L1 adipocytes 
In order to obtain isolated plasma membrane from 3T3-L1 adipocytes, the cells were 
cultured and subjected to sub-cellular fractionation by differential centrifugation, 
as outlined in Section 2.2.4. This method of fractionation has been well 
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characterised (Piper et al, 1991; Thurmond et al, 1998) and isolates purified plasma 
membrane fractions. 
Before harvesting, the cells were left untreated (basal) or treated with 100 nM 
insulin for either 2 or 15 minutes. Usually, ten 10 cm2 plates of confluent adipocytes 
were required to obtain sufficient plasma membrane for each condition. A full 
fractionation, consisting of cytosol, high-density microsome (HDM, containing 
endoplasmic reticulum), low density microsome (LDM, containing insulin-
responsive GSVs) and plasma membrane fractions, was performed to ensure that 
GLUT4 was trafficked from the LDM to the plasma membrane as expected. 
Samples were also analysed for t-SNARE content to investigate whether the levels 
of these proteins in each sub-cellular fraction are altered by insulin stimulation, as 
shown in Figure 5.1. 
 
 
Figure 5.1 Sub-cellular fractionation of 3T3-L1 adipocytes 
After sub-cellular fractionation by differential centrifugation, each 3T3-L1 fraction was 
quantified by Bradford protein assay, and 15 µg of each fraction analysed by SDS PAGE on a 
15 % gel. Proteins were transferred onto nitrocellulose, and analysed by western blotting using 
the antibodies specified. Molecular weight markers are indicated, and these results are 
representative of at least three independent fractionations. GLUT4 translocation was 
quantified using ImageJ software (NIH) and plotted as a bar graph showing mean band 
intensity and standard deviation where n=3.  
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Upon insulin-stimulation, GLUT4 is trafficked from an intracellular pool (located 
within the low density microsome (LDM) fraction of 3T3-L1 adipocytes (James et 
al, 1987)) to the plasma membrane. As Figure 5.1D shows, insulin stimulation 
causes a decrease in the amount of GLUT4 present in the LDM fraction, and an 
increase in the amount in the plasma membrane fraction, indicating that GLUT4 is 
being correctly trafficked in response to insulin. Each time a fractionation was 
performed, a sample was blotted to check for correct GLUT4 trafficking before 
proceeding with any reconstitution. 
The levels of t-SNARE proteins in each sub-cellular fraction were unaffected by 
insulin stimulation, confirming previous observations (Tellam et al, 1997; St-Denis et 
al, 1999), and suggesting that any effect of insulin on the rate of SNARE-mediated 
membrane fusion is not due to an increase in SNARE protein levels, but could 
perhaps be attributed to changes in SNARE conformation, repositioning of the 
SNARE proteins on the plasma membrane or post-translational modifications in 
order to form functional binary  t-SNARE complexes.  
5.3.2 Optimisation of  plasma membrane reconstitution conditions 
In order to examine the effect of insulin on the fusogenic properties of the plasma 
membrane of 3T3-L1 adipocytes, isolated plasma membrane fractions were 
reconstituted into liposomes in order to be tested in a modified in vitro fusion assay. 
The reconstitution method devised for this project was based on the methods 
outlined in both Weber et al (1998) and Koumanov et al (2005) which describe the 
original SNARE liposome reconstitution and fusion experiments, and the 
reconstitution and fusion of endogenous rat plasma membrane fractions 
respectively. In standard in vitro fusion assays using recombinant protein, 500 µl of 
~0.5-1 µg t-SNARE binary complex is reconstituted into the proteoliposomes. Since 
~ 1.5 µg plasma membrane is obtained from each fractionation of ten 10 cm3 plates, it 
was important to determine how much plasma membrane to reconstitute in order 
to obtain sufficient fusion. 
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The protein concentration of each plasma membrane fraction was determined by 
Bradford assay (Section 2.2.3.4) and three dilutions were prepared, with final total 
protein concentrations of 0.3 mg/ml, 0.75 mg/ml and 1.5 mg/ml made up to a total 
volume of 500 µl in HES + PI buffer containing 0.8 % (w/v) n-octyl-β-D-
glucopyranoside in order to solubilise the plasma membrane. Similar to the 
methods outlined for recombinant proteoliposomes (Sections 2.2.5.3 and 3.3.4), 
plasma membrane acceptor vesicles were prepared using a 15 mM lipid mix 
containing 85 mol % POPC and 15 mol % DOPS. The lipid film was dried under 
nitrogen for 15 minutes, and residual chloroform removed by vacuum dessication 
for 30 minutes. The film was resuspended in the plasma membrane protein solution 
by vortexing for 5 minutes and the detergent diluted by drop-wise addition of 1 ml 
Exchange/Reconstitution buffer containing 1 mM DTT. The samples were then 
dialysed overnight in 4 L Exchange/Reconstitution buffer containing 1 mM DTT at 
4°C. The next day, proteoliposomes were recovered by gradient centrifugation 
(Section 2.2.5.4) and protein content analysed by SDS PAGE and western blotting. 
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Figure 5.2 Analysis of t-SNARE reconstitution from 3T3-L1 PM fractions 
Plasma membrane (PM) samples were made up to the final concentrations indicated in a total 
volume of 500 µl with HES buffer + PI and reconstituted with 100 µl of acceptor lipid (Section 
2.2.5.3). Proteoliposomes (Lipo.) were recovered by gradient centrifugation (Section 2.2.5.4). 
10 µg of plasma membrane was run alongside 10 µl of liposome sample for each reconstitution 
condition on an SDS PAGE gel and analysed for t-SNARE content by western blotting with 
the specified antibodies. Molecular weight markers are indicated, and results are 
representative of at least three independent experiments. 
 
The t-SNAREs obtained from each plasma membrane concentration were 
reconstituted into liposomes, as shown in Figure 5.2. The amount of t-SNARE 
reconstituted was dependent on the concentration of plasma membrane added, 
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with higher concentrations of membrane leading to greater amounts of t-SNARE 
reconstitution. It is also interesting to note that doublet bands appear for some 
samples, most strikingly in the 0.75 mg/ml samples. Both t-SNAREs are known to 
be phosphorylated (discussed further in Section 5.3.5), and these bands could 
indicate the presence of phospho-SNAREs. It is important to note, however, that 
the doublet bands are not observed in all samples. This could be due to lower 
protein levels in the 0.3 mg/ml samples, preventing detection of the lower band. 
Similarly, the high protein levels in the 1.5 mg/ml samples could be preventing clear 
resolution of the bands.  
5.3.3 Optimisation of  fusion assay conditions 
Unlike our previous in vitro fusion assays performed using recombinant SNAREs 
(Chapters 3 and 4), the proteoliposomes created using 3T3-L1 adipocyte plasma 
membrane are likely to contain more proteins than simply the t-SNAREs, as it is 
plausible that any protein with a transmembrane domain can be incorporated into 
the lipid bilayer. Therefore, we were required to optimise the assay to ensure that 
the controls and reaction conditions were suitable for this fusion assay. 
5.3.3.1 Optimisation of control reaction 
Previous investigations into SNARE fusion using a recombinant in vitro fusion assay 
used a v-SNARE control in order to ensure that fusion is due to SNARE-SNARE 
interactions, and is not spontaneous. This control utilises the cytosolic domain of 
the v-SNARE VAMP 2. When added to the reaction, the cytosolic v-SNARE binds 
to the t-SNARE complexes, preventing the v-SNARE in the donor vesicles from 
interacting with its cognate t-SNAREs, thus acting as a negative control by 
preventing fusion (Weber et al, 1998; Brandie et al, 2008; Ji et al, 2010). 
In order to optimise the control experiment for our fusion assay using proteins 
isolated from plasma membranes, we performed two controls. The first involved 
incubating the cytosolic domain of VAMP 2 with the plasma membrane- and          
v-SNARE containing vesicles overnight. The second control used protein-free 
donor liposomes in place of the VAMP 2-containing vesicles. 
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Experiments into the fusion of reconstituted rat adipose plasma membrane with 
GLUT4 and VAMP 2-containing donor vesicles were performed slightly differently 
than those using recombinant proteins, as fluorescence was measured for a period 
of 30 minutes rather than two hours. It appears that this was due to the fact that 
close to maximal fluorescence was achieved at this time-point, and this matched 
the time-course for insulin stimulation of glucose transport in intact cells 
(Koumanov et al, 2005; Karnieli et al, 1981). As our experiments combined both 
recombinant and plasma-membrane derived liposomes, we chose to alter our in vitro 
fusion assay protocol in order to account for both systems. 
Plasma membrane-derived vesicles were incubated overnight at 4°C with either      
5 µl protein-free donor liposomes; 5 µl VAMP 2-containing liposomes plus 5 µl 
cytosolic VAMP 2; or 5 µl VAMP 2-containing liposomes. The next morning, the 
plate was warmed to 37 °C in a FLUOstar Optima spectrophotometer for 15 
minutes, before fluorescence readings were taken every two minutes for one hour, 
as this was an intermediate time-point between experiments performed by 
Koumanov et al and the in vitro fusion assay. 10 µl of 2.5 % (w/v) n-dodecylmaltoside 
was then added in order to lyse the vesicles and obtain a maximum NBD 
fluorescence reading. Data was normalised as described previously and plotted as a 
percentage of maximum NBD fluorescence.  
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Figure 5.3 Optimisation of plasma membrane fusion assay controls 
45 µl acceptor liposomes derived from (A) basal (B) 2 minute insulin-stimulated or (C) 15 
minute insulin-stimulated plasma membrane were incubated overnight with either 5 µl 
protein-free liposomes (red squares), 5 µl VAMP 2 vesicles in the presence of the cytosolic 
domain of VAMP 2 (black circles) or 5 µl HES + PI buffer (green squares). Fusion was 
measured for 60 minutes, and maximum NBD fluorescence obtained by lysis of the donor 
vesicles with detergent. Figure shows representative data from three independent experiments. 
 
These experiments revealed the scope of variability in this approach to studying the 
effect of insulin on the plasma membrane of 3T3-L1 adipocytes, and highlighted 
several stages which required further optimisation. Firstly, using the cytosolic 
domain of VAMP 2 as a control was not sufficient, as it did not appear to inhibit 
SNARE-mediated fusion: for both the liposomes derived from basal (Figure 5.3A), 
and 2 minute insulin-stimulated (Figure 5.3B) plasma membrane, the rate of 
“inhibited” fusion is the same or greater than the uninhibited reaction. For the 
liposomes derived from 15 minute insulin-stimulated plasma membrane (Figure 
5.3C), the cytosolic domain of VAMP 2 appears to inhibit fusion, although the final 
level of fluorescence is quite high (~20 %).  
Compared to the cytosolic VAMP 2 control, the empty liposomes inhibited the rate 
of fusion to a greater extent. However, it is interesting to note that the rate of 
fusion for the liposomes derived from 2 minute insulin-stimulated plasma 
membrane was lower than both controls (Figure 5.3B). We chose to continue on 
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using protein-free vesicles as a control for the fusion reactions, as the cytosolic 
VAMP 2 control did not appear to be functioning as expected, and given the 
complex protein content of the plasma membrane-derived vesicles, protein-free 
vesicles would allow us to focus solely on the effect of SNARE-mediated membrane 
fusion. 
These experiments were carried out using 0.3 mg/ml plasma membrane liposomes, 
and due to the varying rates of fusion (for example, the liposomes derived from        
2 minute insulin-stimulated plasma membrane have the lowest level of fusion), we 
were required to further optimise the concentration of plasma membrane required 
to accurately measure fusion. 
5.3.3.2 Optimisation of PM concentrations 
As mentioned previously, three concentrations of plasma membrane were 
reconstituted (final total protein concentrations of 0.3, 0.75 and 1.5 mg/ml in a total 
volume of 500 µl). In order to determine the optimum concentration of plasma 
membrane required, fusion assays were performed using liposomes derived from 
basal and insulin-stimulated plasma membrane at these concentrations. 
Fusion assays were set up and run as described previously (Section 5.3.3.1) using 
empty liposomes as a control, with fluorescence readings recorded every two 
minutes for one hour. The vesicles were then lysed by addition of 10 µl 2.5 % (w/v) 
n-dodecylmaltoside in order to obtain a maximum NBD fluorescence reading from 
the donor vesicles. Normalised data was plotted as a percentage of maximum NBD 
fluorescence and is shown in Figure 5.4. 
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Figure 5.4 Fusion of liposomes containing protein derived from 3T3-L1 plasma membrane 
45 µl (A) 0.3 mg/ml or (B) 0.75 mg/ml plasma membrane-containing liposomes were 
incubated overnight with 5 µl empty (shaded symbols) or VAMP 2-containing (open symbols) 
liposome. Fusion was measured for 60 minutes, and maximum NBD fluorescence obtained by 
lysis of the donor vesicles with detergent. Figure shows representative data from three 
independent experiments. 
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Both populations of liposomes exhibit varying degrees of fusion, dependent on 
insulin-stimulation, as shown in Figure 5.4. Using 0.3 mg/ml liposomes, the rate of 
fusion is lowest at basal insulin, increases after 2 minutes of insulin stimulation, 
and then decreases after 15 minutes of insulin stimulation; whereas the 0.75 mg/ml 
liposomes exhibit and increase in fusion only after 15 minutes of insulin 
stimulation, with no difference between basal and 2 minutes of insulin stimulation. 
It is also of interest to note that fusion assays using 0.75 mg/ml plasma membrane 
show consistent inhibition of fusion using protein-free liposomes, whist there is 
some variation between the 0.3 mg/ml liposome controls. 
No results were obtained from the liposomes created using 1.5 mg/ml plasma 
membrane. After gradient centrifugation, the recovered liposomes appeared 
yellow/orange in colour. When added to the in vitro fusion assay, these liposomes 
produced auto-fluorescence, bleaching the reaction and preventing any 
fluorescence readings from being recorded.  
Based on the data from these experiments, we chose to continue our analysis using 
liposomes created using 0.75 mg/ml plasma membrane. These liposomes closely 
resembled the rates of fusion we would expect to see in vivo, with insulin increasing 
the rate of SNARE-mediated membrane fusion. Furthermore, these liposomes 
produced consistent controls, allowing us to confirm that the fusion observed in 
due to SNARE complex formation. For these reasons, we performed the rest of our 
analysis using these liposomes. 
5.3.4 Silver staining of  plasma membrane-derived liposomes 
As observed in Section 5.3.3, the rate of fusion observed using plasma membrane-
derived liposomes was significantly higher than that observed using liposomes 
containing recombinant t-SNAREs, as shown in Chapter 3. Due to the abundance 
of proteins found in the plasma membrane of 3T3-L1 adipocytes, it was important 
to try to identify any which may have an effect on the rate of SNARE-mediated 
fusion if reconstituted along with the t-SNAREs. These could include Rab 
GTPases, kinases, NSF/α-SNAP or Sec1/Munc-18 proteins. 
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In order to identify potential interacting proteins which may have been 
reconstituted, samples of plasma membrane and liposome were analysed by SDS 
PAGE and silver staining (Figure 5.5).  
 
Figure 5.5 Silver staining of plasma membrane and liposome samples 
10 µg of 3T3-L1 plasma membrane and 20 µl of liposome sample were run on a 15 % SDS 
PAGE gel and subjected to silver staining. Bands of interest, where protein amount appears to 
increase (shaded arrows) or decrease (open arrows) upon insulin stimulation, and molecular 
weight markers have been indicated. Lanes Lip. 1 and Lip.2 represent two separate plasma 
membrane purifications and reconstitutions.  
 
Once stained, bands of interest could be identified, including proteins which 
appeared to change amount depending on insulin stimulation, and those which are 
present in high abundance (indicated in Figure 5.5). Although we were primarily 
interested in the SNARE proteins reconstituted into the liposomes, SNAREs are 
not the only proteins reconstituted, and thus identifying other proteins 
reconstituted could allow for greater dissection of the effect of insulin at the plasma 
membrane, and could also allow us to understand the differing rates of fusion 
observed due to differing lengths of insulin stimulation. 
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5.3.5 Western blotting for SNARE effectors 
As Figure 5.5 shows, many proteins are present in the liposomes reconstituted from 
plasma membrane samples. To identify a few potential SNARE-effectors which 
may have been reconstituted, we decided to perform preliminary analysis on the 
liposome samples by western blotting for proteins known to interact with 
SNAREs. We chose the three kinases Protein Kinase A (PKA), Protein Kinase B 
(Akt), Protein Kinase C (PKC), all of which have a possible role in GLUT4 
translocation.  
Syntaxin 4 has been shown to be a substrate of PKA, and phosphorylated Syntaxin 
4 exhibits less binding to SNAP-23, implying a negative role for this kinase in GSV 
fusion (Foster et al, 1998). PKC has also been identified as an important kinase in 
the regulation of SNARE complex formation. Syntaxin 4, SNAP-23 and VAMP 2 
have all been identified as substrates for PKC and, for Syntaxin 4 and SNAP-23, 
phosphorylation by this kinase leads to a decrease in affinity for their cognate t-
SNARE partner (Chung et al, 2000; Polgár et al, 2003). VAMP 2 has also been 
identified as a substrate for PKC; however no functional role has been attributed to 
this phosphorylation (Braiman et al, 2001). 
The Sec1/Munc-18 protein Munc-18c can be phosphorylated on multiple residues. 
The insulin receptor, specifically the cytosolic β-subunit of the protein (Aran et al, 
2011), was found to phosphorylate Munc-18c directly on residues Tyr219 and 
Tyr521 (Jewell et al, 2011). Phosphorylation at Tyr521 has since been found to 
reduce binding of the SM protein to Syntaxin 4 and VAMP 2 (Aran et al, 2011). PKC 
has also been identified as a kinase for Munc-18c, and phosphorylation leads to a 
decrease in affinity for Syntaxin 4 (Schraw et al, 2003). 
Samples of basal and insulin-stimulated whole-cell lysate (WCL), plasma 
membrane (PM) and liposome were analysed by SDS PAGE and western blotting 
for the presence of kinases. 
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Figure 5.6 Kinases in 3T3-L1 adipocyte lysate, PM and liposomes 
15 µg whole-cell lysates (WCL) and plasma membrane (PM), and 20 µl liposome (Lipo.) were 
analysed on a 12 % SDS PAGE gel. After transfer onto nitrocellulose, the membrane was cut 
into strips and blotted using the antibodies specified, with Syntaxin 4 acting as a loading 
control. Molecular weight markers are indicated, and data is representative of three 
independent experiments. 
 
As Figure 5.6 shows, insulin causes an increase all three kinase levels at the plasma 
membrane of 3T3-L1 adipocytes, consistent with previous studies (Farese et al, 
1992; Carvalho et al, 2000). However, despite an increase in PKA, –B and –C at the 
plasma membrane in response to insulin, none of these kinases are reconstituted 
into the liposomes. Although the kinases are not detectable in the liposomes, their 
effect on the t-SNAREs and SM protein may still be observed in the fusion assay via 
phosphorylation of their target proteins. This may be consistent with the presence 
of doublet bands: the Syntaxin 4 loading control in Figure 5.6 contains a doublet 
which may be consistent with the presence of phospho-Syntaxin 4, however 
further robust tests would be required to link these kinases to the rate of plasma 
membrane fusion. 
5.4 Conclusions 
This chapter aimed to study the effect of insulin on the plasma membrane of 3T3-L1 
adipocytes using a modified version of our previously established in vitro fusion 
assay. Isolated plasma membrane fractions from basal and insulin-stimulated 3T3-
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L1 adipocytes were reconstituted into liposomes and the protein content of these 
vesicles was assessed by silver staining and western blotting. The proteoliposomes 
were then added to the in vitro fusion assay with VAMP 2-containing donor vesicles 
in order to measure their fusogenic properties. 
Previous studies into the effect of insulin on SNARE-mediate fusion of GSVs at the 
plasma membrane of adipocytes utilised liposomes created using both isolated 
plasma membrane fractions and GSVs from rat adipocytes: both were reconstituted 
into separate vesicle populations, and their ability to fuse was analysed (Koumanov 
et al, 2005). Using this method, it was discovered that the fusion of GSVs with the 
plasma membrane of adipocytes was SNARE and cytosol-dependent; in particular, 
the presence of PKB in the cytosol was necessary to sustain rapid insulin-
stimulated fusion (Koumanov et al, 2005). This necessity for PKB is perhaps 
unsurprising, given that many of the effects of insulin signalling are mediated by 
PKB (Taniguchi et al¸ 2006).  
Results from our investigation partially confirm those obtained in the study by 
Koumanov and colleagues. Insulin-stimulation in our system leads to changes in 
the plasma membrane which culminate in an increase in the rate of SNARE-
mediated fusion (Figure 5.4B). However, unlike the experiments performed by 
Koumanov and colleague, our experiments did not require addition of cytosol in 
order to sustain fusion, although it may be interesting to test the effect of cytosol 
addition to our assay in future experiments. Further to this, direct addition of PKB 
to our assay was not required in order to sustain fusion; however we did observe an 
increase in PKB at the plasma membrane of 3T3-L1 adipocytes (Figure 5.6). 
Although the kinase was not detected in our liposomes, it is possible that it had an 
effect on plasma membrane-located proteins which are then reconstituted, leading 
to the observed increase in SNARE-mediated membrane fusion; a hypothesis which 
would warrant further investigation. 
Although our experimental system draws from that outlined by Koumanov and 
colleagues, one fundamental difference exists that may explain the necessity for 
cytosol to sustain fusion in their system. As our investigation sought to understand 
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the effect of insulin solely on the plasma membrane of 3T3-L1 adipocytes, we chose 
to use VAMP 2-containing vesicles as our donor liposomes. This allowed us to 
attribute any changes observed in the rate of fusion to changes at the plasma 
membrane. In contrast, the Koumanov study utilised isolated GSVs as their donor 
liposomes, adding further variables to the reaction. It is therefore plausible that the 
addition of cytosol may have an effect on the GSVs, rather than the plasma 
membrane, leading to their observed increase in fusion. It would be interesting to 
further utilise our assay to investigate the observations made by Koumanov and 
colleagues, for example by isolating the plasma membrane fractions from 3T3-L1 
adipocytes which have been depleted of cytosolic proteins, for example PKB, and 
studying the effect of insulin on membrane fusion in these cells. In this way, our 
assay could be used to further dissect the proteins and interactions involved in 
SNARE-mediated membrane fusion in 3T3-L1 adipocytes. 
Western blot analysis of basal and insulin-stimulated plasma membrane indicated 
that insulin does not alter the amount of t-SNARE present at the plasma 
membrane, however insulin signalling does increase the level of GLUT4 (Figure 
5.1). This suggests that insulin signalling alters the conformation of the proteins; 
induces binding or dissociation of effector proteins; or perhaps alters the plasma 
membrane localisation of the proteins, bringing together binary t-SNARE 
complexes. This hypothesis was further supported by the increase in PKA, PKB and 
PKC at the plasma membrane upon insulin stimulation (Figure 5.6), however we 
could not accurately show the exact effect of these kinases on the rate of fusion due 
to the high number of proteins present in both the plasma membrane and liposome 
samples (Figure 5.5). 
Optimisation of the fusion assay conditions using liposomes derived from basal and 
insulin stimulated plasma membrane indicated that, similar to the recombinant in 
vitro fusion assay, protein-free liposomes were an effective control to ensure that 
the fusion observed was due to SNARE-SNARE interactions. Furthermore, it was 
also observed that liposomes reconstituted using 0.75 mg/ml plasma membrane 
showed more consistent controls and fusion than those with lower (0.3 mg/ml) or 
higher (1.5 mg/ml) protein concentrations. 
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Silver staining indicated that there were more proteins reconstituted into our 
liposomes than the t-SNAREs alone (Figure 5.5); however we have as yet been 
unable to identify any of these proteins. Although preliminary investigation 
detected an increase in PKA, PKB and PKC at the plasma membrane upon insulin 
stimulation, the proteins were not reconstituted into the liposomes with the           
t-SNAREs (Figure 5.6). Although these proteins are not present in the liposomes, it 
is possible that they are still having an effect on the rate of membrane fusion by 
phosphorylation of target proteins which are then reconstituted. Although we 
cannot definitively say that this is the case, the next stage for this project would be 
to identify the bands present in the liposome samples by mass spectrometry and 
confirm any findings by western blotting, alongside further robust investigations 
into the effect of kinases on SNARE-mediated membrane fusion. 
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6 Discussion 
Diabetes UK estimates that around 3 million people in the UK have been diagnosed 
with diabetes, and that 90 % of these have Type 2 diabetes (Diabetes in the UK, 
Diabetes UK 2011/2012). With 552 million people worldwide expected to be 
affected by diabetes by 2030, it is important to understand the molecular 
mechanisms behind the condition with a view to treating or curing it. 
Under normal physiological conditions, after a meal there is an increase in blood-
sugar concentration. To counter this, the pancreas produces the hormone insulin, 
which acts on fat and adipose tissue to translocate the glucose transporter GLUT4 
from intracellular stores to the plasma membrane. Once at the plasma membrane, 
this transporter lowers blood-glucose levels by transporting glucose into muscle 
and adipose tissues where it is stored as glycogen and triglycerides respectively. 
Type 2 diabetes is characterised as an impaired glucose uptake in response to 
insulin signalling due to lower levels of GLUT4 on the cell surface. 
The SNARE proteins Syntaxin 4, SNAP-23 and VAMP 2 have been implicated in 
the fusion of GSVs with the plasma membrane in response to insulin signalling 
(Cheatham et al, 1996), and thus understanding SNARE complex formation and 
regulation is key to unravelling the impaired mechanisms which characterise Type 
2 diabetes. Sec1/Munc-18 (SM) proteins are a family of proteins implicated in the 
regulation of SNARE-mediated membrane fusion, with Munc-18c involved in the 
regulation of GSV fusion at the plasma membrane. This thesis aimed to investigate 
the interactions between the SNARE and the SM protein Munc-18c, which are 
involved in GLUT4 translocation in response to insulin. 
6.1 Regulation of membrane fusion by SNARE proteins in an 
in vitro system 
The original aim of this section of my thesis was to utilise the in vitro fusion assay 
developed previously in our lab (Brandie et al, 2008) to test whether the location of 
the His6 purification tag on Munc-18c affected the function of the SM protein. 
However, as outlined in Chapter 3, our initial attempts at utilising the in vitro fusion 
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assay were unsuccessful and, despite using the same construct and 
purification/reconstitution methods outlined in the paper by Brandie and 
colleagues, we were unable to replicate the results. Investigation into why this may 
be the case indicated the t-SNARE proteins were unable to form stable binary 
complexes (Figure 3.8), hence low levels of t-SNARE complex were reconstituted 
into liposomes (Figure 3.6), leading to low levels of membrane fusion (Figure 3.7). 
The in vitro fusion assay has been long established for other SNARE-mediated 
membrane fusion events; including neurotransmitter release (Weber et al, 1998; Ji 
et al, 2010) and yeast ER-Golgi transport (Scott et al, 2003). Although in these 
assays, binary t-SNARE complexes are formed and reconstituted into liposomes, 
one notable observation is that a higher level of one t-SNARE is purified and 
reconstituted into the vesicles, for example, in the initial SNARE-mediated fusion 
assay developed by Weber and colleagues, more Syntaxin 1a is reconstituted 
relative to SNAP-25; a characteristic which is observed in later studies utilising 
these SNAREs (Ji et al, 2010). Indeed, in the study by Brandie and colleagues into 
the Syntaxin 4/SNAP-23/VAMP 2 fusion system, more SNAP-23 appears to be 
reconstituted into the vesicles in relation to Syntaxin 4. In all cases, the t-SNAREs 
were co-expressed from separate vectors, one under the control of the T7 promoter 
and the other under T5, and expressed in BL21 (DE3) E. coli which, as discussed in 
Chapter 3, is not ideal for the expression of proteins under the control of the T5 
promoter as this exhibits high levels of basal expression, and may account for the 
uneven expression of the t-SNAREs. 
As t-SNARE complex formation appeared to be the root of the issues with our in 
vitro fusion assay, we opted to re-establish the assay utilising binary t-SNARE 
complexes expressed from the vector pETDuet-1 (Novagen), This vector contains 
two multiple cloning sites, allowing for simultaneous expression of two target 
genes. Both multiple cloning sites are under the control of the T7 promoter, 
preventing basal expression and allowing both genes to be expressed at similar 
rates to one another. After optimisation of the purification conditions, binary          
t-SNARE complexes were produced from this vector (Figure 3.9) and reconstituted 
into vesicles (Figure 3.10). Unlike previous studies, the complexes expressed from 
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pETDuet-1 contained a much more even ratio of Syntaxin:SNAP; and in agreement 
with the previous study performed in our lab (Brandie et al, 2008), the SNARE 
complex consisting of Syntaxin 4, SNAP-23 and VAMP 2 was sufficient to drive the 
fusion of two vesicle populations in vitro (Figure 3.11). No published SNARE-
mediated in vitro fusion assay has utilised t-SNAREs purified in this way, but as 
binary t-SNARE complexes it crucial to trans-SNARE complex formation, the 
vector pETDuet-1 may be a useful tool in isolating evenly formed t-SNARE 
complexes. 
It is important to note the presence of contaminant bands in the SNARE 
preparations, in particular the full-length and cytosolic VAMP 2 (Figure 3.2 and 
Figure 3.3).  With the full-length protein, this contaminant band is removed 
through the reconstitution process (Figure 3.5B), possibly through the dialysis 
step. Samples of the cytosolic domain of VAMP 2 were dialysed against 
Exchange/Reconstitution buffer to remove traces of Imidazole present in the 
elution buffer, and it is plausible that this too would remove the contaminant band, 
however as samples of the cytosolic domain of VAMP 2 were generally not run on a 
gel after concentration. It is interesting to note, as mentioned in Chapter 3, a 
contaminant band of the same molecular weight (~25 kDa) was observed in the 
cytosolic v-SNARE purifications by previous students in our lab who studied both 
mammalian and yeast fusion (Dr Fiona Brandie and Dr Chris MacDonald), 
suggesting that this contaminant may be an native E. coli protein which binds with 
affinity to nickel resin, however further study would be required to confirm this, for 
example, extraction of the band and analysis by mass spectroscopy. 
It would also be beneficial to further purify the proteins using techniques such as 
ion exchange chromatograph, which uses the isoelectric point of proteins to 
separate them by charge. This technique was being optimised by a fellow student 
in the lab, Andrew Fuller, who was looking to purify proteins for use in Isothermal 
Titration Calorimetry (ITC). Unfortunately this process was never fully optimised; 
however it would certainly be a useful tool to utilise to ensure that all proteins used 
in the in vitro fusion assay are as pure as possible. It may be difficult to use ion 
exchange chromatography to purify the binary t-SNARE complexes due to their 
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differing isoelectric points (5.84 for Syntaxin 4, 4.88 for SNAP-23), however this 
technique has been used in the past to purify SNARE proteins (Fasshauer et al, 
1998; Domanska et al, 2009) and SNARE complexes (Ernst and Brunger, 2002; 
Strop et al, 2007) and, with optimisation, could be used to further purify the t-
SNARE complexes to remove the contaminant bands present in the reconstituted 
samples (Figure 3.10). 
Although the liposome fusion assay is a useful tool for measuring the rate of 
SNARE-mediate membrane fusion in vitro, there are questions surrounding how 
relevant the assay is with relation to fusion evens in vivo. Firstly, there is debate as 
to how the proteoliposomes utilised in these studies should be generated. At 
present, two methods exist: the “standard” method (utilised in this study), which 
involves forming the liposomes alongside the SNARE proteins (Weber et al, 1998; 
Schuette et al, 2004; Brandie et al, 2008); and the “direct” method, in which the 
SNARE proteins are inserted into pre-formed liposomes (Kweon et al, 2003; Rigaud 
and Levy, 2003; Lu et al, 2005). In the “direct” method, unilamellar vesicles are 
produced with a diameter of 100 nm, whilst the “standard” method produces 
vesicles of with a broader range of diameter: vesicles with a diameter lower than 20 
nm have been shown to have high membrane curvature stress and are more prone 
to spontaneous fusion (Suurkuusk et al, 1976; Chen et al, 2006). Our study showed 
that almost all our vesicles produced by the “standard” method have a diameter of 
20-100 nm, which is within the accepted range outlined by Chen and colleagues. 
Furthermore, as shown in this and other studies, addition of the cytosolic domain 
of the v-SNARE inhibits fusion, indicating that the rates of fusion observed in the 
assay are due to SNARE complex formation, rather that spontaneous fusion of 
small vesicles (Figure 3.11; Weber et al, 1998; Hu et al, 2002; Brandie et al, 2008). 
Contention also surrounds whether the concentration of SNAREs found in 
proteoliposomes is too high to be physiologically relevant. Studies into the 
neuronal SNARE complex have used v-SNARE vesicles with high protein:lipid 
concentration (Weber et al, 1998; Lu et al, 2005), with around 50 times as many       
v-SNARE proteins reconstituted per vesicle than is observed in vivo (Dennison et al, 
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2006). Fusion assays utilising vesicles with a more physiological concentration of  
v-SNAREs did not exhibit fusion, leading to the hypothesis that SNARE complex 
formation may not be the minimal machinery for membrane fusion and that other 
proteins are necessary to regulate SNARE function (Dennison et al, 2005). While 
the concentration of VAMP 2 in GSVs has not been determined, the total SNARE 
content of 3T3-L1 adipocytes has been established (Hickson et al, 2000), and this 
would allow further development of our in vitro fusion system to incorporate 
physiological amounts of SNARE protein, especially since we are now able to 
produce and reconstitute even t-SNARE complexes. 
A final criticism of the in vitro fusion assay is that it does not measure fusion per se, 
rather it measures lipid mixing. Two methods have been developed in order to 
overcome this issue: the use of sodium dithionite, and the development of a content 
mixing in vitro assay. Sodium dithionite is a chemical which reduces NBD to a non-
fluorescent form (McIntyre and Slight, 1991), and was utilised by Weber and 
colleagues to essentially strip the fluorescence from the outer leaflet of the donor 
vesicles and measure the rate of fusion of the inner leaflet, showing that both 
leaflets of the membrane are involved in fusion. The second technique, a content 
mixing assay, is designed to measure the rate of a reaction, for example FRET, 
which occurs when the contents of the donor and acceptor liposomes are mixed: a 
reaction which can only occur through full membrane fusion. This type of assay has 
been used to show that the yeast SNAREs involved in transport to the plasma 
membrane are sufficient to drive membrane fusion (Diao et al, 2010), however these 
assay present the same issues as traditional in vitro fusion assays with regards to the 
concentration of SNAREs present in the vesicles. 
Whilst our in vitro fusion assay shows high levels of lipid mixing, it would be ideal 
to perform further experiments designed using the above mentioned criticisms in 
order to develop our knowledge of the SNARE-mediated fusion events which 
regulate GSV fusion in adipocytes. By designing an assay which utilises SNARE 
densities resembling those found in vivo (Hickson et al, 2000), and changing the 
assay to measure content rather than lipid mixing, we could determine whether the 
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SNARE complex consisting of Syntaxin 4, SNAP-23 and VAMP 2 can truly be 
called the “minimal machinery” driving GSV fusion in vivo. 
6.2 Regulation of Munc-18c/SNARE complex interactions 
and their effect on SNARE-mediated membrane fusion 
The next section of this thesis involved using the in vitro fusion assay to assess the 
effect of the SM protein Munc-18c on the rate of SNARE-mediated membrane 
fusion (Chapter 4). At present, no unified theory exists for the function of SM 
proteins in SNARE-mediated membrane fusion, despite the structural conservation 
which exists between members of the protein family (Gallwitz and Jahn, 2003). 
Three binding modes have been observed between different SM/SNARE proteins 
(outlined in Figure 4.1): binding of the SM protein to “closed” Syntaxin (Mode 1); 
binding of the SM protein to the N-terminus of Syntaxin (Mode 2) and binding of 
the SM protein to the assembled SNARE complex (Mode 3). It has been 
hypothesised that these different binding modes result in different function of the 
SM/SNARE protein complexes, depending on which mode is undertaken. For 
example, the neuronal SM protein Munc-18a was found to bind to Syntaxin 1a via 
both Modes 1 and 2, with each binding mode occurring at a different cellular 
location: Mode 1 binding was found to occur on intracellular membranes, whilst 
Mode 2 occurs at the plasma membrane (Rickman et al, 2007). This 
chaperone/activation duality has also been shown in both UNC64 in Caenorhabditis 
elegans (Johnson et al, 2009) and the yeast SM protein Vps45p (Bryant and James, 
2001). Furthermore, Mode 2 binding has been hypothesised to act as an 
intermediate step between Modes 1 and 3 binding (Khvotchev et al, 2007; Hu et al, 
2011). This suggests that the different binding modes observed between SM and 
SNARE proteins may be due to the SM protein having multiple functions before (as 
a chaperone for Syntaxin during transport) and during (mediating the “opening” of 
Syntaxin) membrane fusion. Conflicting data has been produced on whether some 
SM proteins are able to perform Mode 3 binding, for example, experiments using 
the neuronal SM protein Munc-18a have shown that it is able to perform Mode 3 
binding (Zilly et al, 2006) whilst others have shown that it cannot (Yang et al, 
2000). In contrast, the yeast SM protein Sec1p has been shown to bind to 
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assembled SNARE complexes (Togneri et al, 2006), where it acts as a stimulator of 
fusion (Scott et al, 2004). 
Munc-18c has been shown to exhibit Mode 1 and 2 binding with Syntaxin 4 
(D’Andrea-Merrins et al, 2007; Aran et al, 2009), with Mode 1 being inhibitory to 
SNARE complex formation and Mode 2, in particular the “opening” of Syntaxin 4, 
necessary for SNARE complex formation (D’Andrea-Merrins et al, 2007). It has 
been suggested that the SM protein is also able to bind the assembled Syntaxin 
4/SNAP-23/VAMP 2 SNARE complex (Latham et al, 2006); however no functional 
significance of this binding mode has been established.  
With the in vitro fusion assay now re-established, my first priority was to test our 
previous finding that Munc-18c acts as a negative regulator of SNARE-mediated 
membrane fusion. Information from a collaborator suggested that the location of 
the purification tag on the SM protein could affect the function of the protein in the 
in vitro fusion assay. In order to investigate this, recombinant N- and C-terminally 
tagged wild-type Munc-18c was purified from bacteria (Figure 4.2), and 
functionally analysed using GST pull-down assays (Figure 4.3), which indicated 
that both wild-type proteins bound to Syntaxin 4 equally when incubated 
overnight, suggesting that the purification tag does not affect this interaction. The 
function of the wild-type proteins was further analysed using the in vitro fusion 
assay. Following the protocol previously designed for this experiment, N- and       
C-terminally tagged wild-type SM protein was mixed with t- and v-SNARE 
liposomes, and fusion measured after overnight incubation at 4 °C to induce        
pre-docking of the vesicles. Using this method, I observed that both N- and                    
C-terminally tagged Munc-18c are negative regulators of SNARE-mediated 
membrane fusion (Figure 4.4), confirming previous findings (Brandie et al, 2008). 
In order to study the interactions involved in binding between Munc-18c and the 
assembled SNARE complex, point mutants were created in the SM protein which 
were hypothesised to interfere with this binding mode. Based on mutations made 
in the SM proteins Munc-18a (Déak et al, 2009) and unc-18 (Graham et al, 2009), 
residues E63, E70 and D222 were selected for mutagenesis by sequence alignment 
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and altered in order to disrupt their ability to interact with the SNARE proteins. I 
was able to purify the mutant SM proteins to similar concentrations as the wild-
type proteins (Figure 4.5), and analysed their functionality using both GST        
pull-down assays and the in vitro fusion assay. 
Assembled SNARE complexes were formed using bacterial lysates expressing the 
different SNARE proteins (Figure 4.7A), and were used to study Mode 3 binding 
between the complex and Munc-18c. Unfortunately, high levels of non-specific 
binding were observed between the SM protein and the GST-alone control (Figure 
4.7B), preventing accurate analysis of Mode 3 binding in this manner. In order to 
assess the interactions between the SNARE and SM proteins, I chose to simplify 
the assay and investigate binding between the wild-type and mutant SM proteins 
and the individual SNAREs: although this would not give definitive answers with 
regards to Mode 3 binding (as there is no assembled complex) it was hoped that 
these experiments may highlight some functional significance of the residues 
selected for analysis in Munc-18c. 
Despite multiple optimisation attempts, we were unable to prevent binding of the 
SM proteins to the GST control during our pulldown assays, with the exception of 
the D222N mutant, making it difficult to assign an overall pattern or model. The 
D222N model did not bind the GST control, but was still able to bind all three 
SNARE proteins studied (Figure 4.8), however as we were unable to fully quantify 
binding of the wild-type SM protein, it was impossible to determine the 
significance to these interactions. However, we were able to investigate the effect 
of the wild-type and mutant SM proteins in the in vitro fusion assay. As we were 
attempting to investigate Mode 3 binding between the SNARE complex and SM 
protein, I designed an altered form of the in vitro fusion assay, in which t- and v-
SNARE vesicles were incubated overnight to induce pre-docking of the SNARE 
complexes, before addition of Munc-18c just before the assay began. Using this 
assay, the mutant SM proteins were shown to inhibit SNARE-mediated membrane 
fusion to a greater extent that the wild-type SM protein, with the D222N mutant 
showing the strongest dominant negative effect (Figure 4.9). These results were 
unexpected, as experiments in homologous systems have yielded different results: 
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mutations to residues E63 and E70 in the neuronal SM protein Munc-18a did not 
affect the rate of vesicle fusion compared to the wild-type SM protein (Déak et al, 
2009). In order to understand this effect further, I returned to the C-terminally 
tagged wild-type Munc-18c protein, to test its function in the “Mode 3” fusion 
assay (where the SM protein is added after overnight incubation of the liposomes). 
When tested in this manner, the addition of C-terminally tagged Munc-18c caused 
an increase in the rate of SNARE-mediated membrane fusion (Figure 4.10), in 
contrast to our previous tests with this protein (Figure 4.4). 
It has been previously shown that the location of a GST tag on the N-terminus of 
Syntaxin 4 leads to a decrease in binding to recombinant Munc-18c (Aran et al, 
2009). GST is a large (~25 kDa) purification tag, whilst the polyhistidine tag is 
much smaller (His6 <1 kDa), nevertheless, the polyhistidine tag appears to have 
some effect on the functional properties of Munc-18c when added to the in vitro 
fusion assay in this Mode 3 manner. This also calls into question the results from 
the experiments utilising the mutant Munc-18c proteins as these too contain an          
N-terminal polyhistidine tag, which may account for the unexpected results 
observed when using these proteins in the in vitro fusion assay.  
In a wider context, this observation also throws doubt onto other studies which 
utilise tagged SM proteins. Both N- (Shen et al, 2006; Brandie et al, 2008) and             
C-terminally tagged (Smyth et al, 2010; Schollmeier et al, 2011) SM proteins have 
been used in various studies into the SM protein function. As discussed earlier in 
this thesis, controversy and contradiction surround the field of SM protein biology, 
and the discovery that the position of the purification tag on the SM protein only 
adds to this. 
Comparison of the results obtained when the C-terminally tagged Munc-18c is 
added to the in vitro fusion assay yield an interesting hypothesis into the function of 
Munc-18c in SNARE complex formation: although the results are conflicting, they 
may suggest that the effect of Munc-18c is dependent on the timing of the 
interaction, with Munc-18c acting as a negative regulator when bound to the           
t-SNARE complex, but a positive regulator when interacting with the assembled 
Kimberley Boney, 2013  Chapter 5, 135 
 
SNARE complex, a hypothesis supported by the observation that insulin signalling 
causes repositioning of Munc-18c on Syntaxin 4 (Smithers et al, 2008). Similar 
results were observed in a homologous fusion system, with Munc-18a having both 
inhibitory and stimulatory effects (Schollmeier et al, 2011). In this study, it was 
shown that not only is Munc-18a able to stabilise the “closed” conformation of 
Syntaxin 1a, it is also able to inhibit t-SNARE complex formation, indicating that 
the protein may have more than one inhibitory mechanism.  
As previously mentioned in Section 6.1, there are criticisms surrounding the in vitro 
fusion assay, and these stretch to cover the addition of proteins into the assay to 
study their effect on the rate of SNARE-mediated membrane fusion. Experiments 
using squid Munc-18a (sMunc-18a) showed that adding the SM protein to the in 
vitro fusion assay led to a dose-dependent increase in apparent liposome fusion, 
even in the absence of SNARE proteins (Xu et al, 2011). Denaturing of the sMunc-
18a also appeared to cause the protein to bridge membranes, forming hemifusion 
intermediates, although this study was unable to confirm whether this process had 
any physiological relevance (Xu et al, 2011). It is important to note however, that 
when Munc-18c was added to our fusion assay, the protein concentration was 
lower than that observed in this study (usually 0.2-0.3 µM depending on SNARE 
concentration), and further to this, the squid SM protein was selected for this 
study as it does not denature at high (20 µM) concentrations as mammalian SM 
proteins do. Although these observations cast doubt onto the significance of the 
sMunc-18a study, it is important to recognise that the assay is not without its 
flaws, and all data must be backed up with complementary analyses, for example, 
binding studies between the proteins of interest, or imaging of the liposomes using 
electron microscopy. 
6.3 The effect of insulin on the plasma membrane of 3T3-L1 
plasma membrane fractions 
In the final section of this thesis, I investigated the effect of insulin stimulation on 
the plasma membrane of 3T3-L1 adipocytes, as outlined in Chapter 5. Whilst 
binding of insulin to its receptor is known to trigger a signalling cascade which 
ultimately leads to the translocation of GLUT4 to the cell surface (Cushman et al, 
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1980; Suzuki and Kono, 1980), the exact effect of insulin on the plasma membrane 
of adipose cells is less well understood. A previous study identified the plasma 
membrane of rat adipose cells as being the location of the “key regulated step” in 
GSV fusion, and identified PKB in the cytosol of adipocytes as being important in 
the fusion reaction (Koumanov et al, 2005). 
Fractionation of 3T3-L1 adipocytes showed that insulin-stimulation did not alter 
the levels of the t-SNAREs Syntaxin 4 and SNAP-23 at the plasma membrane; 
however GLUT4 did translocate from an intracellular store to the cell surface 
(Figure 5.1). Although initially used as a quality control step to ensure that the 
adipocytes responded to insulin as they should, the unaltered levels of t-SNARE in 
response to insulin allowed us to hypothesise as to how the hormone may affect 
these proteins. As Syntaxin 4 is known to undergo conformational changes which 
affect its function, it is possible that insulin functions, directly or indirectly, by 
altering the conformation of Syntaxin 4, potentially by recruiting or dissociating 
regulatory proteins. Syntaxin 4 is has also been shown to form distinct clusters on 
the plasma membrane (Sieber et al, 2006), thus it is possible that insulin functions 
by spatially bringing together t-SNARE complexes on the cell surface, aiding 
SNARE complex formation. 
As my aim was to establish a new fusion assay in order to study the protein found 
at the plasma membrane of 3T3-L1 adipocytes, it was important to optimise the 
reaction, as more proteins were likely to be involved than the SNAREs alone. Three 
concentrations of plasma membrane were utilised in this study (0.3, 0.75 and         
1.5 mg/ml total protein) in order to determine the optimum concentration to 
reconstitute in order to observe vesicle fusion. Both Syntaxin 4 and SNAP-23 
reconstituted into liposomes at all three total protein concentrations, with higher 
protein levels reconstituted from higher protein concentrations (Figure 5.2). 
The next stage of optimisation concerned the control reaction for these fusion 
experiments. Addition of the cytosolic domain of VAMP 2 to the plasma 
membrane-derived liposomes had no effect on the rate of SNARE-mediated 
membrane fusion (Figure 5.4) and thus was deemed an insufficient control. It is 
possible that the cytosolic VAMP 2 which was added to the reaction is interacting 
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with another protein (other than the t-SNAREs) on the plasma membrane of     
3T3-L1 adipocytes, meaning that it is not available to bind the t-SNARE complex 
and inhibit fusion. Identification of this binding partner could further elucidate the 
interactions involved in SNARE complex regulation and would be of interest for 
further study. Alternatively, post-translational modifications to the t-SNAREs may 
prevent the cytosolic domain of VAMP 2 from forming a stable complex, instead 
only facilitating a transient interaction.  
Although protein-free vesicles appeared to function as a good control for SNARE-
mediated fusion, further controls could be utilised to ensure that the levels of fusion 
observed are due to SNARE complex formation. Trypsin digestion of vesicles can 
be used to cleave SNARE proteins (Graham et al, 2004; D’Andrea-Merrins et al, 
2007), and pre-treatment of the donor vesicles with trypsin (followed by dialysis to 
remove the protease) could be used to show that cleavage of the v-SNARE prevents 
SNARE complex formation. Further to this, neurotoxins could be used in a similar 
fashion to cleave the SNARE proteins in both the PM-derived and v-SNARE donor 
vesicles; however if these were to be used on the PM-derived vesicles, further 
investigation would be required into the protein content of these vesicles, in 
particular the SNARE protein content, as different toxins have been shown to 
cleave different SNARE proteins (Schiavo et al, 1995; Macaulay et al, 1997; Binz et al, 
2010), which may lead to unexpected effects on membrane fusion. 
In this study, in order to ensure that the observed rate of fusion was due to SNARE 
complex formation, we utilised protein-free liposomes as our control (Figure 5.4), 
which resulted in low levels of fusion compared to the uninhibited reaction, 
indicating the fusion observed is due to SNARE complex formation and is not 
spontaneous. It is interesting to note, however, that the levels of fusion observed in 
these control reactions are higher than those using recombinant SNARE proteins 
(as seen in Chapter 3), suggesting that the liposomes are able to fuse without 
SNARE complex formation. As many proteins are present in the liposomes derived 
from 3T3-L1 plasma membrane, it is possible that we are observing a small amount 
of spontaneous fusion driven by the presence of one or more of these proteins. This 
could be a similar observation to that of Xu et al (2011), where high concentrations 
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of denatured SM protein caused hemifusion and vesicle clustering (mentioned 
above in Section 6.2), and may warrant further investigation. 
The final optimisation step involved investigating which liposomes best 
represented observed in vivo GSV fusion. Liposomes derived from both 0.3 and 0.75 
mg/ml plasma membranes were able to sustain fusion (Figure 5.4). Liposomes 
derived from 0.75 mg/ml plasma membrane best resembled fusion observed in vivo, 
with insulin increasing the rate of membrane fusion. Furthermore, these liposomes 
displayed more consistent controls, allowing us to be certain that our observations 
were indeed due to SNARE-mediated membrane fusion. 
Although silver staining of plasma membrane and liposome samples identified that 
many proteins were present in the samples (Figure 5.5), we were unable to detect 
the presence of any proteins of interest in the liposomes by western blotting 
(Figure 5.5). Although the kinases PKA, –B and –C were not found in the 
liposomes, levels of all three proteins increased at the plasma membrane in 
response to insulin, indicating that they may have functioned to phosphorylate 
proteins on the plasma membrane, despite not being reconstituted themselves. It is 
important to note that these experiments were performed in the absence of ATP 
and phosphatase inhibitors; however these experiments were performed late in this 
study, and were designed as a preliminary investigation into kinase location, not a 
conclusive study into their function in this assay.  
Previous study indicated that SNARE-mediated membrane fusion is dependent on 
the presence of PKB (Koumanov et al, 2005). It is important to note, however, that 
this previous study utilised both plasma membrane and GSVs from rat adipose 
tissue, and attempted to fuse both in a modified in vitro fusion assay. Although our 
results do suggest that PKB may have a function at the plasma membrane of 3T3-L1 
adipocytes, direct addition of the kinase was not necessary to sustain fusion in this 
assay. This is likely due to the fact that we did not use GSVs as our “donor” 
liposomes; rather we used VAMP 2-containing vesicles. Therefore, it is plausible 
that the addition of PKB to the assay relieves inhibition on the GSVs, not the 
plasma membrane. Indeed, it has previously been shown that PKB is targeted to (or 
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near) GSVs upon insulin stimulation (Calera et al, 1998; Kupriyanova and Kandror, 
1999) where it has a positive effect on GSV translocation (Ducluzeau et al, 2002).  
6.4 Future Work 
Several interesting observations have arisen from this work, each of which 
warrants further study. Firstly, the discovery that the location of the polyhistidine 
tag affects the function of the protein deserves further investigation as it impacts 
not only this, but other studies which have utilised tagged SM proteins. Ideally, all 
experiments involving Munc-18c (both wild-type and mutant) should be repeated 
using untagged SM protein in addition to N- and C-terminally tagged protein in 
order to ascertain what the true function of Munc-18c is, and to give insight into 
why the purification tag causes such an effect. In conjunction with this, it would be 
interesting to conduct structural studies using tagged and untagged SM protein to 
investigate why such a small tag has such a profound effect. Nuclear Magnetic 
Resonance (NMR) spectroscopy would be useful in this endeavour, as it utilises 
protein in solution, which may allow us to study the SM protein in complex with 
the assembled SNARE complex as well as individual SNAREs. 
To complement this, binding studies would also be useful, for example, Surface 
Plasmon Resonance (SPR) or Isothermal Titration Calorimetry (ITC), both of 
which have been previously used to study binding between SNARE and SM 
proteins (Burkhardt et al, 2008; Aran et al, 2009). These techniques would allow 
calculation of the dissociation (Kd) and binding constants (KD) which would give 
an insight into the strength of the complexes investigated, allowing us to ascertain 
how physiologically relevant any observed interactions may be. Again, these 
experiments should be performed utilising both tagged and untagged SM protein 
to observe any differences between the proteins. 
I would also like to deconstruct the in vitro liposome fusion assay and utilise the 
method outlined in Schollmeier et al (2011). In this paper, monomeric Syntaxin 1a is 
reconstituted into the “acceptor” liposomes, and soluble SNAP-25 is added to form 
binary t-SNARE complexes. Using this method, they were able to investigate the 
role of the SM protein on t-SNARE complex formation, as well as SNARE complex 
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formation. This method would be useful alongside some of the binding assays 
mentioned previously (SPR, ITC etc.) to help dissect the interactions involved in 
SNARE complex regulation. It is important to note, however, that both Syntaxin 4 
and SNAP-23 may have to be cloned into new expression vectors, as this assay is 
dependent on the formation of binary t-SNARE complexes, something we were 
unable to achieve with our previous constructs (Figure 3.8). It would also be 
interesting to develop this assay to utilise content mixing (as discussed in Section 
6.1) to ensure that full membrane fusion is being observed. 
I would also like to further utilise my plasma membrane fusion assay to study the 
proteins involved in fusion of GSVs with the plasma membrane of 3T3-L1 
adipocytes. Now that the assay has been established, it would be interesting to 
knockdown (or knockout) proteins known to play a role in SNARE-mediated 
membrane fusion, for example, the SNARE proteins themselves, PKB or Munc-18c, 
and to assess what effect this has on membrane fusion in  response to insulin.  It 
would also be interesting to analyse the protein content of the liposomes derived 
from plasma membrane fractions by mass spectrometry in order to identify if any 
known SNARE-interacting proteins, such as Munc-18c, Synip (Min et al, 1999) or 
Rab 4 (Li et al, 2001). This would allow for a greater library of proteins to 
knockdown in 3T3-L1 adipocytes to assess their effect on membrane fusion. 
141 
 
Bibliography 
ALEDO JC, LAVOIE L, VOLCHUK A, KELLER SR, KLIP A, HUNDAL HS. (1997) 
Identification and characterization of two distinct intracellular GLUT4 
pools in rat skeletal muscle: evidence for an endosomal and an insulin-
sensitive GLUT4 compartment. Biochem J. 325: 727-732. 
ARAN V, BRANDIE FM, BOYD AR, KANTIDAKIS T, RIDEOUT EJ, KELLY SM, 
GOULD GW, BRYANT NJ. (2009) Characterization of two distinct 
binding modes between Syntaxin 4 and Munc18c. Biochem J. 419: 655-660. 
ARAN V, BRYANT NJ, GOULD GW. (2011) Tyrosine phosphorylation of 
Munc18c on residue 521 abrogates binding to Syntaxin 4. BMC Biochem. 12: 
19. 
BAI L, WANG Y, FAN J, CHEN Y, JI W, QU A, XU P, JAMES DE, XU T. (2007) 
Dissecting multiple steps of GLUT4 trafficking and identifying the sites of 
insulin action. Cell Metab. 5: 47-57. 
BAUMERT M, TAKEI K, HARTINGER J, BURGER PM, FISCHER VON 
MOLLARD G, MAYCOX PR, DE CAMILLI P, JAHN R. (1990) P29: a novel 
tyrosine-phosphorylated membrane protein present in small clear vesicles 
of neurons and endocrine cells. J Cell Biol. 110: 1285-1294. 
BELL GI, KAYANO T, BUSE JB, BURANT CF, TAKEDA J, LIN D, FUKUMOTO 
H, SEINO S. (1990) Molecular-biology of mammalian glucose transporters. 
Diabetes Care 13: 198-208. 
BENNETT MK, CALAKOS N, SCHELLER RH. (1992) Syntaxin - a synaptic 
protein implicated in docking of synaptic vesicles at presynaptic active 
zones. Science 257: 255-259. 
BENNETT MK, GARCÍA-ARRARÁS JE, ELFERINK LA, PETERSON K, 
FLEMING AM, HAZUKA CD, SCHELLER RH. (1993) The Syntaxin family 
of vesicular transport receptors. Cell 74: 863-873. 
BINZ T, SIKORRA S, MAHRHOLD S. (2010) Clostridial neurotoxins: mechanism 
of SNARE cleavage and outlook on potential substrate specificity 
reengineering. Toxins 2: 665-682. 
BLOCK MR, GLICK BS, WILCOX CA, WIELAND FT, ROTHMAN JE. (1988) 
Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular 
transport. Proc Natl Acad Sci USA 85: 7852-7856. 
BOLIVAR F, RODRIGUEZ RL, GREENE PJ, BETLACH MC, HEYNEKER HL, 
BOYER HW, CROSA JH, FALKOW S. (1977) Construction and 
characterization of new cloning vehicles. II. A multipurpose cloning system. 
Gene 2: 95-113. 
Kimberley Boney, 2013  142 
 
BOSTRÖM P, ANDERSSON L, RUTBERG M, PERMAN J, LIDBERG U, 
JOHANSSON BR, FERNANDEZ-RODRIGUEZ J, ERICSON J, NILSSON 
T, BORÉN J, OLOFSSON, SO. (2007) SNARE proteins mediate fusion 
between cytosolic lipid droplets and are implicated in insulin sensitivity. 
Nat Cell Biol. 9: 1286-1293. 
BOSTRÖM P, ANDERSSON L, VIND B, HÅVERSEN L, RUTBERG M, 
WICKSTRÖM Y, LARSSON E, JANSSON PA, SVENSSON MK, 
BRÅNEMARK R, LING C, BECK-NIELSEN H, BORÉN J, HØJLUND K, 
OLOFSSON SO. (2010) The SNARE protein SNAP23 and the SNARE-
interacting protein Munc18c in human skeletal muscle are implicated in 
insulin resistance/type 2 diabetes. Diabetes 59: 1870-1878. 
BRACHER A, WEISSENHORN W. (2002) Structural basis for the Golgi 
membrane recruitment of Sly1p by Sed5p. Embo J. 21: 6114-6124. 
BRAIMAN L, ALT A, KUROKI T, OHBA M, BAK A, TENNENBAUM T, 
SAMPSON SR. (2001) Activation of protein kinase C zeta induces serine 
phosphorylation of VAMP2 in the GLUT4 compartment and increases 
glucose transport in skeletal muscle. Mol Cell Biol. 21: 7852-7861. 
BRANDIE FM, ARAN V, VERMA A, MCNEW JA, BRYANT NJ, GOULD GW. 
(2008) Negative regulation of Syntaxin4/SNAP-23/VAMP2-mediated 
membrane fusion by Munc18c in vitro. PLoS ONE 3: e4074. 
BRENNER S. (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71-94. 
BRYANT NJ, GOULD GW. (2011) SNARE proteins underpin insulin-regulated 
GLUT4 traffic. Traffic 12: 657-664. 
BRYANT NJ, GOVERS R, JAMES DE. (2002) Regulated transport of the glucose 
transporter GLUT4. Nat Rev Mol Cell Biol. 3: 267-277. 
BRYANT NJ, JAMES DE. (2001) Vps45p stabilizes the Syntaxin homologue Tlg2p 
and positively regulates SNARE complex formation. EMBO J. 20: 3380-3388. 
BURGOYNE RD, MORGAN A. (2007) Membrane trafficking: Three steps to 
fusion. Curr Biol. 17: R255-R258. 
CAIN CC, TRIMBLE WS, LIENHARD GE. (1992) Members of the VAMP family 
of synaptic vesicle proteins are components of glucose transporter-
containing vesicles from rat adipocytes. J Biol Chem. 267: 11681-11684. 
CALERA MR, MARTINEZ C, LIU H, JACK AK, BIRNBAUM MJ, PILCH PF. 
(1998) Insulin increases the association of Akt-2 with GLUT4-containing 
vesicles. J Biol Chem. 273: 7201-7204. 
Kimberley Boney, 2013  143 
 
CARPP LN, CIUFO LF, SHANKS SG, BOYD A, BRYANT NJ. (2006) The 
Sec1p/Munc18 protein Vps45p binds its cognate SNARE proteins via two 
distinct modes. J Cell Biol. 173: 927-936. 
CARR CM, GROTE E, MUNSON M, HUGHSON FM, NOVICK PJ. (1999) Sec1p 
binds to SNARE complexes and concentrates at sites of secretion. J Cell Biol. 
146: 333-344. 
CARVALHO E, ELIASSON B, WESSLAU C, SMITH U. (2000) Impaired 
phosphorylation and insulin-stimulated translocation to the plasma 
membrane of protein kinase B/Akt in adipocytes from Type II diabetic 
subjects. Diabetologia 43: 1107-1115. 
CHAPMAN ER, AN S, BARTON N, JAHN R. (1994) SNAP-25, a t-SNARE which 
binds to both Syntaxin and Synaptobrevin via domains that may form 
coiled coils. J Biol Chem. 269: 27427-27432. 
CHEATHAM B, VOLCHUK A, KAHN CR, WANG L, RHODES CJ, KLIP A. 
(1996) Insulin-stimulated translocation of GLUT4 glucose transporters 
requires SNARE-complex proteins. Proc Natl Acad Sci USA 93: 15169-15173. 
CHEN F, FORAN P, SHONE CC, FOSTER KA, MELLING J, DOLLY JO. (1997) 
Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 
3T3-L1 adipocytes and cleaves cellubrevin unlike type A toxin which failed 
to proteolyze the SNAP-23 present. Biochem. 36: 5719-5128. 
CHEN X, ARAÇ D, WANG TM, GILPIN CJ, ZIMMERBERG J, RIZO J. (2006) 
SNARE-mediated lipid mixing depends on the physical state of the vesicles. 
Biophys J. 90: 2062-74. 
CHEN YA, SCHELLER RH. (2001) SNARE-mediated membrane fusion. Nat Rev 
Mol Cell Biol. 2: 98-106. 
CHERNOMORDIK LV, MELIKOV K. (2006) Are there too many or too few 
SNAREs in proteoliposomes? Biophys J. 90: 2657-2868. 
CHRISTIE MP, WHITTEN AE, KING GJ, HU SH, JARROTT RJ, CHEN KE, 
DUFF AP, CALLOW P, COLLINS BM, JAMES DE, MARTIN JL. (2012) 
Low-resolution solution structures of Munc18:Syntaxin protein complexes 
indicate an open binding mode driven by the Syntaxin N-peptide. Proc Natl 
Acad Sci USA 109: 9816-9821. 
CHUNG SH, POLGAR J, REED GL. (2000) Protein kinase C phosphorylation of 
Syntaxin 4 in thrombin-activated human platelets. J Biol Chem. 275: 25286-
25291. 
CLARY DO, GRIFF IC, ROTHMAN JE. (1990) SNAPs, a family of NSF 
attachment proteins involved in intracellular membrane fusion in animals 
and yeast. Cell 61: 709-721. 
Kimberley Boney, 2013  144 
 
COSTER AC, GOVERS R, JAMES DE. (2004) Insulin stimulates the entry of 
GLUT4 into the endosomal recycling pathway by a quantal mechanism. 
Traffic 5: 763-771. 
CUSHMAN SW, WARDZALA LJ. (1980) Potential mechanism of insulin action 
on glucose-transport in the isolated rat adipose cell - apparent translocation 
of intracellular-transport systems to the plasma-membrane. J Biol Chem. 255: 
4758-4762. 
D'ANDREA-MERRINS M, CHANG L, LAM AD, ERNST SA, STUENKEL EL. 
(2007) Munc18c interaction with Syntaxin 4 monomers and SNARE 
complex intermediates in GLUT4 vesicle trafficking. J Biol Chem. 282: 16553-
16566. 
DEÁK F, XU Y, CHANG WP, DULUBOVA I, KHVOTCHEV M, LIU X, SÜDHOF 
TC, RIZO J. (2009) Munc18-1 binding to the neuronal SNARE complex 
controls synaptic vesicle priming. J Cell Biol. 184: 751-764. 
DIAO J, SU Z, ISHITSUKA Y, LU B, LEE KS, LAI Y, SHIN YK, HA T. (2010) A 
single-vesicle content mixing assay for SNARE-mediated membrane fusion. 
Nat Commun. 1:54. 
DOMANSKA MK, KIESSLING V, STEIN A, FASSHAUER D, TAMM LK. (2009) 
Single vesicle millisecond fusion kinetics reveals number of SNARE 
complexes optimal for fast SNARE-mediated membrane fusion. J Biol Chem. 
284: 32158-32166. 
DUCLUZEAU PH, FLETCHER LM, WELSH GI, TAVARÉ JM. (2002) Functional 
consequence of targeting protein kinase B/Akt to GLUT4 vesicles. J Cell Sci. 
115: 2857-2866. 
DULUBOVA I, KHVOTCHEV M, LIU S, HURYEVA I, SÜDHOF TC, RIZO J. 
(2007) Munc18-1 binds directly to the neuronal SNARE complex. Proc Natl 
Acad Sci USA 104: 2697-2702. 
DULUBOVA I, SUGITA S, HILL S, HOSAKA M, FERNANDEZ I, SÜDHOF TC, 
RIZO J. (1999) A conformational switch in Syntaxin during exocytosis: role 
of Munc18. Embo J. 18: 4372-4382. 
DULUBOVA I, YAMAGUCHI T, ARAC D, LI H, HURYEVA I, MIN SW, RIZO J, 
SÜDHOF TC. (2003) Convergence and divergence in the mechanism of 
SNARE binding by Sec1/Munc18-like proteins. Proc Natl Acad Sci USA       
100: 32-37. 
ERNST JA, BRUNGER AT. (2003) High resolution structure, stability, and 
Synaptotagmin binding of a truncated neuronal SNARE complex. J Biol 
Chem. 278: 8630-8636. 
Kimberley Boney, 2013  145 
 
FARESE RV, STANDAERT ML, FRANCOIS AJ, WAYS K, ARNOLD TP, 
HERNANDEZ H, COOPER DR. (1992) Effects of insulin and phorbol 
esters on subcellular distribution of protein kinase C isoforms in rat 
adipocytes. Biochem J. 288: 319-323. 
FASSHAUER D, SUTTON RB, BRUNGER AT, JAHN R. (1998) Conserved 
structural features of the synaptic fusion complex: SNARE proteins 
reclassified as Q- and R-SNAREs. Proc Nat Acad Sci USA 95: 15781-15786. 
FERNANDEZ I, UBACH J, DULUBOVA I, ZHANG XY, SÜDHOF TC, RIZO J. 
(1998) Three-dimensional structure of an evolutionarily conserved N-
terminal domain of Syntaxin 1A. Cell 94: 841-849. 
FLETCHER LM, WELSH GI, OATEY PB, TAVARÉ JM. (2000) Role for the 
microtubule cytoskeleton in GLUT4 vesicle trafficking and in the 
regulation of insulin-stimulated glucose uptake. Biochem J. 352: 267-276. 
FOSTER LJ, YEUNG B, MOHTASHAMI M, ROSS K, TRIMBLE WS, KLIP A. 
(1998) Binary interactions of the SNARE proteins Syntaxin-4, SNAP23, and 
VAMP-2 and their regulation by phosphorylation. Biochem. 37: 11089-11096. 
FÖRSTER T. (1948) Zwischenmolekulare Energiewanderung und Fluoreszenz 
Annal Phy. 437: 55-75. 
GALLWITZ D, JAHN R. (2003) The riddle of the Sec1/Munc-18 proteins - new 
twists added to their interactions with SNAREs. Trends Biochem Sci. 28: 113-
116. 
GENGYO-ANDO K, KAMIYA Y, YAMAKAWA A, KODAIRA K, NISHIWAKI K, 
MIWA J, HORI I, HOSONO R. (1993) The C. elegans unc-18 gene encodes a 
protein expressed in motor neurons. Neuron 11: 703-711. 
GLICK BS, ROTHMAN JE. (1987) Possible role for fatty acyl-coenzyme-a in 
intracellular protein-transport. Nature 326: 309-312. 
GOVERS R, COSTER AC, JAMES DE. (2004) Insulin increases cell surface 
GLUT4 levels by dose dependently discharging GLUT4 into a cell surface 
recycling pathway. Mol Cell Biol. 24: 6456-6466. 
GRAHAM ME, BARCLAY JW, BURGOYNE RD. (2004) Syntaxin/Munc18 
interactions in the late events during vesicle fusion and release in 
exocytosis. J Biol Chem. 279: 32751-32760. 
GRAHAM ME, EDWARDS MR, HOLDEN-DYE L, MORGAN A, BURGOYNE 
RD, BARCLAY JW. (2009) UNC-18 modulates ethanol sensitivity in 
Caenorhabditis elegans. Mol Biol Cell. 20: 43-55. 
GUIDOTTI G. (1972) Membrane proteins. Ann Rev Biochem. 41: 731-752. 
Kimberley Boney, 2013  146 
 
HATA Y, SLAUGHTER CA, SÜDHOF TC. (1993) Synaptic vesicle fusion complex 
contains UNC-18 homolog bound to Syntaxin. Nature 366: 347-351. 
HAYASHI T, MCMAHON H, YAMASAKI S, BINZ T, HATA Y, SÜDHOF TC, 
NIEMANN H. (1994) Synaptic vesicle membrane fusion complex: action of 
clostridial neurotoxins on assembly. EMBO J. 13: 5051-5061. 
HAYASHI T, YAMASAKI S, NAUENBURG S, BINZ T, NIEMANN H. (1995) 
Disassembly of the reconstituted synaptic vesicle membrane fusion complex 
in vitro. EMBO J. 14: 2317-2325. 
HESS DT, SLATER TM, WILSON MC, SKENE JHP. (1992) The 25 kDa 
synaptosomal-associated protein SNAP-25 is the major methionine-rich 
polypeptide in rapid axonal-transport and a major substrate for 
palmitoylation in adult CNS. J Neurosci. 12: 4634-4641. 
HICKSON GR, CHAMBERLAIN LH, MAIER VH, GOULD GW. (2000) 
Quantification of SNARE protein levels in 3T3-L1 adipocytes: implications 
for insulin-stimulated glucose transport. Biochem Biophys Res Commun. 270: 
841-845. 
HIMSWORTH HP. (1936) Diabetes mellitus: its differentiation into insulin-
sensitive and insulin-insensitive types. Lancet 227: 127-130. 
HODGKINSON CP, MANDER A, SALE GJ. (2005) Protein kinase-zeta interacts 
with Munc18c: role in GLUT4 trafficking. Diabetologia 48: 1627-1636. 
HOHL TM, PARLATI F, WIMMER C, ROTHMAN JE, SÖLLNER TH, 
ENGELHARDT H. (1998) Arrangement of subunits in 20 S particles 
consisting of NSF, SNAPs, and SNARE complexes. Mol Cell 2: 539-548. 
HOLMAN GD, KASUGA M. (1997) From receptor to transporter: insulin 
signalling to glucose transport. Diabetologia 40: 991-1003. 
HOLMAN GD, LO LEGGIO L, CUSHMAN SW. (1994) Insulin-stimulated 
GLUT4 glucose transporter recycling. A problem in membrane protein 
subcellular trafficking through multiple pools. J Biol Chem. 269: 17516-17524. 
HOLT M, VAROQUEAUX F, WIEDERHOLD K, TAKAMORI S, URLAUB H, 
FASSHAUER D, JAHN R. (2006) Identification of SNAP-47, a novel Qbc-
SNARE with ubiquitous expression. J Biol Chem. 281: 17076-17083. 
HU K, CARROLL J, FEDOROVICH S, RICKMAN C, SUKHODUB A, 
DAVLETOV B. (2002) Vesicular restriction of Synaptobrevin suggests a 
role for calcium in membrane fusion. Nature 415: 646-650. 
 
Kimberley Boney, 2013  147 
 
HU S-H, LATHAM CF, GEE CL, JAMES DE, MARTIN JL. (2007) Structure of the 
Munc18c/Syntaxin4 N-peptide complex defines universal features of the N-
peptide binding mode of Sec1/Munc18 proteins. Proc Nat Acad Sci USA 104: 
8773-8778. 
HU SH, CHRISTIE MP, SAEZ NJ, LATHAM CF, JARROTT R, LUA LH, 
COLLINS BM, MARTIN JL. (2011) Possible roles for Munc18-1 domain 3a 
and Syntaxin1 N-peptide and C-terminal anchor in SNARE complex 
formation. Proc Natl Acad Sci USA 108: 1040-1045. 
HU SH, GEE CL, LATHAM CF, ROWLINSON SW, ROVA U, JONES A, 
HALLIDAY JA, BRYANT NJ, JAMES DE, MARTIN JL. (2003) 
Recombinant expression of Munc18c in a baculovirus system and 
interaction with Syntaxin4. Prot Exp Purif. 31: 305-310. 
INOUE A, OBATA K, AKAGAWA K. (1992) Cloning and sequence-analysis of 
cDNA for a neuronal cell-membrane antigen, HPC-1. J Biol Chem. 267: 10613-
10619. 
INOUE M, CHANG L, HWANG J, CHIANG SH, SALTIEL AR. (2003) The 
exocyst complex is required for targeting of GLUT4 to the plasma 
membrane by insulin. Nature 422: 629-633. 
INOUE M, CHIANG SH, CHANG L, CHEN XW, SALTIEL AR. (2006) 
Compartmentalization of the exocyst complex in lipid rafts controls 
GLUT4 vesicle tethering. Mol Biol Cell 17: 2303-2311. 
JAHN R, LANG T, SÜDHOF TC. (2003) Membrane fusion. Cell 112: 519-533. 
JAMES DE, BROWN R, NAVARRO J, PILCH PF. 1988. Insulin-regulatable tissues 
express a unique insulin-sensitive glucose-transport protein. Nature 333: 
183-185. 
JAMES DE, LEDERMAN L, PILCH PF. (1987) Purification of insulin-dependent 
exocytic vesicles containing the glucose transporter. J Biol Chem. 262: 11817-
11824. 
JAMES DJ, KOWALCHYK J, DAILY N, PETRIE M, MARTIN TF. (2009) CAPS 
drives trans-SNARE complex formation and membrane fusion through 
Syntaxin interactions. Proc Natl Acad Sci USA 106: 17308-17313. 
JANZ R, SÜDHOF TC. (1998) Cellugyrin, a novel ubiquitous form of Synaptogyrin 
that is phosphorylated by pp60c-src. J Biol Chem. 273: 2851-2857. 
JANZ R, SÜDHOF TC, HAMMER RE, UNNI V, SIEGELBAUM SA, 
BOLSHAKOV VY. (1999) Essential roles in synaptic plasticity for 
Synaptogyrin I and Synaptophysin I. Neuron 24: 687-700. 
Kimberley Boney, 2013  148 
 
JEWELL JL, OH E, RAMALINGAM L, KALWAT MA, TAGLIABRACCI VS, 
TACKETT L, ELMENDORF JS, THURMOND DC. (2011) Munc18c 
phosphorylation by the insulin receptor links cell signalling directly to 
SNARE exocytosis. J Cell Biol. 193: 185-199. 
JI H, COLEMAN J, YANG R, MELIA TJ, ROTHMAN JE, TARESTE D. (2010) 
Protein Determinants of SNARE-Mediated Lipid Mixing. Biophys J. 99: 553-
560. 
JIANG ZY, ZHOU QL, COLEMAN KA, CHOUINARD M, BOESE Q, CZECH MP. 
(2003) Insulin signaling through Akt/protein kinase B analyzed by small 
interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 100: 7569-
7574. 
JOHNSON JR, FERDEK P, LIAN LY, BARCLAY JW, BURGOYNE RD, MORGAN 
A. (2009) Binding of UNC-18 to the N-terminus of syntaxin is essential for 
neurotransmission in Caenorhabditis elegans. Biochem J. 418: 73-80. 
JOOST HG, THORENS B. (2001) The extended GLUT-family of sugar/polyol 
transport facilitators: nomenclature, sequence characteristics, and potential 
function of its novel members. Mol Mem Biol. 18: 247-256. 
KARNIELI E, ZARNOWSKI MJ, HISSIN PJ, SIMPSON IA, SALANS LB, 
CUSHMAN SW. (1981) Insulin-stimulated translocation of glucose 
transport systems in the isolated rat adipose cell. Time course, reversal, 
insulin concentration dependency, and relationship to glucose transport 
activity. J Biol Chem. 256: 4772-4777. 
KARYLOWSKI O, ZEIGERER A, COHEN A, MCGRAW TE. (2004) GLUT4 is 
retained by an intracellular cycle of vesicle formation and fusion with 
endosomes. Mol Biol Cell 15: 870-882. 
KAWAGUCHI T, TAMORI Y, KANDA H, YOSHIKAWA M, TATEYA S, 
NISHINO N, KASUGA M. (2010) The t-SNAREs Syntaxin4 and SNAP23 
but not v-SNARE VAMP2 are indispensable to tether GLUT4 vesicles at 
the plasma membrane in adipocyte. Biochem Biophys Res Commun. 391:1336-
1341. 
KAWANISHI M, TAMORI Y, OKAZAWA H, ARAKI S, SHINODA H, KASUGA 
M. (2000) Role of SNAP23 in insulin-induced translocation of GLUT4 in 
3T3-L1 adipocytes. Mediation of complex formation between Syntaxin4 and 
VAMP2. J Biol Chem. 275: 8240-8247. 
KEMBLE GW, DANIELI T, WHITE JM. (1994) Lipid-anchored influenza 
hemagglutinin promotes hemifusion, not complete fusion. Cell 76: 383-391. 
KHVOTCHEV M, DULUBOVA I, SUN J, DAI H, RIZO J, SÜDHOF TC. (2007) 
Dual modes of Munc18-1/SNARE interactions are coupled by functionally 
critical binding to syntaxin-1 N terminus. J Neurosci. 27: 12147-12155. 
Kimberley Boney, 2013  149 
 
KOUMANOV F, JIN B, YANG J, HOLMAN GD. (2005) Insulin signaling meets 
vesicle traffic of GLUT4 at a plasma-membrane-activated fusion step. Cell 
Metab. 2: 179-189. 
KUPRIYANOVA TA, KANDROR KV. (1999) Akt-2 binds to Glut4-containing 
vesicles and phosphorylates their component proteins in response to 
insulin. J Biol Chem. 274: 1458-1464. 
KUPRIYANOVA TA, KANDROR KV. (2000) Cellugyrin is a marker for a distinct 
population of intracellular Glut4-containing vesicles. J Biol Chem. 275: 
36263-36268. 
KUPRIYANOVA TA, KANDROR V, KANDROR KV. (2002) Isolation and 
characterization of the two major intracellular GLUT4 storage 
compartments. J Biol Chem. 277: 9133-9138. 
KWEON DH, KIM CS, SHIN YK. (2003) Regulation of neuronal SNARE assembly 
by the membrane. Nat Struct Biol. 10: 440-447. 
LAMB CA, MCCANN RK, STÖCKLI J, JAMES DE, BRYANT NJ. (2010) Insulin-
regulated trafficking of GLUT4 requires ubiquitination. Traffic 11: 1445-
14454. 
LATHAM CF, LOPEZ JA, HU SHH, GEE CL, WESTBURY E, BLAIR DH, 
ARMISHAW CJ, ALEWOOD PF, BRYANT NJ, JAMES DE, MARTIN JL. 
(2006) Molecular dissection of the Munc18c/Syntaxin4 interaction: 
Implications for regulation of membrane trafficking. Traffic 7: 1408-1419. 
LI G, ALEXANDER EA, SCHWARTZ JH. 2003. Syntaxin isoform specificity in 
the regulation of renal H+-ATPase exocytosis. J Biol Chem. 278: 19791-19797. 
LI L, OMATA W, KOJIMA I, SHIBATA H. (2001) Direct interaction of Rab4 with 
Syntaxin 4. J Biol Chem. 276: 5265-5273. 
LIN RC, SCHELLER RH. (1997) Structural organization of the synaptic 
exocytosis core complex. Neuron 19: 1087-1094. 
LIVINGSTONE C, JAMES DE, RICE JE, HANPETER D, GOULD GW. (1996) 
Compartment ablation analysis of the insulin-responsive glucose 
transporter (GLUT4) in 3T3-L1 adipocytes. Biochem J. 315: 487-495. 
LIZUNOV VA, MATSUMOTO H, ZIMMERBERG J, CUSHMAN SW, FROLOV 
VA. (2005) Insulin stimulates the halting, tethering, and fusion of mobile 
GLUT4 vesicles in rat adipose cells. J Cell Biol. 169: 481-489. 
LU X, ZHANG F, MCNEW JA, SHIN YK. (2005) Membrane fusion induced by 
neuronal SNAREs transits through hemifusion. J Biol Chem. 280: 30538-
30541. 
Kimberley Boney, 2013  150 
 
MACAULAY SL, REA S, GOUGH KH, WARD CW, JAMES DE. (1997) Botulinum 
E toxin light chain does not cleave SNAP-23 and only partially impairs 
insulin stimulation of GLUT4 translocation in 3T3-L1 cells. Biochem Biophys 
Res Commun. 237: 388-393. 
MALHOTRA V, ORCI L, GLICK BS, BLOCK MR, ROTHMAN JE. (1988) Role of 
an N-ethylmaleimide-sensitive transport component in promoting fusion of 
transport vesicles with cisternae of the Golgi stack. Cell 54: 221-227. 
MALIDE D, RAMM G, CUSHMAN SW, SLOT JW. (2000) Immunoelectron 
microscopic evidence that GLUT4 translocation explains the stimulation of 
glucose transport in isolated rat white adipose cells. J Cell Sci. 113: 4203-
4210. 
MARTIN LB, SHEWAN A, MILLAR CA, GOULD GW, JAMES DE. (1998) 
Vesicle-associated membrane protein 2 plays a specific role in the insulin-
dependent trafficking of the facilitative glucose transporter GLUT4 in 3T3-
L1 adipocytes. J Biol Chem. 273: 1444-1452. 
MARTIN S, TELLAM J, LIVINGSTONE C, SLOT JW, GOULD GW, JAMES DE. 
(1996) The glucose transporter (GLUT-4) and vesicle-associated membrane 
protein-2 (VAMP-2) are segregated from recycling endosomes in insulin-
sensitive cells. J Cell Biol. 134: 625-635. 
MCINTYRE JC, SLEIGHT RG. (1991) Fluorescence assay for phospholipid 
membrane asymmetry. Biochem. 30: 11819-11827. 
MILLAR CA, SHEWAN A, HICKSON GR, JAMES DE, GOULD GW. (1999) 
Differential regulation of secretory compartments containing the insulin-
responsive glucose transporter 4 in 3T3-L1 adipocytes. Mol Biol Cell 10: 3675-
3688. 
MIMA J, HICKEY CM, XU H, JUN Y, WICKNER W. (2008) Reconstituted 
membrane fusion requires regulatory lipids, SNAREs and synergistic 
SNARE chaperones. EMBO J. 27: 2031-2042. 
MIN J, OKADA S, KANZAKI M, ELMENDORF JS, COKER KJ, CERESA BP, SYU 
LJ, NODA Y, SALTIEL AR, PESSIN JE. (1999) Synip: a novel insulin-
regulated Syntaxin 4-binding protein mediating GLUT4 translocation in 
adipocytes. Mol Cell 3: 751-760. 
MISURA KMS, SCHELLER RH, WEIS WI. (2000) Three-dimensional structure 
of the neuronal-Sec1-Syntaxin 1a complex. Nature 404: 355-362. 
MOLLINEDO F, LAZO PA. (1997) Identification of two isoforms of the vesicle-
membrane fusion protein SNAP-23 in human neutrophils and HL-60 cells. 
Biochem Biophys Res Commun. 231: 808-812. 
Kimberley Boney, 2013  151 
 
MUNSON M, BRYANT NJ. (2009) A role for the Syntaxin N-terminus. Biochem J. 
418: e1-3. 
NOVICK P, FIELD C, SCHEKMAN R. (1980) Identification of 23 
complementation groups required for post-translational events in the yeast 
secretory pathway. Cell 21: 205-215. 
NOVICK P, SCHEKMAN R. (1979) Secretion and cell-surface growth are blocked 
in a temperature-sensitive mutant of Saccharomyces cerevisiae. Proc Nat Acad Sci 
USA 76: 1858-1862. 
OH E, SPURLIN BA, PESSIN JE, THURMOND DC. (2005) Munc18c 
heterozygous knockout mice display increased susceptibility for severe 
glucose intolerance. Diabetes 54: 638-647. 
OH E, THURMOND DC. (2006) The stimulus-induced tyrosine phosphorylation 
of Munc18c facilitates vesicle exocytosis. J Biol Chem. 281: 17624-17634. 
OH E, THURMOND DC. (2009) Munc18c depletion selectively impairs the 
sustained phase of insulin release. Diabetes 58: 1165-1174. 
OYLER GA, HIGGINS GA, HART RA, BATTENBERG E, BILLINGSLEY M, 
BLOOM FE, WILSON MC. (1989) The identification of a novel 
synaptosomal-associated protein, SNAP-25, differentially expressed by 
neuronal subpopulations. J Cell Biol. 109: 3039-3052. 
PALADE G. (1975) Intracellular aspects of process of protein-synthesis. Science 189: 
347-358. 
PENG RW, GALLWITZ D. (2004) Multiple SNARE interactions of an SM 
protein: Sed5p/Sly1p binding is dispensable for transport. Embo J. 23: 3939-
3949. 
PEVSNER J, HSU SC, SCHELLER RH. (1994) N-sec1 - a neural-specific Syntaxin-
binding protein. Proc Nat Acad Sci USA 91: 1445-1449. 
PIPER RC, HESS LJ, JAMES DE. (1991) Differential sorting of two glucose 
transporters expressed in insulin-sensitive cells. Am J Physiol. 260: C570-580. 
POLGÁR J, LANE WS, CHUNG SH, HOUNG AK, REED GL. (2003) 
Phosphorylation of SNAP-23 in activated human platelets. J Biol Chem. 278: 
44369-44376. 
PORTIS A, NEWTON C, PANGBORN W, PAPAHADJOPOULOS D. (1979) 
Studies on the mechanism of membrane fusion: evidence for an 
intermembrane Ca2+-phospholipid complex, synergism with Mg2+, and 
inhibition by Spectrin. Biochem. 18: 780-790. 
Kimberley Boney, 2013  152 
 
RAMM G, SLOT JW, JAMES DE, STOORVOGEL W. (2000) Insulin recruits 
GLUT4 from specialized VAMP2-carrying vesicles as well as from the 
dynamic endosomal/trans-Golgi network in rat adipocytes. Mol Biol Cell 11: 
4079-4091. 
RAND RP. (1981) Interacting phospholipid-bilayers - measured forces and induced 
structural-changes. Ann Rev Biophys Bioeng. 10: 277-314. 
RANDHAWA VK, BILAN PJ, KHAYAT ZA, DANEMAN N, LIU Z, RAMLAL T, 
VOLCHUK A, PENG XR, COPPOLA T, REGAZZI R, TRIMBLE WS, KLIP 
A. (2000) VAMP2, but not VAMP3/Cellubrevin, mediates insulin-
dependent incorporation of GLUT4 into the plasma membrane of L6 
myoblasts. Mol Biol Cell 11: 2403-2417. 
RAVICHANDRAN V, CHAWLA A, ROCHE PA. (1996) Identification of a novel 
syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23, expressed 
in non-neuronal tissues. J Biol Chem. 271: 13300-13303. 
REA S, MARTIN LB, MCINTOSH S, MACAULAY SL, RAMSDALE T, BALDINI 
G, JAMES DE. (1998) Syndet, an adipocyte target SNARE involved in the 
insulin-induced translocation of GLUT4 to the cell surface. J Biol Chem. 273: 
18784-18792. 
RICKMAN C, MEDINE CN, BERGMANN A, DUNCAN RR. (2007) Functionally 
and spatially distinct modes of Munc18-Syntaxin 1 interaction. J Biol Chem. 
282: 12097-12103. 
RIGAUD JL, LÉVY D. (2003) Reconstitution of membrane proteins into 
liposomes. Methods Enzymol. 372: 65-86. 
RODKEY TL, LIU S, BARRY M, MCNEW JA. (2008) Munc18a scaffolds SNARE 
assembly to promote membrane fusion. Mol Biol Cell 19: 5422-5434. 
ROSSI G, SALMINEN A, RICE LM, BRÜNGER AT, BRENNWALD P. (1997) 
Analysis of a yeast SNARE complex reveals remarkable similarity to the 
neuronal SNARE complex and a novel function for the C-terminus of the 
SNAP-25 homolog, Sec9. J Biol Chem. 272: 16610-16617. 
SALZBERG A, COHEN N, HALACHMI N, KIMCHIE Z, LEV Z. (1993) The 
drosophila-Ras2 and Rop gene pair - a dual homology with a yeast Ras-like 
gene and a suppressor of its loss-of-function phenotype. Development 117: 
1309-1319. 
SCHIAVO G, SHONE CC, BENNETT MK, SCHELLER RH, MONTECUCCO C. 
(1995) Botulinum neurotoxin type C cleaves a single Lys-Ala bond within 
the carboxyl-terminal region of Syntaxins. J Biol Chem. 270: 10566-10570. 
 
Kimberley Boney, 2013  153 
 
SCHOLLMEIER Y, KRAUSE JM, KREYE S, MALSAM J, SÖLLNER TH. (2011) 
Resolving the function of distinct Munc18-1/SNARE protein interaction 
modes in a reconstituted membrane fusion assay. J Biol Chem. 286: 30582-
30590. 
SCHRAW TD, LEMONS PP, DEAN WL, WHITEHEART SW. (2003) A role for 
Sec1/Munc18 proteins in platelet exocytosis. Biochem J. 374: 207-217. 
SCHUETTE CG, HATSUZAWA K, MARGITTAI M, STEIN A, RIEDEL D, 
KÜSTER P, KÖNIG M, SEIDEL C, JAHN R. (2004) Determinants of 
liposome fusion mediated by synaptic SNARE proteins. Proc Natl Acad Sci 
USA 101: 2858-2863. 
SCOTT BL, VAN KOMEN J, LIU S, WEBER T, MELIA TJ, MCNEW JA. (2003) 
Liposome fusion assay to monitor intracellular membrane fusion machines. 
Liposomes 372: 274-300. 
SCOTT BL, VAN KOMEN JS, IRSHAD H, LIU S, WILSON KA, MCNEW JA. 
(2004) Sec1p directly stimulates SNARE-mediated membrane fusion in 
vitro. J Cell Biol. 167: 75-85. 
SHEN J, TARESTE DC, PAUMET F, ROTHMAN JE, MELIA TJ. (2007) Selective 
activation of cognate SNAREpins by Sec1/Munc18 proteins. Cell 128: 183-
195. 
SHEWAN AM, VAN DAM EM, MARTIN S, LUEN TB, HONG W, BRYANT NJ, 
JAMES DE. (2003) GLUT4 recycles via a trans-Golgi network (TGN) 
subdomain enriched in Syntaxins 6 and 16 but not TGN38: involvement of 
an acidic targeting motif. Mol Biol Cell 14: 973-986. 
SIEBER JJ, WILLIG KI, HEINTZMANN R, HELL SW, LANG T. (2006) The 
SNARE motif is essential for the formation of Syntaxin clusters in the 
plasma membrane. Biophys J. 90: 2843-2851. 
SIMONSEN A, BREMNES B, RONNING E, AASLAND R, STENMARK H. (1998) 
Syntaxin-16, a putative Golgi t-SNARE. Euro J Cell Biol. 75: 223-231. 
SLOT JW, GEUZE HJ, GIGENGACK S, LIENHARD GE, JAMES DE. (1991) 
Immuno-localization of the insulin regulatable glucose transporter in 
brown adipose tissue of the rat. J Cell Biol. 113: 123-135. 
SMITHERS NP, HODGKINSON CP, CUTTLE M, SALE GJ. (2008) Insulin-
triggered repositioning of Muncl8c on Syntaxin-4 in GLUT4 signalling. 
Biochem J. 410: 255-260. 
SMYTH AM, RICKMAN C, DUNCAN RR. (2010) Vesicle fusion probability is 
determined by the specific interactions of munc18. J Biol Chem. 285: 38141-
38148. 
Kimberley Boney, 2013  154 
 
SÖLLNER T, WHITEHART SW, BRUNNER M, ERDJUMENTBROMAGE H, 
GEROMANOS S, TEMPST P, ROTHMAN JE. (1993) SNAP receptors 
implicated in vesicle targeting and fusion. Nature 362: 318-324. 
SÖLLNER T, BENNETT MK, WHITEHEART SW, SCHELLER RH, ROTHMAN 
JE. (1993b) A protein assembly-disassembly pathway in vitro that may 
correspond to sequential steps of synaptic vesicle docking, activation, and 
fusion. Cell 75: 409-418. 
ST-DENIS JF, CABANIOLS JP, CUSHMAN SW, ROCHE PA. (1999) SNAP-23 
participates in SNARE complex assembly in rat adipose cells. Biochem J. 338: 
709-715. 
STEEGMAIER M, YANG B, YOO JS, HUANG B, SHEN M, YU S, LUO Y, 
SCHELLER RH. (1998) Three novel proteins of the Syntaxin/SNAP-25 
family. J Biol Chem. 273: 34171-34179. 
STEIN A, WEBER G, WAHL MC, JAHN R. (2009) Helical extension of the 
neuronal SNARE complex into the membrane. Nature  460: 525-528. 
STENKULA KG, LIZUNOV VA, CUSHMAN SW, ZIMMERBERG J. (2010) 
Insulin controls the spatial distribution of GLUT4 on the cell surface 
through regulation of its postfusion dispersal. Cell Metab. 12: 250-259. 
STORLIEN LH, PAN DA, KRIKETOS AD, O'CONNOR J, CATERSON ID, 
COONEY GJ, JENKINS AB, BAUR LA. (1996) Skeletal muscle membrane 
lipids and insulin resistance. Lipids 31: S261-265. 
STROP P, KAISER SE, VRLJIC M, BRUNGER AT. (2008) The structure of the 
yeast plasma membrane SNARE complex reveals destabilizing water-filled 
cavities. J Biol Chem. 283: 1113-1119. 
STRUCK DK, HOEKSTRA D, PAGANO RE. (1981) Use of resonance energy-
transfer to monitor membrane-fusion. Biochem. 20: 4093-4099. 
STRYER L. (1978) Fluorescence energy transfer as a spectroscopic ruler. Annu Rev 
Biochem. 47: 819-846. 
SÜDHOF TC. (1995) The synaptic vesicle cycle - a cascade of protein-protein 
interactions. Nature 375: 645-653. 
SUGITA S, JANZ R, SÜDHOF TC. (1999) Synaptogyrins regulate Ca2+-dependent 
exocytosis in PC12 cells. J Biol Chem. 274: 18893-18901. 
SUMITANI S, RAMLAL T, LIU Z, KLIP A. (1995) Expression of Syntaxin 4 in rat 
skeletal muscle and rat skeletal muscle cells in culture. Biochem Biophys Res 
Commun. 213: 462-468. 
Kimberley Boney, 2013  155 
 
SUTTON RB, FASSHAUER D, JAHN R, BRUNGER AT. (1998) Crystal structure 
of a SNARE complex involved in synaptic exocytosis at 2.4 angstrom 
resolution. Nature 395: 347-353. 
SUURKUUSK J, LENTZ BR, BARENHOLZ Y, BILTONEN RL, THOMPSON TE. 
(1976) A calorimetric and fluorescent probe study of the gel-liquid 
crystalline phase transition in small, single-lamellar 
dipalmitoylphosphatidylcholine vesicles. Biochem. 15: 1393-1401. 
SUZUKI K, KONO T. (1980) Evidence that insulin causes translocation of 
glucose-transport activity to the plasma-membrane from an intracellular 
storage site. Proc Nat Acad Sci USA 77: 2542-2545. 
TANIGUCHI CM, EMANUELLI B, KAHN CR. (2006) Critical nodes in signalling 
pathways: insights into insulin action. Nat Rev Mol Cell Biol. 7: 85-96. 
TELLAM JT, MACAULAY SL, MCINTOSH S, HEWISH DR, WARD CW, JAMES 
DE. (1997) Characterization of Munc-18c and Syntaxin-4 in 3T3-L1 
adipocytes - Putative role in insulin-dependent movement of GLUT-4. J Biol 
Chem. 272: 6179-6186. 
TELLAM JT, MCINTOSH S, JAMES DE. (1995) Molecular-identification of 2 
novel Munc-18 isoforms expressed in nonneuronal tissues. J Biol Chem. 270: 
5857-5863. 
TENG FYH, WANG Y, TANG BL. (2001) The Syntaxins. Genome Biol. 2: 7. 
THURMOND DC, CERESA BP, OKADA S, ELMENDORF JS, COKER K, PESSIN 
JE. (1998) Regulation of insulin-stimulated GLUT4 translocation by 
Munc18c in 3T3L1 adipocytes. J Biol Chem. 273: 33876-33883. 
THURMOND DC, KANZAKI M, KHAN AH, PESSIN JE. (2000) Munc18c 
function is required for insulin-stimulated plasma membrane fusion of 
GLUT4 and insulin-responsive amino peptidase storage vesicles. Mol Cell 
Biol. 20: 379-388. 
TOGNERI J, CHENG YS, MUNSON M, HUGHSON FM, CARR CM. (2006) 
Specific SNARE complex binding mode of the Sec1/Munc-18 protein, Sec1p. 
Proc Natl Acad Sci USA 103: 17730-17735. 
UMAHARA M, OKADA S, YAMADA E, SAITO T, OHSHIMA K, HASHIMOTO 
K, YAMADA M, SHIMIZU H, PESSIN JE, MORI M. (2008) Tyrosine 
phosphorylation of Munc18c regulates platelet-derived growth factor-
stimulated glucose transporter 4 translocation in 3T3L1 adipocytes. Endocr. 
149: 40-49. 
 
Kimberley Boney, 2013  156 
 
VERHAGE M, MAIA AS, PLOMP JJ, BRUSSAARD AB, HEEROMA JH, 
VERMEER H, TOONEN RF, HAMMER RE, VAN DEN BERG TK, 
MISSLER M, GEUZE HJ, SÜDHOF TC. (2000) Synaptic assembly of the 
brain in the absence of neurotransmitter secretion. Science 287: 864-869. 
VESSBY B. (2000) Dietary fat and insulin action in humans. Br J Nutr. 83: S91-96. 
VICOGNE J, PESSIN JE. (2008) SNARE-mediated fusion of liposomes. Methods Mol 
Biol. 457: 241-251. 
VOLCHUK A, WANG Q, EWART HS, LIU Z, HE L, BENNETT MK, KLIP A. 
(1996) Syntaxin 4 in 3T3-L1 adipocytes: regulation by insulin and 
participation in insulin-dependent glucose transport. Mol Biol Cell 7: 1075-
1082. 
WATSON RT, PESSIN JE. (2000) Functional cooperation of two independent 
targeting domains in syntaxin 6 is required for its efficient localization in 
the trans-Golgi network of 3T3L1 adipocytes. J Biol Chem. 275: 1261-1268. 
WEBER T, ZEMELMAN BV, MCNEW JA, WESTERMANN B, GMACHL M, 
PARLATI F, SÖLLNER TH, ROTHMAN JE. (1998) SNAREpins: Minimal 
machinery for membrane fusion. Cell 92: 759-772. 
WEIDMAN PJ, MELANÇON P, BLOCK MR, ROTHMAN JE. (1989) Binding of 
an N-ethylmaleimide-sensitive fusion protein to Golgi membranes requires 
both a soluble protein(s) and an integral membrane receptor. J Cell Biol. 108: 
1589-1596. 
WILLIAMS D, PESSIN JE. (2008) Mapping of R-SNARE function at distinct 
intracellular GLUT4 trafficking steps in adipocytes. J Cell Biol. 180: 375-387. 
WILSON DW, WILCOX CA, FLYNN GC, CHEN E, KUANG WJ, HENZEL WJ, 
BLOCK MR, ULLRICH A, ROTHMAN JE. (1989) A fusion protein required 
for vesicle-mediated transport in both mammalian cells and yeast. Nature 
339: 355-259. 
WIMMER C, HOHL TM, HUGHES CA, MÜLLER SA, SÖLLNER TH, ENGEL A, 
ROTHMAN JE. (2001) Molecular mass, stoichiometry, and assembly of 20S 
particles. J Biol Chem. 276: 29091-29097. 
WOLF DE, WINISKI AP, TING AE, BOCIAN KM, PAGANO RE. (1992) 
Determination of the transbilayer distribution of fluorescent lipid analogues 
by nonradiative fluorescence resonance energy transfer. Biochem. 31: 2865-
2873. 
XU Y, SEVEN AB, SU L, JIANG QX, RIZO J. (2011) Membrane bridging and 
hemifusion by denaturated Munc18. PLoS One 6: e22012. 
Kimberley Boney, 2013  157 
 
YANG B, STEEGMAIER M, GONZALEZ LC, SCHELLER RH. (2000) nSec1 binds 
a closed conformation of syntaxin1A. J Cell Biol. 148: 247-252. 
YANG C, COKER KJ, KIM JK, MORA S, THURMOND DC, DAVIS AC, YANG B, 
WILLIAMSON RA, SHULMAN GI, PESSIN JE. (2001) Syntaxin 4 
heterozygous knockout mice develop muscle insulin resistance. J Clin Invest. 
107: 1311-1318. 
YANG Y, XIA Z, LIU Y. (2000) SNAP-25 functional domains in SNARE core 
complex assembly and glutamate release of cerebellar granule cells. J Biol 
Chem. 275: 29482-29487. 
YASSINE W, MILOCHAU A, BUCHOUX S, LANG J, DESBAT B, ODA R. (2010) 
Effect of monolayer lipid charges on the structure and orientation of protein 
VAMP 1 at the air-water interface. Biochim Biophys Acta 1798: 928-937. 
ZHAO P, YANG L, LOPEZ JA, FAN J, BURCHFIELD JG, BAI L, HONG W, XU T, 
JAMES DE. (2009) Variations in the requirement for v-SNAREs in GLUT4 
trafficking in adipocytes. J Cell Sci. 122: 3472-3480. 
ZILLY FE, SORENSEN JB, JAHN R, LANG T. (2006) Munc18-bound syntaxin 
readily forms SNARE complexes with synaptobrevin in native plasma 
membranes. Plos Biol. 4: 1789-1797. 
ZIMMERBERG J, VOGEL SS, CHERNOMORDIK LV. (1993) Mechanisms of 
membrane-fusion. Ann Rev Biophys Biomol Struct. 22: 433-466. 
 
Kimberley Boney, 2013  158 
 
7 Appendices 
7.1 Oligonuleotides used in this study 
Oligo name Sequence (5’ 3’) 
NheINHisM18c GCTAGCCGCCGCCGGTATCGGAGC 
XhoISTOPNHisM18c CTCGAGTTACTCATCCTTAAAGGAAACTTT
ATCCTTTG 
NcoICHisM18c CCATGGCGCCGCCGGTATCGGAGC 
XhoICHisM18c CTCGAGCTCATCCTTAAAGGAAACTTTATC
CTTTG 
E63KM18c_F CTAGAGGAGGCCATAACTGTTATAAAGAA
TATTTATAAGAATCGTGAACCTGTC 
E63KM18c_R GACAGGTTCACGATTCTTATAAATATTCTT
TATAACAGTTATGCCCTCCTCTAG 
E70AM18c_F GTTATAGAGAATATTTATAAGAATCGTGCA
CCTGTCAGACAAATGAAAGCTCTT 
E70AM18c_R AAGAGCTTTCATTTGTCTGACAGGTGCAC
GATTCTTATAAATATTCTCTATAAC 
D222NM18c_F CTTGAAGACTACTACAAAATTAATGAAAAA
GGCCTAATAAAGGGT 
D222NM18c_R ACCCTTTATTAGGCCTTTTTCATTAATTTT
GTAGTAGTCTTCAAG 
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7.2 Raw Fluorescence for in vitro fusion assay 
7.2.1 Supplementary figures for Chapter 3 
 
Figure I  Raw fluorescence for Figure 3.7 
45 l t-SNARE and 5 l v-SNARE liposomes were incubated overnight at 4 °C in the 
presence (black circles) or absence (red squares) of the cytosolic domain of VAMP 2, before 
analysis of fusion. Raw fluorescence data was exported from Microsoft Excel and imported to 
KaleidaGraph software (Synergy systems) for analysis. Raw fluorescence readings are 
presented here: data is shown before normalisation or adjustment to 100 % detergent signal. 
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Figure II Raw fluorescence for Figure 3.12 
45 l t-SNARE and 5 l v-SNARE liposomes were incubated overnight at 4 °C in the 
presence (black circles) or absence (red squares) of the cytosolic domain of VAMP 2, before 
analysis of fusion. Raw fluorescence data was exported from Microsoft Excel and imported to 
KaleidaGraph software (Synergy systems) for analysis. Raw fluorescence readings are 
presented here: data is shown before normalisation or adjustment to 100 % detergent signal.
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Figure III Raw fluorescence for Figure 3.13(B) 
45 l t-SNARE and 5 l v-SNARE liposomes were incubated overnight at 4 °C in the 
presence (black circles) or absence (red squares) of the cytosolic domain of VAMP 2, before 
analysis of fusion. Raw fluorescence data was exported from Microsoft Excel and imported to 
KaleidaGraph software (Synergy systems) for analysis. Raw fluorescence readings are 
presented here: data is shown before normalisation or adjustment to 100 % detergent signal. 
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7.2.2 Supplementary figures for Chapter 4 
 
Figure IV  Raw fluorescence for Figure 4.4 
45 l t-SNARE and 5 l either protein-free (black circles) or v-SNARE liposomes 
(triangles/squares) were incubated overnight at 4 °C in the presence of wild-type NHis6 
(purple triangles) or CHis6 (green triangles) Munc-18c before analysis of fusion. Raw 
fluorescence data was exported from Microsoft Excel and imported to KaleidaGraph software 
(Synergy systems) for analysis. Raw fluorescence readings are presented here: data is shown 
before normalisation or adjustment to 100 % detergent signal. 
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Figure V Raw fluorescence for Figure 4.8 
45 l t-SNARE and 5 l either protein-free (black circles) or v-SNARE liposomes 
(triangles/squares) were incubated overnight at 4 °C. (A) E63K (B) E70A or (C) D222N 
Munc-18c was added to wells before analysis of fusion. Raw fluorescence data was exported 
from Microsoft Excel and imported to KaleidaGraph software (Synergy systems) for analysis. 
Raw fluorescence readings are presented here: data is shown before normalisation or 
adjustment to 100 % detergent signal. 
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Figure 7.1 Raw Fluorescence for Figure 4.10 
45 µl t-SNARE and either 5µl protein-free (black circles) or v-SNARE liposomes 
(triangles/squares) were incubated together overnight at 4°C. N- (purple triangles) or C-
terminally (green triangles) tagged wild-type Munc-18c was added to separate experimental 
wells before analysis of fusion. Raw fluorescence data was exported from Microsoft Excel and 
imported to KaleidaGraph software (Synergy systems) for analysis. Raw fluorescence readings 
are presented here: data is shown before normalisation or adjustment to 100 % detergent 
signal. 
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7.2.3 Supplementary figures for Chapter 5 
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Figure VII Raw Fluorescence for Figure 5.3 
Basal or insulin-stimulated plasma membrane was isolated from 3T3-L1 adipocytes, and 
reconstituted into liposomes. 45 µl of each liposome population was incubated overnight with 
5 µl protein-free liposomes (black circles), or with 5 µl v-SNARE liposomes in the presence 
(green squares) or absence (red squares) of cytosolic VAMP 2. The next day, the plate was 
warmed to reaction temperature and the fusogenic ability of (A) basal (B) 2 minute insulin-
stimulated or (C) 15 minute insulin-stimulated plasma membrane was assessed. Raw 
fluorescence data was exported from Microsoft Excel and imported to KaleidaGraph software 
(Synergy systems) for analysis. Raw fluorescence readings are presented here: data is shown 
before normalisation or adjustment to 100 % detergent signal. 
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Figure 7.2 Raw Fluorescence for Figure 5.4 
45 µl liposome derived from basal and insulin-stimulated (A) 0.3 mg/ml or (B) 0.75 mg/ml 
plasma membrane were incubated overnight with either protein-free (black symbols) or 
VAMP 2 vesicles (red symbols). After warming to reaction temperature, the fusogenic ability 
of the basal and insulin-stimulated plasma membrane was assessed. Raw fluorescence data 
was exported from Microsoft Excel and imported to KaleidaGraph software (Synergy 
systems) for analysis. Raw fluorescence readings are presented here: data is shown before 
normalisation or adjustment to 100 % detergent signal. 
